• SHOP
      • COMBOS
      • TESTIMONIALS
      • CART
      • INGREDIENTS
        • 2-DEOXY-D-GLUCOSE (2DG)
        • ACACIA CYANOPHYLLA FLOWER
        • ACORI GRAMINEI RHIZOMA
        • AEGLE MARMELOS CORREA
        • AGARICUS BLAZEI
        • AGED GARLIC EXTRACT
        • AFRAMOMUM MELEGUETA
        • ALOE ARBORESCENS
        • ALBIZIA
        • ALPINIA OFFICINARUM
        • ALTERNANTHERA SESSILIS
        • AMERICAN GINSENG
        • AMYGDALIN
        • ANACYCLUS PYRETHRUM
        • ANGELICA ARCHANGELICA
        • ANGELICA SINENSIS
        • ANTRODIA
        • ARTICHOKE LEAF
        • ARTOCARPIN
        • AJUGA TURKESTANICA
        • ASHWAGANDHA
        • ASPALATHIN
        • ASTRAGALUS COMPLANATUS
        • AVENA SATIVA
        • BACOPA MONNIERI
        • BAVACHIN
        • BEE POLLEN
        • BETULINIC ACID
        • BOSWELLIC ACID
        • BREVILIN A
        • CAMPESTEROL
        • CAPSAICIN
        • CARCININE
        • CASTICIN
        • CHRYSIN
        • CIANIDANOL
        • CINNAMOMUM ZEYLANICUM
        • CITRULLUS COLOCYNTHIS
        • CITRUS RETICULATA PEEL
        • CODONOPSIS
        • CONJUGATED LINOLEIC ACID
        • COSTUNOLIDE
        • CYANIDIN
        • CUCURBITACIN D
        • DAIDZEIN
        • DECURSIN
        • DELPHINIDIN
        • DIGITALIS PURPREA (DIGOXIN)
        • DIOSMIN
        • ECKLONIA CAVA
        • ELLAGIC ACID
        • EMBELIN
        • ERIODICTYOL
        • GALLIC ACID
        • GLYCITEIN
        • GLYCYRRHIZIN
        • HYPERFORIN
        • ICARIIN
        • ISORHAMNETIN
        • ISOORIENTIN
        • ISOVITEXIN
        • JACEOSIDIN
        • KAEMPFEROL
        • KIGELIA AFRICANA
        • KURARINONE
        • LEMON BALM
        • LICORICIDIN
        • LIPOIC ACID
        • LUPEOL
        • MAGNOLOL
        • MENAQUINONE 4
        • MULBERRY LEAF
        • NARINGENIN
        • NOBILETIN
        • OLEACEIN
        • OLEANOLIC ACID
        • OLIVE OIL
        • ORIDONIN
        • PARTHENOLIDE
        • PHLOROGLUCINOL
        • PHLORIZIN
        • PICEATANNOL
        • PRISTIMERIN
        • PROANTHOCYANIDINS
        • PROCYANIDIN B3
        • PSEUDOLARIC ACID B
        • PTEROSTILBENE
        • RUTIN
        • SOLIDAGO VIRGAUREA
        • TANGERETIN
        • TARAXASTEROL
        • TRICHOSTATIN A
        • WEDELOLACTONE
        • WOGONIN
        • YERBA MATE
      • ABOUT
      • SCIENTIFIC STUDIES
        • ADAPTOGENS
        • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
        • ADDICTION & THE BRAIN
        • ADDICTION & STRESS
        • ADDICTION WITHDRAWAL
        • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
        • ADIPOCYTE DIFFERENTIATION
        • ADROPIN
        • ALLERGIES & CYTOKINES
        • ALDOSTERONE & OBESITY/HYPERTENSION
        • ALZHEIMER’S, DEMENTIA, PARKINSON’S
        • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
        • ADVANCED GLYCATION END PRODUCTS (AGES)
        • ADDICTION TREATMENT
        • ADDICTION & DOPAMINE
        • AMPK
        • ANTI AGING
        • ANTIAGING EFFECTS OF COFFEE
        • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI-APOPTOTIC PATHWAYS
        • ANTI ATHEROGENIC
        • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI CARIOGENIC (Protecting From Tooth Decay)
        • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
        • ANTI GLYCATIVE
        • ANTI GLYCATION AGENTS
        • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI WRINKLE AGENTS
        • ANXIOGENIC
        • ANXIOLYTIC
        • APOPTOSIS
        • APOPTOSIS IN 3T3-L1
        • AUTOPHAGY
        • BCL-2
        • BCL-W
        • BCL-XL
        • BDNF
        • BECLIN-1 & AUTOPHAGY
        • BH3 MIMETICS
        • BIM aka BCL2L11
        • BIOMIMETIC HYDROXYAPATITE
        • BMI-1
        • BPA & OBESITY
        • BRASSINOSTEROIDS
        • CALORIE RESTRICTION
        • CALORIE RESTRICTION & LIFESPAN EXTENSION
        • CARBAMYLATION
        • CARBONYL SCAVENGER
        • CARBONYL STRESS
        • CARDIOPROTECTIVE AGENTS
        • CARDIAC GLYCOSIDES
        • CATALASE
        • CELL CYCLE ARREST
        • CENTENARIANS
        • CDK5
        • CHOLESTEROL EFFLUX
        • COGNITIVE ENHANCEMENT
        • COLD SHOCK PROTEINS
        • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
        • CONDITIONED PLACE PREFERENCE
        • CORTICOTROPIN RELEASING FACTOR
        • COSMECEUTICAL
        • CRYOTHERAPY
        • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
        • CYP2E1
        • CYTOKINES IN PAIN, INFLAMMATION & AGING
        • DAF-16
        • DEPERSONALIZATION
        • DIABETES & CANCER
        • DIHYDROTESTOSTERONE (DHT)
        • DNA METHYLATION & AGING
        • DNA REPAIR
        • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
        • DRY FASTING AND FLUID RESTRICTION FASTING
        • DYNORPHIN
        • ELLAGITANNINS
        • ENDOCRINE DISRUPTING CHEMICALS
        • ENLARGED HEART AND CARDIOMEGALY
        • EPIGENETIC ALTERATIONS
        • EPIGENETIC MODIFIERS
        • EPINEPHRINE
        • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
        • EXCITOXICITY & THE BRAIN
        • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
        • EXTRACELLULAR MICROVESICLES
        • EXTENDS LIFESPAN
        • EXTINCTION TRAINING
        • FASTING & THE BRAIN
        • FASTING & CANCER
        • FASTING MIMICKING DIET
        • FEAR EXTINCTION
        • FGF21
        • FLAVONES
        • GABA (γ-AMINOBUTYRIC ACID)
        • GALLOTANNINS
        • GLUCONEOGENESIS
        • GLUCOCORTICOID RECEPTOR ACTIVATION
        • GLUTAMATE & BRAIN
        • GLYCATION
        • GUT BRAIN AXIS
        • GYPENOSIDE
        • KLOTHO
        • K OPIOD RECEPTOR & ADDICTION
        • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
        • FGF21
        • FOXO3
        • FOXO4
        • HALLMARKS OF AGING
        • HAIR GROWTH
        • HAIR REGENERATION
        • HAIR REPIGMENTATION
        • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
        • HMGB1
        • HORMESIS
        • HPA AXIS
        • HSP70, THE ANTI-AGING PROTEIN
        • HSP90 INHIBITORS
        • HYPERGLYCEMIA
        • HYPERALGESIA
        • HYPERINSULINEMIA
        • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
        • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
        • HYPOCRETIN OREXIN
        • IKK
        • IL-6/STAT3
        • IRISIN
        • ISOFLAVONES
        • IMMUNOSENESCENCE
        • INHIBITION OF ADVANCED GLYCATION END PRODUCTS
        • INCREASE PROTEIN SYNTHESIS
        • INCREASES SPERMATOGENESIS
        • INFECTOBESITY
        • INFLAMMATION & ANXIETY
        • INFLAMMATION & CANCER
        • INFLAMMATION & DEPRESSION
        • INFLAMMATION & OBESITY
        • INFLAMMAGING
        • INHIBITION OF RENAL GLUCOSE REABSORPTION
        • INSULIN & AGING
        • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
        • INSULIN & MTOR
        • INSULIN & OBESITY
        • INSULIN OXIDATIVE STRESS
        • INTERMITTENT FASTING
        • JAK INHIBITION ALLEVIATES SASP
        • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
        • KETONE BODIES
        • KETOGENIC DIET
        • LACTOBACILLUS REUTERI
        • LACTOFERRIN
        • LEYDIG CELL STEROIDOGENESIS
        • LIFESPAN EXTENSION
        • LIVER REGENERATION
        • LIPOLYTIC AGENTS
        • LIPID DROPLETS
        • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
        • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
        • MATRIX METALLOPROTEINASES (MMPs)
        • MCL-1
        • MDM2 INHIBITION AS SASP INHIBITOR
        • MEDICINAL MUSHROOMS
        • MEDITERRANEAN DIET
        • METABOLIC REPROGRAMMING
        • METABOLIC SYNDROME
        • METHIONINE RESTRICTION
        • MITOCHONDRIAL UNCOUPLING
        • MONKEYPOX
        • MSG (MONOSOSODIUM GLUTAMATE)
        • MUSCLE FORCE PRODUCTION
        • MUSCLE ATROPHY (PREVENTING)
        • MYOGENESIS
        • MYOSTATIN INHIBITION
        • MYOSTATIN INHIBITION PRESERVES MUSCLE
        • mTORC2
        • mTOR: THE RAPID AGING PATHWAY
        • NATURAL ANTICOAGULANTS
        • NATURAL AROMATASE INHIBITORS
        • NEUROGENESIS (GROWING NEW BRAIN CELLS)
        • NEUROCHEMISTRY OF ADDICTION
        • NEUROPLASTICITY
        • NEUROINFLAMMATION
        • NEUROPROTECTIVE AGENTS
        • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
        • NMDA & ANXIETY & DEPRESSION
        • NMDA RECEPTOR & FEAR
        • NON OPIOD ANALGESICS
        • NOOTROPICS
        • NORADRENERGIC
        • NOREPINEPHRINE
        • NRF2: MASTER REGULATOR OF THE AGING PROCESS
        • NF-KB
        • NUTRACEUTICAL
        • OBESOGENS
        • ONCOGENE ACTIVATION INDUCED SENESCENCE
        • ORGANOTINS
        • OVERNUTRITION
        • OXIDATIVE STRESS & AGING
        • P16INK4A
        • P38MAPK
        • P53: TUMOR SUPRESSOR
        • PERIODONTITIS
        • PHOSPHATIDYLINOSITOL 3 KINASE
        • PHYTOCHEMICALS
        • PHYTOSTEROLS
        • PHYTOSTANOLS
        • PHYTOECDYSTEROIDS
        • PROANTHOCYANIDINS
        • PROTEIN CARBONYLATION
        • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
        • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
        • PPARY2
        • PREMATURE SENESCENCE
        • PREVENTING SKIN AGING
        • PUFAS
        • PURGATIVES
        • RADIATION EXTRACT
        • RAPAMYCIN (MTOR INHIBITION)
        • RED WINE
        • RENAL (KIDNEY) PROTECTIVE AGENTS
        • REMINERALIZATION OF TEETH
        • REMYELINATION
        • REPAIR OF DNA BREAKS “DOUBLE STRAND”
        • RESTORE INSULIN SENSITIVITY
        • REVERSAL OF OBESITY
        • SASP & ADIPOSE TISSUE
        • SEX HORMONE BINDING GLOBULIN
        • SENESCENT CELLS, SASP & SENOLYTICS
        • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
        • SGLT2 INHIBITORS
        • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
        • SHBG
        • SIRT1
        • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
        • SKIN ELASTICITY
        • SKIN PHOTOAGING (Preventing & Repairing)
        • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
        • SIRT1 & LONGEVITY
        • SMALLPOX
        • SUGAR & AGING
        • STAR PROTEIN
        • STAT3
        • STEM CELL EXHAUSTION
        • STEM CELL REGENERATION
        • STEM CELL THERAPY
        • STIMULATED LIPOLYSYS
        • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
        • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
        • STRESS & AGING
        • STRESS & THE BRAIN
        • TELOMERE SHORTENING & PREMATURE AGING
        • TIME RESTRICTED FEEDING
        • THROMBOLYTICS (PLANT BASED)
        • TRAUMATIC BRAIN INJURY (HEALING)
        • TRYPTOPHAN HYDROXYLASE 2
        • VISCERAL ADIPOSITY
        • XENOBIOTICS
        • XENOESTROGEN
      • HOME
      • CONTACT
      • TELEGRAM PORTAL
      • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
      • The Ultimate Dry Fasting Resource
      0
      blank
      REVERSAL OF OBESITY
      September 23, 2022
      blank
      ORGANOTINS
      September 23, 2022
      1. Phosphatidylinositol 3‐kinase
      2. Activation of Phosphatidylinositol 3–kinase by insulin.
      3. The activation of Phosphatidylinositol 3–kinase by Ras
      4. Association of focal adhesion kinase with its potential substrate Phosphatidylinositol 3–kinase.
      5. Phosphatidylinositol 3–kinase related kinases
      6. Phosphatidylinositol 3–kinase Encoded by Yeast VPS34 Gene Essential for Protein Sorting
      7. Phosphatidylinositol 3–kinase: structure and expression of the 110 kd catalytic subunit
      8. Wortmannin is a potent Phosphatidylinositol 3–kinase inhibitor: the role of Phosphatidylinositol 3, 4, 5-trisphosphate in neutrophil responses
      9. Requirement for Phosphatidylinositol–3 kinase in the prevention of apoptosis by nerve growth factor
      10. Ras-dependent induction of cellular responses by constitutively active Phosphatidylinositol–3 kinase
      11. Activation of Phosphatidylinositol–3′ kinase by Src-family kinase SH3 binding to the p85 subunit
      12. Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation.
      13. A human Phosphatidylinositol 3‐kinase complex related to the yeast Vps34p‐Vps15p protein sorting system.
      14. Wortmannin, a potent and selective inhibitor of Phosphatidylinositol–3–kinase
      15. A specific inhibitor of Phosphatidylinositol 3–kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
      16. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated Phosphatidylinositol 3–kinase
      17. Membrane localization of Phosphatidylinositol 3–kinase is sufficient to activate multiple signal-transducing kinase pathways
      18. The Phosphatidylinositol 3–kinase alpha is required for DNA synthesis induced by some, but not all, growth factors.
      19. Cloning of a novel, ubiquitously expressed human Phosphatidylinositol 3–kinase and identification of its binding site on p85
      20. Inhibition of Phosphatidylinositol 3–kinase activity by association with 14-3–3 proteins in T cells.
      21. Phosphatidylinositol 3‘kinase: one of the effectors of Ras
      22. Association of p21ras with Phosphatidylinositol 3–kinase.
      23. Interaction of Phosphatidylinositol 3–kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors
      24. ErbB3 is involved in activation of Phosphatidylinositol 3–kinase by epidermal growth factor
      25. Phosphatidylinositol–3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
      26. Activation of the Eck receptor protein tyrosine kinase stimulates Phosphatidylinositol 3–kinase activity.
      27. Phosphatidylinositol 3–kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation
      28. The inhibition of Phosphatidylinositol 3–kinase by quercetin and analogs
      29. Phosphatidylinositol 3–kinase inhibitors block differentiation of skeletal muscle cells
      30. Studies on the mechanism of Phosphatidylinositol 3–kinase inhibition by wortmannin and related analogs
      31. CD19 of B cells as a surrogate kinase insert region to bind Phosphatidylinositol 3–kinase
      32. DNA-dependent protein kinase catalytic subunit: a relative of Phosphatidylinositol 3–kinase and the ataxia telangiectasia gene product
      33. Involvement of Phosphatidylinositol 3–kinase in Fc gamma receptor signaling.
      34. The interaction of small domains between the subunits of Phosphatidylinositol 3–kinase determines enzyme activity
      35. Interkinase domain of kit contains the binding site for Phosphatidylinositol 3‘kinase.
      36. Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, Phosphatidylinositol 3‘-kinase, and protein kinase C.
      37. Mouse p170 is a novel Phosphatidylinositol 3–kinase containing a C2 domain
      38. Inhibition of the Phosphatidylinositol 3–kinase/p70S6-kinase pathway induces B16 melanoma cell differentiation
      39. Epidermal growth factor-dependent association of Phosphatidylinositol 3–kinase with the erbB3 gene product.
      40. The structure and function of p55PIK reveal a new regulatory subunit for Phosphatidylinositol 3–kinase
      41. Phosphatidylinositol 3–kinase and its novel product, Phosphatidylinositol 3-phosphate, are present in Saccharomyces cerevisiae
      42. Phosphatidylinositol 3–kinase Is an Early Intermediate in the Gβγ-mediated Mitogen-activated Protein kinase Signaling Pathway (∗)
      43. Phosphatidylinositol (3, 4, 5) P3 interacts with SH2 domains and modulates PI 3–kinase association with tyrosine-phosphorylated proteins
      44. Rac GTPase interacts specifically with Phosphatidylinositol 3–kinase
      45. The Phosphatidylinositol 3–kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin.
      46. Insulin stimulation of Phosphatidylinositol 3–kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.
      47. A novel recognition motif for Phosphatidylinositol 3–kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor
      48. In vitro and in vivo antitumor activity of the Phosphatidylinositol–3–kinase inhibitor, wortmannin.
      49. Essential role of Phosphatidylinositol 3–kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor …
      50. Activation of Phosphatidylinositol 3–kinase in cells expressing abl oncogene variants
      51. Regulation of Phosphatidylinositol 3–kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
      52. EGF or PDGF receptors activate atypical PKClambda through Phosphatidylinositol 3‐kinase.
      53. T-cell antigen CD28 interacts with the lipid kinase Phosphatidylinositol 3–kinase by a cytoplasmic Tyr (P)-Met-Xaa-Met motif.
      54. Investigation of neutrophil signal transduction using a specific inhibitor of Phosphatidylinositol 3–kinase.
      55. Evidence for Phosphatidylinositol 3–kinase as a regulator of endocytosis via activation of Rab5.
      56. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with Phosphatidylinositol 3–kinase.
      57. Insulin activates a p21-activated kinase in muscle cells via Phosphatidylinositol 3–kinase
      58. Phosphatidylinositol 3–kinase signals activate a selective subset of Rac/Rho-dependent effector pathways
      59. Inhibition of histamine secretion by wortmannin through the blockade of Phosphatidylinositol 3–kinase in RBL-2H3 cells.
      60. Phosphatidylinositol 3–kinase binds to α-actinin through the p85 subunit
      61. Phospholipase C-γ1 and Phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor’s mitogenic signal
      62. Identification of c‐erbB‐3 binding sites for Phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera.
      63. Akt Is a Direct Target of the Phosphatidylinositol 3–kinase: ACTIVATION BY GROWTH FACTORS, v-src and v-Ha-ras, IN Sf9 AND MAMMALIAN CELLS
      64. SH2 domains of the p85 alpha subunit of Phosphatidylinositol 3–kinase regulate binding to growth factor receptors
      65. Role for Phosphatidylinositol 3–kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells.
      66. Oligodendrocytes and their precursors require Phosphatidylinositol 3–kinase signaling for survival
      67. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the Phosphatidylinositol 3–kinase inhibitor, wortmannin
      68. Identification of Trk binding sites for SHC and Phosphatidylinositol 3‘-kinase and formation of a multimeric signaling complex.
      69. Phosphatidylinositol 3–kinase activity is required for early endosome fusion
      70. CTLA-4 binding to the lipid kinase Phosphatidylinositol 3–kinase in T cells.
      71. Wortmannin, a specific inhibitor of Phosphatidylinositol–3 kinase, blocks osteoclastic bone resorption
      72. Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of Phosphatidylinositol 3–kinase.
      73. Dominant missense mutations in a novel yeast protein related to mammalian Phosphatidylinositol 3–kinase and VPS34 abrogate rapamycin cytotoxicity
      74. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for Phosphatidylinositol 3‘kinase.
      75. Molecular cloning, cDNA sequence, and chromosomal localization of the human Phosphatidylinositol 3–kinase p110α (PIK3CA) gene
      76. Phosphatidylinositol 3–kinase Activity Is Required at a Postendocytic Step in Platelet-derived Growth Factor Receptor Trafficking∗
      77. Requirement of Phosphatidylinositol–3 kinase modification for its association with p60src
      78. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of Phosphatidylinositol 3–kinase.
      79. Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for Phosphatidylinositol 3 kinase.
      80. CD28 of T lymphocytes associates with Phosphatidylinositol 3–kinase
      81. The v-Src SH3 domain binds Phosphatidylinositol 3‘-kinase
      82. Signal transduction via CD40 involves activation of lyn kinase and Phosphatidylinositol–3–kinase, and phosphorylation of phospholipase C gamma 2.
      83. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of Phosphatidylinositol 3–kinase.
      84. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires Phosphatidylinositol 3–kinase
      85. Role of Phosphatidylinositol–3–kinase in insulin receptor signaling: studies with inhibitor, LY294002
      86. Identification of two SH3-binding motifs in the regulatory subunit of Phosphatidylinositol 3–kinase.
      87. Acute regulation by insulin of Phosphatidylinositol–3–kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle.
      88. Phosphatidylinositol 3‐kinase regulation of fluid phase endocytosis
      89. Phosphatidylinositol 3–kinase activation in normal human B lymphocytes.
      90. Wortmannin, a specific Phosphatidylinositol 3–kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells
      91. A Phosphatidylinositol–3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine
      92. Solution structure and ligand-binding site of the SH3 domain of the p85α subunit of Phosphatidylinositol 3–kinase
      93. Polyphosphoinositides produced by Phosphatidylinositol 3–kinase are poor substrates for phospholipases C from rat liver and bovine brain
      94. Stimulation of CD28 triggers an association between CD28 and Phosphatidylinositol 3–kinase in Jurkat T cells.
      95. A comparison of demethoxyviridin and wortmannin as inhibitors of Phosphatidylinositol 3‐kinase
      96. Activated Phosphatidylinositol 3–kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes
      97. Interactions of Cbl with Grb2 and Phosphatidylinositol 3‘-kinase in activated Jurkat cells
      98. Membrane Ig cross-linking regulates Phosphatidylinositol 3–kinase in B lymphocytes.
      99. Growth factor-dependent survival of rodent fibroblasts requires Phosphatidylinositol 3–kinase but is independent of pp70S6K activity.
      100. Selective CD28pYMNM mutations implicate Phosphatidylinositol 3–kinase in CD86-CD28-mediated costimulation
      101. Direct activation of the Phosphatidylinositol 3‘-kinase by the insulin receptor.
      102. Nerve growth factor promotes the activation of Phosphatidylinositol 3–kinase and its association with the trk tyrosine kinase.
      103. … factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or Phosphatidylinositol 3–kinase.
      104. Phosphorylation of middle T by pp60c-src: a switch for binding of Phosphatidylinositol 3–kinase and optimal tumorigenesis
      105. Activation of Src-like protein-tyrosine kinase Lyn and its association with Phosphatidylinositol 3–kinase upon B-cell antigen receptor-mediated signaling.
      106. Direct Association of Grb2 with the p85 Subunit of Phosphatidylinositol 3–kinase (∗)
      107. Overexpression of a constitutively active form of Phosphatidylinositol 3–kinase is sufficient to promote Glut 4 translocation in adipocytes
      108. Antagonists of Phosphatidylinositol 3–kinase block activation of several novel protein kinases in neutrophils
      109. Interleukin-2 triggers a novel Phosphatidylinositol 3–kinase-dependent MEK activation pathway
      110. GTPase-activating protein and Phosphatidylinositol 3–kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit
      111. Defect in skeletal muscle Phosphatidylinositol–3–kinase in obese insulin-resistant mice.
      112. Protein kinase C δ specifically associates with Phosphatidylinositol 3–kinase following cytokine stimulation
      113. p56Lck and p59Fyn regulate CD28 binding to Phosphatidylinositol 3–kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase …
      114. Phosphatidylinositol 3–kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits
      115. AtVPS34, a Phosphatidylinositol 3–kinase of Arabidopsis thaliana, is an essential protein with homology to a calcium-dependent lipid binding domain.
      116. Efficient coupling with Phosphatidylinositol 3–kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other …
      117. Requirement for Phosphatidylinositol 3–kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells
      118. Modulation of insulin receptor, insulin receptor substrate-1, and Phosphatidylinositol 3–kinase in liver and muscle of dexamethasone-treated rats.
      119. Adrenergic Receptors Activate Phosphatidylinositol 3–kinase in Human Vascular Smooth Muscle Cells: ROLE IN MITOGENESIS (∗)
      120. Phosphatidylinositol–3 kinase activation induced upon Fc gamma RIIIA-ligand interaction.
      121. Phosphatidylinositol 3–kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells.
      122. Insulin-stimulated Phosphatidylinositol 3–kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density …
      123. Regulation of Phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins: full activation requires occupancy of Both SH2 domains in the 85-kDa regulatory …
      124. Wortmannin causes mistargeting of procathepsin D. evidence for the involvement of a Phosphatidylinositol 3–kinase in vesicular transport to lysosomes.
      125. Phosphatidylinositol 3–kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor
      126. Phosphatidylinositol 3–kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion
      127. The Phosphatidylinositol 3–kinase Inhibitor Wortmannin Sensitizes Murine Fibroblasts and Human Tumor Cells to Radiation and Blocks Induction of p53 following …
      128. 1-Phosphatidylinositol 3–kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.
      129. The inability of Phosphatidylinositol 3–kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated …
      130. Insulin stimulation of Phosphatidylinositol 3–kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation.
      131. Overexpression of catalytic subunit p110α of Phosphatidylinositol 3–kinase increases glucose transport activity with translocation of glucose transporters in …
      132. Platelet-derived growth factor-induced Phosphatidylinositol 3–kinase activation mediates actin rearrangements in fibroblasts
      133. Regulated coupling of the Neu receptor to Phosphatidylinositol 3‘-kinase and its release by oncogenic activation.
      134. Requirement for Phosphatidylinositol 3‘-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
      135. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the Phosphatidylinositol–3‘kinase …
      136. Internalization of activated platelet-derived growth factor receptor-Phosphatidylinositol–3‘kinase complexes: potential interactions with the microtubule cytoskeleton
      137. A regulatory role for cAMP in Phosphatidylinositol 3–kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine …
      138. Phosphatidylinositol 3–kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation.
      139. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and Phosphatidylinositol 3–kinase in human monocytes.
      140. Two types of Phosphatidylinositol 3–kinase from bovine thymus. Monomer and heterodimer form
      141. Multiple roles of Phosphatidylinositol 3–kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells
      142. Stimulation of Phosphatidylinositol 3‘-kinase association with foca adhesion kinase by platelet-derived growth factor.
      143. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and Phosphatidylinositol 3–kinase activity are decreased in intact skeletal muscle strips …
      144. Association of Phosphatidylinositol 3–kinase with SHC in chronic myelogeneous leukemia cells.
      145. Both Phosphatidylinositol 3–kinase and Phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
      146. Profilin and gelsolin stimulate Phosphatidylinositol 3–kinase activity
      147. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding Phosphatidylinositol 3–kinase
      148. … Inhibit Stimulated Phospholipase A2 Activity in Swiss 3T3 Cells: WORTMANNIN IS NOT A SPECIFIC INHIBITOR OF Phosphatidylinositol 3–kinase (∗ …
      149. Insulin and insulinomimetic agents induce activation of Phosphatidylinositol 3‘-kinase upon its association with pp185 (IRS-1) in intact rat livers.
      150. Multiple cytokines activate Phosphatidylinositol 3–kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins.
      151. IRS-1 activates Phosphatidylinositol 3‘-kinase by associating with src homology 2 domains of p85.
      152. Requirement of Phosphatidylinositol–3 kinase for epithelial cell migration activated by human macrophage stimulating protein.
      153. Effect of aging on insulin receptor, insulin receptor substrate-1, and Phosphatidylinositol 3–kinase in liver and muscle of rats
      154. Biased combinatorial libraries: novel ligands for the SH3 domain of Phosphatidylinositol 3–kinase
      155. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the Phosphatidylinositol 3‘-kinase
      156. Phosphatidylinositol 3–kinase Recruitment by p185erbB-2 and erbB-3 Is Potently Induced by neu Differentiation Factor/Heregulin during Mitogenesis and Is …
      157. Genetic analysis of a Phosphatidylinositol 3–kinase SH2 domain reveals determinants of specificity
      158. Interleukin-10 stimulation of Phosphatidylinositol 3–kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine
      159. Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3–kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3 (∗)
      160. Phosphatidylinositol–3–kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution.
      161. A Phosphatidylinositol 3–kinase is induced during soybean nodule organogenesis and is associated with membrane proliferation.
      162. A role for Phosphatidylinositol 3–kinase in the regulation of beta 1 integrin activity by the CD2 antigen.
      163. Association of Phosphatidylinositol 3–kinase with a specific sequence of the T cell receptor zeta chain is dependent on T cell activation.
      164. Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-kinase (∗)
      165. Platelet-derived growth factor-dependent activation of Phosphatidylinositol 3–kinase is regulated by receptor binding of SH2-domain-containing proteins which …
      166. Activation of Mitogen-activated Protein kinase and Phosphatidylinositol 3′-kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake …
      167. … through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/Phosphatidylinositol 3–kinase complex in human B cell …
      168. Novel functions of Phosphatidylinositol 3–kinase in terminally differentiated cells
      169. Phosphatidylinositol 3–kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding
      170. Activation of the zeta isozyme of protein kinase C by Phosphatidylinositol 3, 4, 5-trisphosphate.
      171. … Mitogen-activated Protein kinase Activation by Platelet-activating Factor through a Mechanism Independent of p85/p110-type Phosphatidylinositol 3–kinase …
      172. Phosphatidylinositol 3–kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I
      173. Specific association of the β isoform of the p85 subunit of Phosphatidylinositol–3 kinase with the proto-oncogene c-cbl
      174. Insulin-mediated Targeting of Phosphatidylinositol 3–kinase to GLUT4-containing Vesicles (∗)
      175. HGF-mediated chemotaxis and tubulogenesis require activation of the Phosphatidylinositol 3–kinase
      176. CD28-mediated costimulation in the absence of Phosphatidylinositol 3–kinase association and activation
      177. Phosphatidylinositol 3–kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription
      178. Expression and characterization of the p85 subunit of the Phosphatidylinositol 3–kinase complex and a related p85β protein by using the baculovirus expression …
      179. Involvement of Phosphatidylinositol 3–kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells
      180. Two Distinct Intracytoplasmic Regions of the T-cell Adhesion Molecule CD28 Participate in Phosphatidylinositol 3–kinase Association (∗)
      181. Receptor tyrosine kinase stimulates cell-matrix adhesion by Phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways
      182. CD28 delivers costimulatory signals independently of its association with Phosphatidylinositol 3–kinase.
      183. Thrombin-dependent association of Phosphatidylinositol–3 kinase with p60c-src and p59fyn in human platelets
      184. Polyoma virus middle T antigen-pp60c-src complex associates with purified Phosphatidylinositol 3–kinase in vitro.
      185. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of Phosphatidylinositol 3–kinase and Ras/MAPK pathway.
      186. Brush Border Phosphatidylinositol 3–kinase Mediates Epidermal Growth Factor Stimulation of Intestinal NaCl Absorption and Na+/H+ Exchange (∗)
      187. Interaction of the Flt-1 Tyrosine kinase Receptor with the p85 Subunit of Phosphatidylinositol 3–kinase: MAPPING OF A NOVEL SITE INVOLVED IN BINDING …
      188. Activation of Phosphatidylinositol–3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity
      189. … receptor activation of Phosphatidylinositol 3–kinase. von Willebrand factor stimulates the cytoskeletal association and activation of Phosphatidylinositol 3–kinase and …
      190. Fc receptor stimulation of Phosphatidylinositol 3–kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated …
      191. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of Phosphatidylinositol 3–kinase to phosphorylated platelet-derived …
      192. Interleukin‐7 induces the association of Phosphatidylinositol 3‐kinase with the α chain of the interleukin‐7 receptor
      193. A biosensor approach to probe the structure and function of the p85 alpha subunit of the Phosphatidylinositol 3–kinase complex
      194. ADP-ribosylation of rho p21 inhibits lysophosphatidic acid-induced protein tyrosine phosphorylation and Phosphatidylinositol 3–kinase activation in cultured …
      195. Activation of Phosphatidylinositol 3–kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells.
      196. Insulin Stimulates Phosphatidylinositol‐3‐kinase activity in rat adipocytes
      197. Wortmannin binds specifically to 1-Phosphatidylinositol 3–kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil …
      198. Erythropoietin-dependent association of Phosphatidylinositol 3–kinase with tyrosine-phosphorylated erythropoietin receptor.
      199. The colony stimulating factor-1 receptor associates with and activates Phosphatidylinositol–3 kinase
      200. Phosphatidylinositol–3 kinase and growth regulation
      201. Divergent regulation of Phosphatidylinositol 3–kinase P85 alpha and P85 beta isoforms upon T cell activation
      202. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of Phosphatidylinositol 3–kinase in muscle and brain
      203. Tumor Necrosis Factor Promotes Phosphorylation and Binding of Insulin Receptor Substrate 1 to Phosphatidylinositol 3–kinase in 3T3-L1 Adipocytes (∗)
      204. A region of the 85-kilodalton (kDa) subunit of Phosphatidylinositol 3–kinase binds the 110-kDa catalytic subunit in vivo
      205. Phosphatidylinositol 3–kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells
      206. Functional association of CD7 with Phosphatidylinositol 3–kinase: interaction via a YEDM motif
      207. Roles of 1-Phosphatidylinositol 3–kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells
      208. … within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated Phosphatidylinositol–3 kinase activity without affecting …
      209. Nuclear translocation of Phosphatidylinositol 3–kinase in rat pheochromocytoma PC 12 cells after treatment with nerve growth factor.
      210. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of Phosphatidylinositol 3–kinase p85.
      211. Phosphatidylinositol 3–kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells
      212. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates Phosphatidylinositol 3–kinase in vitro.
      213. An inhibitory role for Phosphatidylinositol 3–kinase in insulin secretion from pancreatic B cell line MIN6
      214. Rapid turnover of Phosphatidylinositol 3-phosphate in the green alga Chlamydomonas eugametos: signs of a phosphatidylinositide 3–kinase signalling pathway in …
      215. Ionizing Radiation Stimulates a Grb2-mediated Association of the Stress-activated Protein kinase with Phosphatidylinositol 3–kinase (∗)
      216. Essential role of Phosphatidylinositol 3‐kinase in insulin‐induced activation and phosphorylation of the cGMP‐inhibited cAMP phosphodiesterase in rat adipocytes …
      217. Inhibition of Phosphatidylinositol 3‐kinase blocks T cell antigen receptor/CD3‐induced activation of the mitogen‐activated kinase Erk2
      218. Insulin receptor substrate-1 mediates Phosphatidylinositol 3‘-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation.
      219. Purification and characterization of a Phosphatidylinositol 3–kinase complex from bovine brain by using phosphopeptide affinity columns
      220. Association of the p85 regulatory subunit of Phosphatidylinositol 3–kinase with an essential erythropoietin receptor subdomain
      221. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with Phosphatidylinositol 3‘-kinase
      222. A Novel 55-kDa Regulatory Subunit for Phosphatidylinositol 3–kinase Structurally Similar to p55PIK Is Generated by Alternative Splicing of the p85α Gene (∗)
      223. The Phosphatidylinositol 3–kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production.
      224. In vivo binding properties of SH2 domains from GTPase-activating protein and Phosphatidylinositol 3–kinase
      225. … . Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and Phosphatidylinositol 3–kinase.
      226. Wortmannin, a potent inhibitor of Phosphatidylinositol 3–kinase, inhibits osteoclastic bone resorption in vitro
      227. Structure and function of Phosphatidylinositol 3–kinase: a potential second messenger system involved in growth control
      228. Role of Phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: Phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in …
      229. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of Phosphatidylinositol 3–kinase in FcεRI-mediated signal transduction
      230. The SH3 domain of p56lck is involved in binding to Phosphatidylinositol 3‘-kinase from T lymphocytes
      231. Activation of Phosphatidylinositol 3–kinase by prolactin in Nb2 cells
      232. Selective inhibition of p70 S6 kinase activation by Phosphatidylinositol 3‐kinase inhibitors
      233. Expression of Dominant Negative Mutant SHPTP2 Attenuates Phosphatidylinositol 3′-kinase Activity via Modulation of Phosphorylation of Insulin Receptor …
      234. Src-homology 3 domain of protein kinase p59fyn mediates binding to Phosphatidylinositol 3–kinase in T cells.
      235. Effect of the Activation of Phosphatidylinositol 3–kinase by a Thiophosphotyrosine Peptide on Glucose Transport in 3T3-L1 Adipocytes (∗)
      236. A mutational analysis of Phosphatidylinositol–3–kinase activation by human colony-stimulating factor-1 receptor
      237. Phosphatidylinositol–3 kinase is activated in v-src, v-yes, and v-fps transformed chicken embryo fibroblasts.
      238. Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and Phosphatidylinositol 3–kinase activation: studies with brefeldin A …
      239. Phosphatidylinositol 3–kinase, but Not p70/p85 Ribosomal S6 Protein kinase, Is Required for the Regulation of Phosphoenolpyruvate Carboxykinase …
      240. Activation of Phosphatidylinositol‐3‐kinase in Jurkat T cells depends on the presence of the p56lck tyrosine kinase
      241. Embryonic mesoderm cells spread in response to platelet-derived growth factor and signaling by Phosphatidylinositol 3–kinase.
      242. Inhibition of the signalling enzyme Phosphatidylinositol–3–kinase by antitumor ether lipid analogues
      243. Formation of c-Cbl· Phosphatidylinositol 3–kinase Complexes on Lymphocyte Membranes by a p56lck-independent Mechanism
      244. Activation of protein kinase C by Phosphatidylinositol 3, 4, 5-trisphosphate
      245. Activation of Phosphatidylinositol–3 kinase by ligation of the interleukin-7 receptor on human thymocytes.
      246. T Cell Activation-dependent Association between the p85 Subunit of the Phosphatidylinositol 3–kinase and Grb2/Phospholipase C-γ1-binding Phosphotyrosyl …
      247. Phosphatidylinositol 3–kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis
      248. Microinjection of the SH2 domain of the 85-kilodalton subunit of Phosphatidylinositol 3–kinase inhibits insulin-induced DNA synthesis and c-fos expression
      249. Phosphatidylinositol 3–kinase activity is important for progesterone-induced Xenopus oocyte maturation
      250. Phosphatidylinositol 3–kinase is necessary and sufficient for insulin-stimulated stress fiber breakdown
      251. Interleukin-2 receptor regulates activation of Phosphatidylinositol 3–kinase
      252. … interact with the effector molecules phospholipase C-gamma 2, microtubule-associated protein kinase, GTPase-activating protein, and Phosphatidylinositol 3–kinase
      253. The Src-family kinase, Fyn, regulates the activation of Phosphatidylinositol 3–kinase in an interleukin 2-responsive T cell line.
      254. Insulin like growth factor-I induces limited association of Phosphatidylinositol 3–kinase to its receptor.
      255. Requirement for Phosphatidylinositol 3′-kinase Activity in Platelet-derived Growth Factor-stimulated Tyrosine Phosphorylation of p125 Focal Adhesion …
      256. PDGF-mediated activation of Phosphatidylinositol 3 kinase in human mesangial cells
      257. Direct association of p110 beta Phosphatidylinositol 3–kinase with p85 is mediated by an N-terminal fragment of p110 beta
      258. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of Phosphatidylinositol–3‘kinase
      259. Activation of Phosphatidylinositol–3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains
      260. … Receptor Stimulation and Interacts in Vivo with Fyn and Syk Tyrosine kinases, Grb2 and Shc Adaptors, and the p85 Subunit of Phosphatidylinositol 3–kinase …
      261. Signal transduction in neutrophil activation Phosphatidylinositol 3‐kinase is stimulated without tyrosine phosphorylation
      262. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of Phosphatidylinositol 3–kinase
      263. Different Effects of Insulin and Platelet‐Derived Growth Factor on Phosphatidylinositol 3‐kinase at the Subcellular Level in 3T3‐L1 Adipocytes: A Possible Explanation …
      264. … translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and Phosphatidylinositol 3–kinase
      265. A multiwell assay for inhibitors of Phosphatidylinositol–3–kinase and the identification of natural product inhibitors.
      266. Physiologic Levels of β‐Amyloid Activate Phosphatidylinositol 3‐kinase with the Involvement of Tyrosine Phosphorylation
      267. Regulation of Phosphatidylinositol 3–kinase by insulin in rat skeletal muscle
      268. … p120: demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and Phosphatidylinositol 3–kinase
      269. Evidence for a role of Phosphatidylinositol 3–kinase in the regulation of glucose transport in Xenopus oocytes.
      270. … Stimulates the Tyrosine Phosphorylation of the Insulin Receptor Substrate-1 and Its Association with Phosphatidylinositol 3–kinase in Primary Adipocytes (∗)
      271. Modification of the 85-kilodalton subunit of Phosphatidylinositol–3 kinase in platelet-derived growth factor-stimulated cells
      272. Regulation of insulin receptor, insulin receptor substrate-1 and Phosphatidylinositol 3–kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and …
      273. IL-2 binding activates a tyrosine-phosphorylated Phosphatidylinositol–3–kinase.
      274. Phosphatidylinositol 3–kinase and the actin network are not required for the stimulation of glucose transport caused by mitochondrial uncoupling: comparison with …
      275. Extracellular human immunodeficiency virus type-1 Tat protein activates Phosphatidylinositol 3–kinase in PC12 neuronal cells
      276. Evidence that protein tyrosine kinase p56-Lck regulates the activity of Phosphatidylinositol–3‘-kinase in interleukin-2-dependent T-cells.
      277. Association of IRS-1 with the insulin receptor and the Phosphatidylinositol 3‘-kinase. Formation of binary and ternary signaling complexes in intact cells.
      278. Differential effects of okadaic acid on insulin-stimulated glucose and amino acid uptake and Phosphatidylinositol 3–kinase activity
      279. … a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptamine1A receptor is sensitive not only to inhibitors of Phosphatidylinositol 3–kinase, but to an …
      280. Association of Phosphatidylinositol 3–kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts
      281. SH2-dependent association of Phosphatidylinositol 3‘-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain.
      282. Association between Phosphatidylinositol–3 kinase, Cbl and other tyrosine phosphorylated proteins in colony-stimulating factor-1-stimulated macrophages
      283. Phosphatidylinositol–3–kinase activity is required for the anti-Ig-mediated growth inhibition of a human B-lymphoma cell line
      284. Role of p85 subunit of Phosphatidylinositol–3–kinase as an adaptor molecule linking the insulin receptor, p62, and GTPase-activating protein.
      285. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of Phosphatidylinositol–3–kinase
      286. Association of activated Phosphatidylinositol 3–kinase with p120cbl in antigen receptor-ligated B cells
      287. The alpha-type 85-kDa subunit of Phosphatidylinositol 3–kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor.
      288. Inhibition of Phosphatidylinositol–3′-kinase Prevents Induction of Endotoxin Tolerancein Vitro
      289. Synthesis and in Vitro Evaluation of New Wortmannin Esters:  Potent Inhibitors of Phosphatidylinositol 3–kinase
      290. Schizosaccharomyces pombe Vps34p, a Phosphatidylinositol-specific PI 3–kinase essential for normal cell growth and vacuole morphology
      291. Effects of growth factors on Phosphatidylinositol‐3 kinase in astroglial cells
      292. … -like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with Phosphatidylinositol–3 kinase in human thymocytes.
      293. Phosphatidylinositol 3′‐kinase associates with p145c‐kit as part of a cell type characteristic multimeric signalling complex.
      294. The Phosphatidylinositol 3–kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C …
      295. Characterization of the bovine brain cytosolic Phosphatidylinositol 3–kinase complex
      296. Phosphatidylinositol 3–kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor
      297. Structure of a specific peptide complex of the carboxy‐terminal SH2 domain from the p85 alpha subunit of Phosphatidylinositol 3‐kinase.
      298. … characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and Phosphatidylinositol 3–kinase.
      299. Specific activity of Phosphatidylinositol 3–kinase is increased by insulin stimulation
      300. Mutations in the juxtamembrane region of the insulin receptor impair activation of Phosphatidylinositol 3–kinase by insulin
      301. CD38-mediated growth suppression of B-cell progenitors requires activation of Phosphatidylinositol 3–kinase and involves its association with the protein product of …
      302. Signal transduction by the hepatocyte growth factor receptor, c-met. Activation of the Phosphatidylinositol 3–kinase.
      303. Transformation-defective mutants of polyomavirus middle T antigen associate with Phosphatidylinositol 3–kinase (PI 3–kinase) but are unable to maintain wild-type …
      304. Structural features of the colony‐stimulating factor 1 receptor that affect its association with Phosphatidylinositol 3‐kinase.
      305. Activation of Na+/H+ exchange by platelet-derived growth factor involves Phosphatidylinositol 3‘-kinase and phospholipase C gamma.
      306. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the Phosphatidylinositol 3–kinase inhibitor wortmannin
      307. Phosphatidylinositol–3 kinase in fission yeast: a possible role in stress responses
      308. Insulin-dependent formation of a complex containing an 85-kDa subunit of Phosphatidylinositol 3–kinase and tyrosine-phosphorylated insulin receptor …
      309. Regulation by insulin of Phosphatidylinositol 3‘-kinase bound to alpha-and beta-isoforms of p85 regulatory subunit.
      310. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with Phosphatidylinositol 3‘kinase.
      311. Novel quinone antiproliferative inhibitors of Phosphatidylinositol–3–kinase.
      312. … and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, Phosphatidylinositol–3–kinase, and deoxyribonucleic acid …
      313. Oncostatin M activates Phosphatidylinositol–3–kinase in Kaposi’s sarcoma cells.
      314. Interleukin 2-and polyomavirus middle T antigen-induced modification of Phosphatidylinositol 3–kinase activity in activated T lymphocytes
      315. Erythropoietin induces the association of Phosphatidylinositol 3′‐kinase with a tyrosine‐phosphorylated protein complex containing the erythropoietin receptor
      316. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by Phosphatidylinositol 3–kinase and inhibited by cyclic AMP
      317. In vitro association of Phosphatidylinositol 3–kinase activity with the activated insulin receptor tyrosine kinase.
      318. Phosphatidylinositol 3‐kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin
      319. Effect of epidermal growth factor on Phosphatidylinositol 3–kinase activity in rabbit corneal epithelial cells
      320. Insulin-stimulated Phosphatidylinositol 3–kinase activity and 2-deoxy-D-glucose uptake in rat skeletal muscles
      321. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on Phosphatidylinositol 3–kinase
      322. Localization of mRNA for Phosphatidylinositol 3–kinase in brain of developing and mature rats
      323. Phosphatidylinositol 3–kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
      324. The human gene encoding Phosphatidylinositol–3 kinase associated p85α is at chromosome region 5q12–13
      325. Role of p85 subunit of Phosphatidylinositol–3–kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1.
      326. An 11-Amino Acid Sequence from c-met Initiates Epithelial Chemotaxis via Phosphatidylinositol 3–kinase and Phospholipase C (∗)
      327. Specific binding of Fyn and Phosphatidylinositol 3‐kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains
      328. … Interfere with Chemoattractant-induced Respiratory Burst in Neutrophils as a Result of the Inhibition of Phosphatidylinositol 3–kinase Rather than Receptor …
      329. Differential effects of spermine on Phosphatidylinositol 3–kinase and Phosphatidylinositol phosphate 5-kinase
      330. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with Phosphatidylinositol 3–kinase in rat heart
      331. Cooperation of Src homology domains in the regulated binding of Phosphatidylinositol 3–kinase: a role for the Src homology 2 domain
      332. Evidence for a role of Phosphatidylinositol 3–kinase in IL-4-induced germline Cϵ transcription
      333. Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of Phosphatidylinositol 3–kinase activity as well as association of p85 subunit to tyrosine …
      334. Hepatocyte growth factor-induced proliferation of primary hepatocytes is mediated by activation of Phosphatidylinositol 3–kinase
      335. Platelet-derived growth factor activates membrane-associated Phosphatidylinositol 3–kinase and mediates its translocation from the cytosol. Detection of …
      336. Mutations in the SH3 domain of the src oncogene which decrease association of Phosphatidylinositol 3‘-kinase activity with pp60v-src and alter cellular morphology
      337. T cell receptor-associated alpha-Phosphatidylinositol 3–kinase becomes activated by T cell receptor cross-linking and requires pp56lck.
      338. … of the free catalytic p110 alpha and the complexed heterodimeric p110 alpha. p85 alpha forms of the mammalian Phosphatidylinositol 3–kinase.
      339. Translocation, Activation and Association of Protein‐tyrosine kinase (p72syk) with Phosphatidylinositol 3‐kinase are Early Events During Platelet Activation
      340. Molecular cloning of an amphibian insulin receptor substrate 1-like cDNA and involvement of Phosphatidylinositol 3–kinase in insulin-induced Xenopus oocyte …
      341. … colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and Phosphatidylinositol 3‘-kinase.
      342. Thrombin-stimulated immunoprecipitation of Phosphatidylinositol 3–kinase from human platelets.
      343. Regulation of phosphoinositide kinases in T cells. Evidence that Phosphatidylinositol 3–kinase is not a substrate for T cell antigen receptor-regulated tyrosine …
      344. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate Phosphatidylinositol 3–kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 …
      345. Enhanced gene expression for Phosphatidylinositol 3–kinase in the hypoglossal motoneurons following axonal crush
      346. Phosphatidylinositol 3–kinase
      347. Agonist-induced association of the p21rasGTPase-activating protein with Phosphatidylinositol 3–kinase
      348. Insulin induces a change in Rab5 subcellular localization in adipocytes independently of Phosphatidylinositol 3–kinase activation
      349. Cytoplasmic and nuclear localization sites of Phosphatidylinositol 3–kinase in human osteosarcoma sensitive and multidrug-resistant Saos-2 cells
      350. Functional interactions of Phosphatidylinositol 3–kinase with GTPase-activating protein in 3T3-L1 adipocytes
      351. Phosphatidylinositol–3′ kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase
      352. … a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and Phosphatidylinositol–3 kinase, activation of c …
      353. Potent activation of Phosphatidylinositol 3‘-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for …
      354. The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with Phosphatidylinositol 3–kinase.
      355. Specific association of Phosphatidylinositol 3‐kinase with the protooncogene product Cbl in Fcγ receptor signaling
      356. Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and Phosphatidylinositol 3–kinase in Fao hepatoma cells
      357. Phosphatidylinositol 3–kinase activity in murine erythroleukemia cells during DMSO-induced differentiation
      358. Activation of Src-family protein tyrosine kinases and Phosphatidylinositol 3–kinase in 3T3-L1 mouse preadipocytes by interleukin-11.
      359. The level of insulin receptor tyrosine kinase activity modulates the activities of Phosphatidylinositol 3–kinase, microtubule-associated protein, and S6 kinases.
      360. Wortmannin inhibits insulin secretion in pancreatic islets and β-TC3 cells independent of its inhibition of Phosphatidylinositol 3–kinase
      361. … derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through Phosphatidylinositol 3–kinase binding sites on …
      362. Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both Phosphatidylinositol 3–kinase and acidic sphingomyelinase signals.
      363. CD28-mediated up-regulation of beta 1-integrin adhesion involves Phosphatidylinositol 3–kinase.
      364. The HIV-1 Nef Protein Interferes with Phosphatidylinositol 3–kinase Activation 1 (∗)
      365. Monocyte Colony-stimulating Factor Stimulates Binding of Phosphatidylinositol 3–kinase to Grb2· Sos Complexes in Human Monocytes
      366. The protein product of the proto-oncogene c-cbl forms a complex with Phosphatidylinositol 3–kinase p85 and CD19 in anti-IgM-stimulated human B-lymphoma …
      367. Potentiation of insulin stimulation of Phosphatidylinositol 3–kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human …
      368. Modulation of the substrate specificity of the mammalian Phosphatidylinositol 3–kinase by cholesterol sulfate and sulfatide
      369. Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of Phosphatidylinositol 3–kinase
      370. Involvement of Phosphatidylinositol 3–kinase in stimulation of glucose transport by growth factors in 3T3-L1 adipocytes.
      371. 17β-hydroxywortmannin: A potent inhibitor of bone resorption and Phosphatidylinositol–3–kinase
      372. Activation of Phosphatidylinositol–3–kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine …
      373. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of Phosphatidylinositol 3–kinase, and protein kinase C …
      374. Association of Phosphatidylinositol 3 kinase to protein kinase C ζ during interleukin‐2 stimulation
      375. Interaction of the molecular weight 85K regulatory subunit of the Phosphatidylinositol 3–kinase with the insulin receptor and the insulin-like growth factor-1 (IGF-I) …
      376. A tyrosine kinase signaling pathway accounts for the majority of Phosphatidylinositol 3, 4, 5-trisphosphate formation in chemoattractant-stimulated human …
      377. Phorbol ester treatment inhibits Phosphatidylinositol 3–kinase activation by, and association with, CD28, a T-lymphocyte surface receptor.
      378. Chromosomal localization of human p85 alpha, a subunit of Phosphatidylinositol 3–kinase, and its homologue p85 beta.
      379. Phosphatidylinositol 3′-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and …
      380. Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the Phosphatidylinositol 3–kinase
      381. Identification of amino acid residues required for a specific interaction between Src-tyrosine kinase and proline-rich region of Phosphatidylinositol–3′ kinase
      382. Studies with wortmannin suggest a role for Phosphatidylinositol 3–kinase in the activation of glycogen synthase and mitogen-activated protein kinase by insulin in rat …
      383. Insulin treatment stimulates the tyrosine phosphorylation of the alpha-type 85-kDa subunit of Phosphatidylinositol 3–kinase in vivo.
      384. NMR Analysis of Interactions of a Phosphatidylinositol 3 ‘-kinase SH2 Domain with Phosphotyrosine Peptides Reveals Interdependence of Major Binding Sites
      385. Endotoxin tolerance alters phospholipase C-γ1 and Phosphatidylinositol–3′-kinase expression in peritoneal macrophages
      386. … cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and Phosphatidylinositol–3–kinase …
      387. Phosphatidylinositol–3–kinase is a non-tyrosine phosphorylated member of the insulin receptor signalling complex
      388. Activation of Phosphatidylinositol–3–kinase by insulin is mediated by both A and B human insulin receptor types
      389. CD28 co-stimulatory regimes differ in their dependence on Phosphatidylinositol 3–kinase: common co-signals induced by CD80 and CD86
      390. Naturally occurring ether‐linked phosphatidylcholine activates Phosphatidylinositol 3‐kinase and stimulates cell growth
      391. … colony-stimulating factor 1 receptor impairs mitogenesis without abrogating tyrosine kinase activity, association with Phosphatidylinositol 3–kinase, or induction of c …
      392. Interleukin-4 induces association of the c-fes proto-oncogene product with Phosphatidylinositol–3 kinase
      393. Cyclic peptide inhibitors of Phosphatidylinositol 3–kinase p85 SH2 domain binding
      394. Studies of partially transforming polyomavirus mutants establish a role for Phosphatidylinositol 3–kinase in activation of pp70 S6 kinase
      395. Lysophosphatidic acid stimulates glucose transport in Xenopus oocytes via a Phosphatidylinositol 3′-kinase with distinct properties
      396. Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines
      397. Growth factor-regulated Phosphatidylinositol–3–kinase in astrocytes. Involvement of pp60c-Src.
      398. Selective inhibition of Phosphatidylinositol 3–kinase by phosphatidic acid and related lipids
      399. Evidence of the Involvement of Phosphatidylinositol 3–kinase in the Migration, Actin Stress Fiber Formation, and αvβ3-Integrin–Mediated Adherence of Human …
      400. The effects of wortmannin, a potent inhibitor of Phosphatidylinositol 3–kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA …
      401. Phosphatidylinositol 3–kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 …
      402. Phosphatidylinositol 3–kinase participates in p56 (lck)/CD4-dependent down-regulation of LFA-1-mediated T cell adhesion.
      403. Wortmannin, a specific inhibitor of Phosphatidylinositol–3–kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
      404. Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL-4 receptor and association of Phosphatidylinositol 3–kinase to the IL-4 receptor in a mouse T cell …
      405. Mammalian Phosphatidylinositol 3′‐kinase induces a lethal phenotype on expression in Schizosaccharomyces pombe; comparison with the VPS34 gene product
      406. A role for Phosphatidylinositol 3–kinase in generating T cell help for B cell growth and differentiation.
      407. Insulin Stimulates Phosphatidylinositol 3‐kinase Activity in Rat Neuronal Primary Cultures
      408. Comparison of CD28‐B7. 1 and B7. 2 functional interaction in resting human T cells: Phosphatidylinositol 3‐kinase association to CD28 and cytokine production
      409. Tyrosine 508 of the 85-kilodalton subunit of Phosphatidylinositol 3–kinase is phosphorylated by the platelet-derived growth factor receptor
      410. Interleukin 7 receptor mediates the activation of Phosphatidylinositol–3 kinase in human B-cell precursors
      411. Association of Phosphatidylinositol 3‐kinase with the photo‐oncogene product Cbl upon CD38 ligation by a specific monoclonal antibody in THP‐1 cells
      412. Regulation of CD4-p561ck-associated Phosphatidylinositol 3–kinase (PI 3–kinase) and Phosphatidylinositol 4-kinase (PI 4-kinase)
      413. … in downstream signaling pathways of p185BCR-ABL in Ph+ ALL involve GTPase-activating protein, phospholipase C-gamma 1, and Phosphatidylinositol 3‘-kinase.
      414. … That Signals DNA Synthesis in NIH 3T3 Cells Specifically Binds a Complex of Src and Janus Family Tyrosine kinases and Phosphatidylinositol 3–kinase (∗)
      415. Anti-phosphotyrosine immunoprecipitation of Phosphatidylinositol 3′ kinase activity in different cell types after exposure to epidermal growth factor
      416. … B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of Phosphatidylinositol 3–kinase
      417. The Gene That Encodes the Phosphatidylinositol–3 kinase Regulatory Subunit (p85α) Maps to Chromosome 13 in the Mouse
      418. The catalytic subunit of Phosphatidylinositol 3–kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src …
      419. Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells.
      420. Effects of phorbol esters on insulin‐induced activation of Phosphatidylinositol 3‐kinase, glucose transport, and glycogen synthase in rat adipocytes
      421. The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and Phosphatidylinositol–3′-kinase in NIH 3T3 cells
      422. … by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and Phosphatidylinositol 3–kinase
      423. … site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate Phosphatidylinositol–3 kinase but show differential …
      424. Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing Phosphatidylinositol–3–kinase, guanosine triphosphatase-activating protein …
      425. Phosphatidylinositol 3–kinase
      426. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and Phosphatidylinositol-specific PI 3–kinase …
      427. Wortmannin-mediated inhibition of Phosphatidylinositol 3–kinase activity triggers apoptosis in normal and neoplastic B lymphocytes which are in cell cycle
      428. … in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and Phosphatidylinositol 3–kinase …
      429. … exerts a full insulin-like effect on glucose transport and glucose transporter 4 translocation in human adipocytes: evidence for a Phosphatidylinositol 3–kinase …
      430. Phosphatidylinositol 3–kinase: inhibition of intrinsic protein-serine kinase activity by phosphoinositides, and of lipid kinase activity by Mn2+
      431. Alternative binding of p56lck and Phosphatidylinositol 3–kinase in T cells by sulfhydryl oxidation: implication of aberrant signaling due to oxidative stress in T …
      432. Effect of IGF-I on Phosphatidylinositol 3–kinase in soleus muscle of lean and insulin-resistant obese mice
      433. Activation of Phosphatidylinositol 3–kinase and Phosphatidylinositol 4-kinase during rat parotid acinar cell proliferation
      434. A product of Phosphatidylinositol–3 kinase is elevated in dividing HT29 colonic epithelial cells
      435. Phosphorylation in vitro of the 85 kDa subunit of Phosphatidylinositol 3–kinase and its possible activation by insulin receptor tyrosine kinase
      436. Structure-activity studies of phosphorylated peptide inhibitors of the association of Phosphatidylinositol 3–kinase with PDGF-β receptor
      437. Mitogenic inhibition by phorbol esters is associated with decreased Phosphatidylinositol–3 kinase activation
      438. Structure of 85 kDa subunit of human Phosphatidylinositol 3‐kinase analyzed by using monoclonal antibodies
      439. Activation of Phosphatidylinositol 3–kinase by concanavalin A through dual signaling pathways, G-protein-coupled and phosphotyrosine-related, and an essential role …
      440. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and Phosphatidylinositol 3–kinase p85
      441. Activation of Akt by nerve growth factor via Phosphatidylinositol–3 kinase in PC12 pheochromocytoma cells
      442. SH3 domain-mediated dimerization of an n-terminal fragment of the Phosphatidylinositol 3–kinase p85 subunit
      443. EFFECT OF LOVASTATIN AND FLUOROMEVALONATE ON Phosphatidylinositol 3‐kinase ACTIVITY STIMULATED WITH PDGF
      444. … factor induces the tyrosine phosphorylation and activation of phospholipase C-gamma 1, Fyn and Lyn kinases, and Phosphatidylinositol 3–kinase in a human B cell …
      445. Protein kinase C-mediated formation of Phosphatidylinositol 3, 4-bisphosphate in human platelets
      446. EJ-Ras Inhibits Phospholipase Cγ1 but Not Actin Polymerization Induced by Platelet-Derived Growth Factor-BB via Phosphatidylinositol 3–kinase
      447. Controlled overexpression of selected domains of the P85 subunit of Phosphatidylinositol 3–kinase reverts v-Ha-Ras transformation
      448. Insulin-like growth factor-1-mediated association of p85 Phosphatidylinositol 3–kinase with pp 185: requirement of SH2 domains for in vivo interaction.
      449. The differential activation of Phosphatidylinositol–3 kinase and mitogen-activated protein kinases by PDGF-AA and IGF-I might explain the synergistic effect of the two …
      450. CD28‐dependent killing by human YT cells requires Phosphatidylinositol 3‐kinase activation
      451. Phosphoinositide 3-phosphatase segregates from Phosphatidylinositol 3–kinase in EGF-stimulated A431 cells and fails to in vitro hydrolyse Phosphatidylinositol (3, 4 …
      452. … p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or Phosphatidylinositol–3–kinase.
      453. Synthesis of Phosphatidylinositol 3, 4-bisphosphate is regulated by protein-tyrosine phosphorylation but the p85α subunit of Phosphatidylinositol 3–kinase may not be …
      454. Peptide antisera to human colony-stimulating factor 1 receptor detect ligand-induced conformational changes and a binding site for Phosphatidylinositol 3–kinase
      455. Inhibition of IGF II-induced redistribution of mannose 6-phosphate receptors by the Phosphatidylinositol 3–kinase inhibitor, wortmannin
      456. A novel pathway for the formation of Phosphatidylinositol 3, 4-bisphosphate. Phosphorylation of Phosphatidylinositol 3-monophosphate by …
      457. Novel protein kinase/Phosphatidylinositol 3–kinase complex essential for receptor-mediated protein sorting to the vacuole in yeast
      458. Haematopoietic colony stimulating factors CSF-1 and GM-CSF increase Phosphatidylinositol 3–kinase activity in murine bone marrow-derived macrophages
      459. Isolation of the active form of RAC‐protein kinase (PKB/Akt) from transfected COS‐7 cells treated with heat shock stress and effects of Phosphatidylinositol 3, 4, 5 …
      460. Association of the insulin receptor and Phosphatidylinositol 3–kinase requires a third component
      461. Interleukin-4 activates two distinct pathways of Phosphatidylinositol–3 kinase in the same cells
      462. Dominant negative effect of the truncated p110 subunit of Phosphatidylinositol‐3 kinase
      463. … FTI-244 decreases platelet-derived growth factor receptor tyrosine phosphorylation levels and inhibits stimulation of Phosphatidylinositol 3–kinase but not mitogen …
      464. Inhibition of Neuroblastoma Cell Phosphatidylinositol 3‐kinase by CDP‐Diacylglycerol and Phosphatidate
      465. Regulation of Phosphatidylinositol–3 kinase by tyrosyl phosphoproteins
      466. D-myo-Inositol 1, 4, 5-trisphosphate analogues modified at the 3-position inhibit Phosphatidylinositol 3–kinase
      467. Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of Phosphatidylinositol 3–kinase
      468. Serine-rich region of the IL-2 receptor β-chain is required for activation of Phosphatidylinositol 3–kinase
      469. In vitro association of the Phosphatidylinositol 3‐kinase regulatory subunit (p85) with the human insulin receptor
      470. Phosphatidylinositol 3–kinase is involved in TRE-dependent gene expression in response to arginine vasopressin
      471. Dissociation of Phosphatidylinositol–3 kinase activity and mitogenic inhibition in vascular smooth muscle cells
      472. … H2O2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS‐1 leading to IRS‐1 association with the Phosphatidylinositol 3‐kinase
      473. Characterization of a Phosphatidylinositol-specific phosphoinositide 3–kinase from mammalian cells
      474. Insulin-dependent Phosphatidylinositol 3′-kinase activity co-precipitates with insulin receptor in human circulating mononuclear cells
      475. Phosphatidylinositol (PI) 3–kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3–kinase but not PI 4-kinase
      476. O-17: Overexpression of a constitutively active form of Phosphatidylinositol 3 kinase is sufficient to Promote GLUT 4 translocation in transfected rat adipose cells
      477. Platelet-Derived Growth Factor Induces Phosphatidylinositol 3–kinase Release from the Middle T-pp60c-src Complex and Association with the Platelet-Derived …
      478. Phosphatidylinositol 3–kinase: A Novel Signal Transduction Pathway?
      479. Up-regulation of Expression of Phosphatidylinositol 3–kinase in Psoriatic Lesions
      480. A Phosphatidylinositol (PI) kinase gene family in Dictyostelium discoideum: biological roles of putative mammalian p110 and yeast Vps34p PI 3–kinase homologs …
      481. Differential roles of Phosphatidylinositol 3–kinase in mitogen-activated prote in kinase activation by insulin and epidermal growth factor
      482. Production of monoclonal antibodies specific to the carboxyl terminal region of the 85 kDa subunit of Phosphatidylinositol 3‐kinase: Use of the antibodies in …
      483. Phosphatidylinositol 3–kinase is involved in the colony-stimulating factor-1-induced spreading of macrophages and osteoclasts.
      484. Purification of Phosphatidylinositol 3–kinase by SDS-agarose gel electrophoresis and HPEC
      485. Does Phosphatidylinositol 3‐kinase play a role in insulin‐induced outgrowth of pseudopodial cables in cultured cells derived from micromeres of sea urchin embryos?
      486. Phosphatidylinositol–3–kinase Pathway is Stimulated by Fungal Lipid Containing Cocoa Butter Equivalents (CBE) in FMet-Leu-Phe (FMLP)-and Phorbolester (PMA) …
      487. A structural and functional analysis of the Phosphatidylinositol 3–kinase
      488. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates Phosphatidylinositol 3-hydroxyl kinase activity
      489. O-49: A prevalent amino acid polymorphism at codon 325Met-> IIe in the gene encoding the Phosphatidylinositol 3–kinase p85α regulatory subunit is associated with …
      490. Activation of PRK1 by Phosphatidylinositol 4, 5-Bisphosphate and Phosphatidylinositol 3, 4, 5-Trisphosphate: A COMPARISON WITH PROTEIN kinase C …
      491. Characterization of tyrosine kinase-associated Phosphatidylinositol–3 kinase.
      492. The experimental study on Phosphatidylinositol 3–kinase/Akt in neural stem cells in vitro
      493. Phosphatidylinositol 3–kinase activation by IGF-I is independent of irs-1 in hl-60 cells
      494. Role of Phosphatidylinositol 3–kinase in growth factor and oncogene signaling
      495. Purification and characterisation of Phosphatidylinositol 3–kinase from bovine brain
      496. CD19 and Phosphatidylinositol 3–kinase
      497. Activation of Phosphatidylinositol 3–kinase in hepatocyte growth and hepatocellular transformation
      498. Phosphatidylinositol 3–kinase (PI3k) is required for chemoattractant-stimulated homotypic aggregation of human neutropfflls
      499. Shear stress-induced signal transduction through Phosphatidylinositol–3 kinase in endothelial cells
      500. Early events in insulin signaling: Tyrosine phosphorylation and Phosphatidylinositol 3–kinase activation
      501. Profilin and gelsolin stimulate Phosphatidylinositol 3–kinase activity
      502. Phosphatidylinositol 3–kinase Activity in 3T3-L1 Adipocytes: Effects of Pioglitazone on Insulin-and IGF-1-Stimulated Cells
      503. Phosphatidylinositol 3–kinase Activity Is Required for Hepatocyte Growth Factor-induced Mitogenic Signals in Epithelial Cells
      504. Role of Phosphatidylinositol 3–kinase during the first cell cycles of the sea urchin embryo. Effect on map kinase and MPF activities.
      505. P-62: Role of Phosphatidylinositol–3–kinase and S6 kinase in insulin-stimulated glycogen synthesis
      506. The effects of fluid shear stress on the activity of protein kinase C, Phosphatidylinositol 3–kinase and Rho in aortic endothelial cells
      507. Role of p38 and Phosphatidylinositol 3 kinase (PI3K) in the signal transduction of apoptosis of activated human?? T cells induced by restimulating with Mycobacterium …
      508. Phosphatidylinositol 3 kinase (PI 3 K) regulates glomerular mesangial cell chemotaxis and proliferation: Involvement of mitogen activated protein kinase (MAPK) …
      509. Phosphatidylinositol 3–kinase regulates actin stress fiber formation and the avidity of the integrin-receptor α, β 3 in human melanoma cells.
      510. Regulation of early endosomal transport and fusion by ADP-ribosylation factors and Phosphatidylinositol 3–kinase
      511. P-78: Role of p85 isoforms of Phosphatidylinositol–3–kinase in insulin receptor signaling
      512. Translocation of Phosphatidylinositol–3 kinase (PI3–kinase) and small GTPase Rho A to the cytoskeleton upon osteoclast attachment to bone.
      513. Phosphatidylinositol 3–kinase regulates actin stress fiber formation and the avidity of the integrin-receptor αvβ3 in human melanoma cells.
      514. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of Phosphatidylinositol (PI) 3–kinase and for c-kit-associated PI 3–kinase activity in …
      515. … derived growth factor triggers translocation of the insulin-regulatable glucose transporter (type 4) predominantly through Phosphatidylinositol 3–kinase binding sites on …
      516. P-77: Insulinomimetic agent, vanadyl sulfate (VS)-stimulated Phosphatidylinositol 3–kinase (PI 3-K) and RAS/MAP kinase activation is independent of insulin receptor …
      517. Effect of phosphotyrosyl‐IRS‐1 level and insulin receptor tyrosine kinase activity on insulin‐stimulated Phosphatidylinositol 3, MAP, and S6 kinase activities
      518. Phosphorylation of Tyrosine 503 in the Erythropoietin Receptor (EpR) Is Essential for Binding the P85 Subunit of Phosphatidylinositol (PI) 3–kinase and for …
      519. Protein kinase B (c-Akt): a multifunctional mediator of Phosphatidylinositol 3–kinase activation
      520. A requirement for Phosphatidylinositol 3–kinase in pseudopod extension
      521. Downstream signalling events regulated by Phosphatidylinositol 3–kinase activity
      522. p110δ, a novel Phosphatidylinositol 3–kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes
      523. A specific product of Phosphatidylinositol 3–kinase directly activates the protein kinase Akt through its pleckstrin homology domain
      524. The role of Phosphatidylinositol 3–kinase in vascular endothelial growth factor signaling
      525. Cyclin D expression is controlled post-transcriptionally via a Phosphatidylinositol 3–kinase/Akt-dependent pathway
      526. Role of glycogen synthase kinase–3 in the Phosphatidylinositol 3–kinase/Akt cell survival pathway
      527. Antiapoptotic signalling by the insulin-like growth factor I receptor, Phosphatidylinositol 3–kinase, and Akt
      528. Calmodulin activates Phosphatidylinositol 3–kinase
      529. Phosphatidylinositol 3–kinase-dependent membrane association of the Bruton’s tyrosine kinase pleckstrin homology domain visualized in single living cells
      530. Regulation of the p85/p110 Phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit
      531. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and Phosphatidylinositol 3–kinase
      532. Phosphatidylinositol 3–kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
      533. Ezrin, a plasma membrane–microfilament linker, signals cell survival through the Phosphatidylinositol 3–kinase/Akt pathway
      534. Suppression of transforming growth factor-β-induced apoptosis through a Phosphatidylinositol 3–kinase/Akt-dependent pathway
      535. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the Phosphatidylinositol 3–kinase/Akt pathway
      536. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent Phosphatidylinositol 3–kinase/Akt cell survival pathway
      537. Vascular endothelial growth factor regulates endothelial cell survival through the Phosphatidylinositol 3′-kinase/Akt signal transduction pathway …
      538. Depolarization and neurotrophins converge on the Phosphatidylinositol 3–kinase–Akt pathway to synergistically regulate neuronal survival
      539. Relationship between flavonoid structure and inhibition of Phosphatidylinositol 3–kinase: a comparison with tyrosine kinase and protein kinase C inhibition
      540. Myogenic signaling of Phosphatidylinositol 3–kinase requires the serine-threonine kinase Akt/protein kinase B
      541. Requirement of Phosphatidylinositol 3–kinase in focal adhesion kinase-promoted cell migration
      542. Identification of an early endosomal protein regulated by Phosphatidylinositol 3–kinase
      543. Activation of the Phosphatidylinositol 3–kinase serine kinase by IFN-alpha.
      544. The Phosphatidylinositol 3‐kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes
      545. Constitutive activation of Phosphatidylinositol 3–kinase by a naturally occurring mutant epidermal growth factor receptor
      546. Akt, a target of Phosphatidylinositol 3–kinase, inhibits apoptosis in a differentiating neuronal cell line
      547. Regulation of the p85/p110α Phosphatidylinositol 3′-kinase: distinct roles for the N-terminal and C-terminal SH2 domains
      548. Activated Phosphatidylinositol 3–kinase and Akt kinase promote survival of superior cervical neurons
      549. Increased levels of Phosphatidylinositol 3‐kinase activity in colorectal tumors
      550. Protein kinase C-ζ as a downstream effector of Phosphatidylinositol 3–kinase during insulin stimulation in rat adipocytes: potential role in glucose transport
      551. Phosphatidylinositol 3–kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons
      552. Phosphatidylinositol 3‐kinase‐mediated regulation of neuronal apoptosis and necrosis by insulin and IGF‐I
      553. Identification and analysis of PH domain-containing targets of Phosphatidylinositol 3–kinase using a novel in vivo assay in yeast
      554. Phosphatidylinositol 3–kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation
      555. Comparison of the roles of mitogen-activated protein kinase kinase and Phosphatidylinositol 3–kinase signal transduction in neutrophil effector function
      556. Activation of Phosphatidylinositol 3–kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit
      557. Induction of Vascular Endothelial Growth Factor by Hypoxia Is Modulated by a Phosphatidylinositol 3–kinase/Akt Signaling Pathway in Ha-ras-Transformed Cells …
      558. Activation of Phosphatidylinositol 3–kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation
      559. STAT3 as an adapter to couple Phosphatidylinositol 3–kinase to the IFNAR1 chain of the type I interferon receptor
      560. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires Phosphatidylinositol 3–kinase
      561. Heregulin induces phosphorylation of BRCA1 through Phosphatidylinositol 3–kinase/AKT in breast cancer cells
      562. Phosphatidylinositol 3–kinase is required for platelet-derived growth factor’s actions on hepatic stellate cells
      563. FAK is the upstream signal protein of the Phosphatidylinositol 3–kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human …
      564. An essential role of Phosphatidylinositol 3–kinase in myogenic differentiation
      565. Phosphatidylinositol 3–kinase-γ activates Bruton’s tyrosine kinase in concert with Src family kinases
      566. Phosphatidylinositol 3–kinase in interleukin 1 signaling: physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-1 activation
      567. Insulin-like growth factor 1 inhibits apoptosis using the Phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways
      568. The Phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
      569. … the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions: evidence for the association of Phosphatidylinositol 3–kinase with the E …
      570. Angiotensin II activates Phosphatidylinositol 3–kinase in vascular smooth muscle cells
      571. p85α gene generates three isoforms of regulatory subunit for Phosphatidylinositol 3–kinase (PI 3–kinase), p50α, p55α, and p85α, with different PI 3–kinase …
      572. Effects of free fatty acids on glucose transport and IRS-1–associated Phosphatidylinositol 3–kinase activity
      573. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction–and Phosphatidylinositol–3–kinase–independent pathway
      574. Adenoviral gene transfer of activated Phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
      575. Interleukin 8-stimulated Phosphatidylinositol–3–kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and …
      576. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and Phosphatidylinositol 3–kinase
      577. The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and Phosphatidylinositol 3–kinase-dependent signaling
      578. Inhibition of adipose differentiation by Phosphatidylinositol 3‐kinase inhibitors
      579. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of Phosphatidylinositol 3–kinase
      580. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and Phosphatidylinositol 3–kinase in cultured neurons.
      581. Phosphatidylinositol 3–kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase
      582. Distinct roles of the Phosphatidylinositol 3–kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors
      583. MAP kinases, Phosphatidylinositol 3‐kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor
      584. Requirement for both Shc and Phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis
      585. Negative regulation by Phosphatidylinositol 3–kinase of inducible nitric oxide synthase expression in macrophages
      586. c-Src is required for stimulation of gelsolin-associated Phosphatidylinositol 3–kinase
      587. Altered expression levels and impaired steps in the pathway to Phosphatidylinositol 3–kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats
      588. Contribution of Phosphatidylinositol 3‐kinase to radiation resistance in human melanoma cells
      589. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the Phosphatidylinositol 3–kinase signaling pathway.
      590. Increase in nuclear Phosphatidylinositol 3‐kinase activity and Phosphatidylinositol (3, 4, 5) trisphosphate synthesis precede PKC‐ζ translocation to the nucleus of NGF …
      591. Src-induced activation of inducible T cell kinase (ITK) requires Phosphatidylinositol 3–kinase activity and the Pleckstrin homology domain of inducible T cell kinase
      592. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a Phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism
      593. … oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the Phosphatidylinositol 3–kinase …
      594. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell–cell adhesion or cell migration and is regulated by Phosphatidylinositol 3–kinase
      595. Platelet-derived growth factor β receptor regulates interstitial fluid homeostasis through Phosphatidylinositol–3′ kinase signaling
      596. Wortmannin, a specific inhibitor of Phosphatidylinositol–3–kinase, enhances LPS-induced NO production from murine peritoneal macrophages
      597. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of Phosphatidylinositol 3′-kinase and Akt/protein kinase B
      598. Extracellular‐regulated kinases and Phosphatidylinositol 3‐kinase are involved in brain‐derived neurotrophic factor‐mediated survival and neuritogenesis of the …
      599. Phosphatidylinositol 3–kinase mediates mitogen-induced human airway smooth muscle cell proliferation
      600. Phosphatidylinositol 3‐kinase is recruited to a specific site in the activated IL‐1 receptor I
      601. Phosphatidylinositol 3–kinase is a negative regulator of cellular differentiation
      602. Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of Phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced …
      603. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of Phosphatidylinositol 3–kinase and Akt
      604. The Antiapoptotic Gene mcl-1 Is Up-Regulated by the Phosphatidylinositol 3–kinase/Akt Signaling Pathway through a Transcription Factor Complex Containing …
      605. Cyclin D1 Expression Mediated by Phosphatidylinositol 3–kinase through mTOR-p70S6K-Independent Signaling in Growth Factor-Stimulated NIH 3T3 Fibroblasts
      606. Regulation of vascular smooth muscle cell apoptosis: modulation of Bad by a Phosphatidylinositol 3–kinase–dependent pathway
      607. Activated MEK stimulates expression of AP-1 components independently of Phosphatidylinositol 3–kinase (PI3–kinase) but requires a PI3–kinase signal to stimulate …
      608. Phosphatidylinositol 3–kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway
      609. Distinct Phosphatidylinositol 3–kinase lipid products accumulate upon oxidative and osmotic stress and lead to different cellular responses
      610. Activation of Phosphatidylinositol 3–kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
      611. Inhibition of Phosphatidylinositol 3–kinase activity blocks depolarization-and insulin-like growth factor I-mediated survival of cerebellar granule cells
      612. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via Phosphatidylinositol–3 kinase
      613. p70s6k Integrates Phosphatidylinositol 3–kinase and Rapamycin-Regulated Signals for E2F Regulation in T Lymphocytes
      614. Inhibition of Phosphatidylinositol 3–kinase activity by adenovirus-mediated gene transfer and its effect on insulin action
      615. … -permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a Phosphatidylinositol 3–kinase-dependent stimulation of the …
      616. Insulin stimulation of the fatty acid synthase promoter is mediated by the Phosphatidylinositol 3–kinase pathway: involvement of protein kinase B/Akt
      617. Phosphatidylinositol 3–kinase γ mediates shear stress-dependent activation of JNK in endothelial cells
      618. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not Phosphatidylinositol 3–kinase in rat skeletal muscle.
      619. αPIX nucleotide exchange factor is activated by interaction with Phosphatidylinositol 3–kinase
      620. Insulin receptor substrate-1 phosphorylation and Phosphatidylinositol 3–kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation
      621. Dedifferentiation of adenocarcinomas by activation of Phosphatidylinositol 3–kinase
      622. Role of Phosphatidylinositol 3–kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes
      623. A redox-triggered ras-effector interaction: recruitment of Phosphatidylinositol 3′-kinase to Ras by redox stress
      624. Intermolecular interactions of the p85α regulatory subunit of Phosphatidylinositol 3–kinase
      625. Vac1p coordinates Rab and Phosphatidylinositol 3–kinase signaling in Vps45p-dependent vesicle docking/fusion at the endosome
      626. Requirement of Phosphatidylinositol–3 kinase for activation of JNK/SAPKs by PDGF
      627. 1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3–kinase Signaling Complex
      628. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and Phosphatidylinositol 3–kinase in 3T3-L1 adipocytes: a …
      629. … rescue cerebellar granule neurons from oxidative stress‐mediated apoptotic death: selective involvement of Phosphatidylinositol 3‐kinase and the mitogen‐activated …
      630. Phosphatidylinositol 3–kinase activation is required for insulin-stimulated sodium transport in A6 cells
      631. Requirement of Phosphatidylinositol 3–kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts
      632. The p85 subunit of Phosphatidylinositol 3–kinase associates with the Fc receptor γ-chain and linker for activitor of T cells (LAT) in platelets stimulated by …
      633. Phosphatidylinositol 3–kinase-dependent activation of protein kinase C-ζ in bacterial lipopolysaccharide-treated human monocytes
      634. Expression of a constitutively active Phosphatidylinositol 3–kinase induces process formation in rat PC12 cells: use of Cre/loxP recombination system
      635. Inhibition of Phosphatidylinositol 3–kinase induces nitric-oxide synthase in lipopolysaccharide-or cytokine-stimulated C6 glial cells
      636. Receptors of the glial cell line-derived neurotrophic factor family of neurotrophic factors signal cell survival through the Phosphatidylinositol 3–kinase pathway in spinal …
      637. AKT2, a Member of the Protein kinase B Family, Is Activated by Growth Factors, v-Ha-ras, and v-src through Phosphatidylinositol 3–kinase in Human Ovarian …
      638. Activation of protein kinase C-ζ and Phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I
      639. Phosphatidylinositol 3–kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering
      640. Downstream of Phosphatidylinositol–3 kinase, a multifunctional signaling molecule, and its regulation in cell responses
      641. Human dopamine D3 receptors mediate mitogen-activated protein kinase activation via a Phosphatidylinositol 3–kinase and an atypical protein kinase C-dependent …
      642. Phosphatidylinositol‐3 kinase is involved in ruffled border formation in osteoclasts
      643. Membrane-targeted Phosphatidylinositol 3–kinase mimics insulin actions and induces a state of cellular insulin resistance
      644. A function for Phosphatidylinositol 3–kinase β (p85α-p110β) in fibroblasts during mitogenesis: requirement for insulin-and lysophosphatidic acid-mediated signal …
      645. Phosphatidylinositol 3‐kinase and Akt protein kinase mediate IGF‐I‐and prosaptide‐induced survival in Schwann cells
      646. Activation of Phosphatidylinositol 3‐kinase, but not extracellular‐regulated kinases, is necessary to mediate brain‐derived neurotrophic factor‐induced motoneuron …
      647. Phosphatidylinositol 3–kinase contributes to cell volume regulation through effects on ATP release
      648. Phosphatidylinositol 3–kinase is required for the formation of constitutive transport vesicles from the TGN
      649. Enhanced Phosphatidylinositol 3–kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation
      650. A collagen-related peptide regulates phospholipase Cγ2 via Phosphatidylinositol 3–kinase in human platelets
      651. Phosphatidylinositol 3‐kinase: increased activity and protein level in amyotrophic lateral sclerosis
      652. Enhanced insulin-stimulated activation of Phosphatidylinositol 3–kinase in the liver of high-fat-fed rats.
      653. SHP-1 regulates Lck-induced Phosphatidylinositol 3–kinase phosphorylation and activity
      654. Insulin-like growth factors require Phosphatidylinositol 3–kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells
      655. DHEA improves glucose uptake via activations of protein kinase C and Phosphatidylinositol 3–kinase
      656. Insulin-like growth factor-II, Phosphatidylinositol 3–kinase, nuclear factor-κB and inducible nitric-oxide synthase define a common myogenic signaling pathway
      657. Phosphorylation of CD19 Y484 and Y515, and linked activation of Phosphatidylinositol 3–kinase, are required for B cell antigen receptor-mediated activation of …
      658. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase–3 signaling pathway via Phosphatidylinositol 3–kinase
      659. Endosomal recycling of the Na+/H+ exchanger NHE3 isoform is regulated by the Phosphatidylinositol 3–kinase pathway
      660. Differential effects of constitutively active Phosphatidylinositol 3–kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes
      661. Interleukin-6 inhibits transforming growth factor-β-induced apoptosis through the Phosphatidylinositol 3–kinase/Akt and signal transducers and activators of …
      662. … in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated Phosphatidylinositol 3–kinase activity in cultured muscle …
      663. Requirement for Phosphatidylinositol–3′-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse
      664. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for Phosphatidylinositol 3–kinase in adipocytes from subjects with non-insulin …
      665. Defective regulation of Phosphatidylinositol–3–kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients
      666. … transporter mRNAs in response to insulin: role of mammalian target of rapamycin, protein kinase b, and Phosphatidylinositol 3–kinase in GLUT1 mRNA …
      667. Grb2-associated binder-1 mediates Phosphatidylinositol 3–kinase activation and the promotion of cell survival by nerve growth factor
      668. Phosphorylation–dependent interaction of the N‐methyl‐ d‐aspartate receptor ε2 subunit with Phosphatidylinositol 3‐kinase
      669. Differential regulation of insulin receptor substrates-1 and-2 (IRS-1 and IRS-2) and Phosphatidylinositol 3–kinase isoforms in liver and muscle of the obese diabetic (ob …
      670. Phosphatidylinositol 3–kinase-mediated Endocytosis of Renal Na+,K+-ATPase α Subunit in Response to Dopamine
      671. Involvement of Phosphatidylinositol 3–kinase in stromal cell-derived factor-1α-induced lymphocyte polarization and chemotaxis
      672. Protein kinase B (c-Akt), Phosphatidylinositol 3–kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an …
      673. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via Phosphatidylinositol 3–kinase
      674. Inhibition of Phosphatidylinositol–3–kinase blocks development of functional embryonic cardiomyocytes
      675. … prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1,-2, and-3, their association with p85 Phosphatidylinositol 3–kinase (PI3–kinase), and …
      676. Roles of Phosphatidylinositol 3–kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic …
      677. TGF-β1 modulates EGF-stimulated Phosphatidylinositol 3–kinase activity in human airway smooth muscle cells
      678. Phosphatidylinositol 3–kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis
      679. Phosphatidylinositol 3–kinase is a target for protein tyrosine nitration
      680. Phosphatidylinositol–3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation
      681. p21 ras and Phosphatidylinositol–3 kinase are required for survival of wild-type and NF1 mutant sensory neurons
      682. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/Phosphatidylinositol 3–kinase pathway
      683. … -activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by Phosphatidylinositol 3–kinase and calcineurin in …
      684. Microinjection of activated Phosphatidylinositol–3 kinase induces process outgrowth in rat PC12 cells through the Rac-JNK signal transduction pathway
      685. Prolactin induced tyrosine phosphorylation of p59fyn may mediate Phosphatidylinositol 3–kinase activation in Nb2 cells.
      686. Glucagon-like peptide-1 promotes DNA synthesis, activates Phosphatidylinositol 3–kinase and increases transcription factor pancreatic and duodenal homeobox gene …
      687. Phosphatidylinositol 3–kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein
      688. Phosphatidylinositol 3–kinase Requirement in Activation of the ras/C-raf-1/MEK/ERK and p70s6k Signaling Cascade by the Insulinomimetic Agent Vanadyl Sulfate
      689. Ataxia‐telangiectasia without immunodeficiency: Novel point mutations within and adjacent to the Phosphatidylinositol 3‐kinase‐like domain
      690. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, Phosphatidylinositol 3–kinase, and p120CBL
      691. Modification of Phosphatidylinositol 3–kinase SH2 domain binding properties by Abl-or Lck-mediated tyrosine phosphorylation at Tyr-688
      692. Identification of a common amino acid polymorphism in the p85α regulatory subunit of Phosphatidylinositol 3–kinase: effects on glucose disappearance constant …
      693. Region‐specific mRNA expression of Phosphatidylinositol 3‐kinase regulatory isoforms in the central nervous system of C57BL/6J mice
      694. Heat shock activates c-Src tyrosine kinases and Phosphatidylinositol 3–kinase in NIH3T3 fibroblasts
      695. Evidence of a role for Phosphatidylinositol 3–kinase activation in the blocking of apoptosis by polyomavirus middle T antigen
      696. Comparative Effects of GTPγS and Insulin on the Activation of Rho, Phosphatidylinositol 3–kinase, and Protein kinase N in Rat Adipocytes: RELATIONSHIP …
      697. Nerve growth factor protects PC12 cells against peroxynitrite‐induced apoptosis via a mechanism dependent on Phosphatidylinositol 3‐kinase
      698. Activation of Phosphatidylinositol 3–kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin …
      699. Phosphatidylinositol 3–kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading
      700. … of the ADP-ribosylation factor-exchange factor GRP1 to the plasma membrane of PC12 cells requires activation of Phosphatidylinositol 3–kinase and the GRP1 …
      701. Thymocyte activation induces the association of Phosphatidylinositol 3‐kinase and pp120 with CD5
      702. Heregulin β1-activated Phosphatidylinositol 3–kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase
      703. Phosphatidylinositol 3–kinase Is Required for Growth Factor–Induced Amino Acid Uptake by Vascular Smooth Muscle Cells
      704. The proto-oncogene product p120cbl links c-Src and Phosphatidylinositol 3′-kinase to the integrin signaling pathway
      705. CD28 receptor endocytosis is targeted by mutations that disrupt Phosphatidylinositol 3–kinase binding and costimulation
      706. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a Phosphatidylinositol 3–kinase-dependent mechanism
      707. Assessment of the roles of mitogen-activated protein kinase, Phosphatidylinositol 3–kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP …
      708. Thrombopoietin induces activation of the Phosphatidylinositol‐3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL
      709. Signaling through CD5 activates a pathway involving Phosphatidylinositol 3–kinase, Vav, and Rac1 in human mature T lymphocytes
      710. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with Phosphatidylinositol 3–kinase
      711. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and Phosphatidylinositol 3–kinase
      712. Epidermal growth factor modulates tyrosine phosphorylation of p130Cas: involvement of Phosphatidylinositol 3′-kinase and actin cytoskeleton
      713. Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the …
      714. Selective up-regulation of Phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 …
      715. Inhibition of Phosphatidylinositol 3–kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons
      716. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of Phosphatidylinositol 3–kinase and is independent of insulin receptor tyrosine …
      717. Phosphatidylinositol 3–kinase-dependent and-independent cytolytic effector functions
      718. Activation of Phosphatidylinositol 3–kinase by interleukin-13: an inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29
      719. G1 phase arrest by the Phosphatidylinositol 3–kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal …
      720. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation …
      721. … Tyrosine Phosphorylation of p130Cas, Focal Adhesion kinase, and Paxillin: ROLE OF Phosphatidylinositol 3′-kinase AND FORMATION OF A …
      722. Gastrin stimulates the formation of a p60Src/p125FAK complex upstream of the Phosphatidylinositol 3–kinase signaling pathway
      723. A Phosphatidylinositol 3–kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts
      724. A Phosphatidylinositol 3–kinase and Phosphatidylinositol transfer protein act synergistically in formation of constitutive transport vesicles from the trans-Golgi …
      725. Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the Phosphatidylinositol 3–kinase, protein kinase B/Akt, and p70 S6 …
      726. α-Adrenergic stimulation mediates glucose uptake through Phosphatidylinositol 3–kinase in rat heart
      727. A Phosphatidylinositol 3‐kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation
      728. Intracellular movement of green fluorescent protein–tagged Phosphatidylinositol 3–kinase in response to growth factor receptor signaling
      729. Activation and translocation of Rho (and ADP ribosylation factor) by insulin in rat adipocytes: apparent involvement of Phosphatidylinositol 3–kinase
      730. Intermediate affinity interleukin-2 receptor mediates survival via a Phosphatidylinositol 3–kinase-dependent pathway
      731. The Phosphatidylinositol 3–kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human …
      732. … pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of Phosphatidylinositol 3–kinase and protein kinase C.
      733. The Phosphatidylinositol 3‐kinase inhibitor wortmannin alters the metabolism of the Alzheimer’s amyloid precursor protein
      734. … tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: Phosphatidylinositol–3 kinase is required for …
      735. Involvement of Phosphatidylinositol 3–kinase in NFAT activation in T cells
      736. Endothelin-1 modulates insulin signaling through Phosphatidylinositol 3–kinase pathway in vascular smooth muscle cells.
      737. Phosphatidylinositol 3–kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocytic differentiation
      738. Multiple isoforms of the regulatory subunit for Phosphatidylinositol 3–kinase (PI3–kinase) are expressed in neurons in the rat brain
      739. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 Phosphatidylinositol 3–kinase and the class II PI3K-C2α
      740. The p85 and p110 subunits of Phosphatidylinositol 3–kinase-α are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets
      741. Phosphatidylinositol 3–kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma …
      742. The epidermal growth factor receptor associates with and recruits Phosphatidylinositol 3–kinase to the platelet-derived growth factor β receptor
      743. The Phosphatidylinositol 3′ kinase pathway is required for the survival signal of leukocyte tyrosine kinase
      744. Phosphatidylinositol 3–kinase is a requirement for insulin-like growth factor I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes
      745. Stimulation of IRS-1-associated Phosphatidylinositol 3–kinase and Akt/protein kinase B but not glucose transport by β1-integrin signaling in rat adipocytes
      746. … colony-stimulating factor-activated signaling pathways in human neutrophils: involvement of Jak2 in the stimulation of Phosphatidylinositol 3–kinase
      747. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and Phosphatidylinositol 3–kinase.
      748. MAP kinase activation by mu opioid receptor involves Phosphatidylinositol 3–kinase but not the cAMP/PKA pathway
      749. Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cγ or Phosphatidylinositol 3 kinase
      750. Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and Phosphatidylinositol 3–kinase
      751. … novel pathway for tumor necrosis factor-α and ceramide signaling involving sequential activation of tyrosine kinase, p21ras, and Phosphatidylinositol 3–kinase
      752. Synergistic roles of neuregulin-1 and insulin-like growth factor-I in activation of the Phosphatidylinositol 3–kinase pathway and cardiac chamber …
      753. Calmodulin is involved in membrane depolarization-mediated survival of motoneurons by Phosphatidylinositol–3 kinase-and MAPK-independent pathways
      754. p70 S6 kinase is activated by sodium arsenite in adult rat cardiomyocytes: roles for Phosphatidylinositol 3–kinase and p38 MAP kinase
      755. Phosphatidylinositol 3–kinase and Ca2+ influx dependence for ligand-stimulated internalization of the c-Kit receptor
      756. Epidermal growth factor receptor-regulated human bladder cancer motility is in part a Phosphatidylinositol 3–kinase-mediated process
      757. Involvement of Phosphatidylinositol–3 kinase in prevention of low K+-induced apoptosis of cerebellar granule neurons
      758. PTEN modulates cell cycle progression and cell survival by regulating Phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway
      759. … lipopolysaccharide stimulate extracellularly regulated kinase activation in macrophages by a mechanism involving Phosphatidylinositol 3–kinase and phospholipase D …
      760. CD28 can promote T cell survival through a Phosphatidylinositol 3‐kinase‐independent mechanism
      761. SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and Phosphatidylinositol 3–kinase
      762. Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires Phosphatidylinositol 3–kinase
      763. Lysophosphatidylcholine generates superoxide anions through activation of Phosphatidylinositol 3–kinase in human neutrophils
      764. Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with Phosphatidylinositol 3–kinase in skeletal muscle cells
      765. The survival of sympathetic neurons promoted by potassium depolarization, but not by cyclic AMP, requires Phosphatidylinositol 3‐kinase and Akt
      766. Nuclear translocation of PKCζ during ischemia and its inhibition by wortmannin, an inhibitor of Phosphatidylinositol 3–kinase
      767. CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of Phosphatidylinositol 3–kinase.
      768. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate Phosphatidylinositol 3–kinase
      769. 14-3–3β protein associates with insulin receptor substrate 1 and decreases insulin-stimulated Phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes
      770. Evidence that Phosphatidylinositol 3–kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol.
      771. Inhibition of Phosphatidylinositol 3‐kinase activity blocks cellular differentiation mediated by glial cell line‐derived neurotrophic factor in dopaminergic neurons
      772. Roles of Phosphatidylinositol 3–kinase and Rac in the nuclear signaling by tumor necrosis factor-α in rat-2 fibroblasts
      773. Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting Phosphatidylinositol–3′ kinase
      774. The role of Phosphatidylinositol 3–kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression
      775. Mitogen-activated protein kinase and Phosphatidylinositol 3–kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis
      776. Fc receptor-mediated platelet activation is dependent on Phosphatidylinositol 3–kinase activation and involves p120cbl
      777. Variant in the regulatory subunit of Phosphatidylinositol 3–kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin …
      778. … 3–kinase/p70 ribosomal S6 protein kinase pathway is required for the regulation by insulin of the p85α regulatory subunit of Phosphatidylinositol 3–kinase …
      779. The involvement of Phosphatidylinositol 3–kinase in crystal induced human neutrophil activation.
      780. Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive Phosphatidylinositol–3–kinase
      781. … receptors gives rise to the selective modulation of intracellular signaling in B cells: regulation of the association of Phosphatidylinositol 3–kinase and inositol 5 …
      782. Phosphatidylinositol 3′-kinase and tyrosine-phosphatase activation positively modulate Convulxin-induced platelet activation. Comparison with collagen
      783. Phosphorylation of cbl after Stimulation of Nb2 Cells with Prolactin and Its Association with Phosphatidylinositol 3–kinase
      784. Phosphatidylinositol 3–kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6-phosphatase during refeeding
      785. Regulation of endocytic-transcytotic pathways and bile secretion by Phosphatidylinositol 3–kinase in rats
      786. Cripto-1 induces Phosphatidylinositol 3′-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3β in human cervical carcinoma cells
      787. Epidermal growth factor stimulation of Phosphatidylinositol 3–kinase during wound closure in rabbit corneal epithelial cells.
      788. … induces the tyrosine phosphorylation of insulin receptor substrate-2: an alternate pathway for erythropoietin-induced Phosphatidylinositol 3–kinase activation
      789. Localization of a class II Phosphatidylinositol 3–kinase, PI3KC2α, to clathrin-coated vesicles
      790. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and Phosphatidylinositol 3–kinase activity
      791. Possible involvement of Phosphatidylinositol 3‐kinase in regulated exocytosis: studies in chromaffin cells with inhibitor LY294002
      792. Src-family Tyrosine kinases in Activation of ERK-1 and p85/p110-Phosphatidylinositol 3–kinase by G/CCKBReceptors
      793. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of Phosphatidylinositol 3–kinase via a CD19-independent pathway
      794. Cloning of human p55γ, a regulatory subunit of Phosphatidylinositol 3–kinase, by a yeast two-hybrid library screen with the insulin-like growth factor-I receptor
      795. Angiotensin II induces activation of Phosphatidylinositol 3–kinase in cardiomyocytes
      796. Involvement of Phosphatidylinositol 3′‐kinase in stem‐cell‐factor‐induced phospholipase D activation and arachidonic acid release
      797. CD45-induced tumor necrosis factor α production in monocytes is Phosphatidylinositol 3–kinase-dependent and nuclear factor-κB-independent
      798. Wortmannin, a Phosphatidylinositol 3–kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells.
      799. Phosphatidylinositol 3–kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinase EMT/ITK/TSK: functional and physical interaction of EMT …
      800. Endothelin-1-induced GLUT4 translocation is mediated via Gαq/11 protein and Phosphatidylinositol 3–kinase in 3T3-L1 adipocytes
      801. N-Methyl-D-aspartate inhibits apoptosis through activation of Phosphatidylinositol 3–kinase in cerebellar granule neurons: a role for insulin receptor substrate …
      802. Phosphatidylinositol 3‐kinase binds to profilin through the p85α subunit and regulates cytoskeletal assembly
      803. HMG-CoA reductase inhibitor-induced L6 myoblast cell death: involvement of the Phosphatidylinositol 3–kinase pathway
      804. Requirement for Ras and Phosphatidylinositol 3–kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial electrical …
      805. Cell Interactions with Collagen Matrices In Vivo and In Vitro Depend on Phosphatidylinositol 3–kinase and Free Cytoplasmic Calcium
      806. Affinity modulation of very late antigen-5 through Phosphatidylinositol 3–kinase in mast cells
      807. Tyrosine phosphorylation of the CD3-ε subunit of the T cell antigen receptor mediates enhanced association with Phosphatidylinositol 3–kinase in Jurkat T …
      808. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated Phosphatidylinositol 3–kinase in 3T3-L1 adipocytes without …
      809. … choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and Phosphatidylinositol 3′-kinase through an extracellular site …
      810. Functional cooperation of the interleukin-2 receptor β chain and Jak1 in Phosphatidylinositol 3–kinase recruitment and phosphorylation
      811. … Factor–Activated Signaling Pathways in Human Neutrophils. I. Tyrosine Phosphorylation-Dependent Stimulation of Phosphatidylinositol 3–kinase and Inhibition by …
      812. Insulin receptor substrate-1 and Phosphatidylinositol 3–kinase regulate extracellular signal-regulated kinase-dependent and-independent signaling pathways during …
      813. Binding of receptor-recognized forms of α2-macroglobulin to the α2-macroglobulin signaling receptor activates Phosphatidylinositol 3–kinase
      814. … HT-29 cells is independent of nitric oxide formation: evidence for an interleukin-13-driven Phosphatidylinositol 3–kinase-dependent survival mechanism
      815. Involvement of protein tyrosine kinase p72syk and Phosphatidylinositol 3–kinase in CD2-mediated granular exocytosis in the natural killer cell line, NK3. 3.
      816. Expression of Phosphatidylinositol 3–kinase during EGF-Stimulated Wound Repair in Rabbit Corneal Epithelium
      817. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and Phosphatidylinositol 3–kinase dependent mechanism
      818. SHP-1 associates with both platelet-derived growth factor receptor and the p85 subunit of Phosphatidylinositol 3–kinase
      819. CD72‐mediated B cell activation involves recruitment of CD19 and activation of Phosphatidylinositol 3‐kinase
      820. Action of insulin on the surface morphology of hepatocytes: role of Phosphatidylinositol 3–kinase in insulin-induced shape change of microvilli
      821. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and Phosphatidylinositol 3–kinase
      822. … factor of src-and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells: Phosphatidylinositol 3′-kinase is a critical …
      823. Identification and chromosome assignment of a human gene encoding a novel Phosphatidylinositol–3 kinase
      824. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid …
      825. Epidermal growth factor and insulin-induced deoxyribonucleic acid synthesis in primary rat hepatocytes is Phosphatidylinositol 3–kinase dependent and dissociated …
      826. … (p125FAK) and paxillin in rat pancreatic acini by a phospholipase C-independent process that depends on Phosphatidylinositol 3–kinase, the small GTP …
      827. Effects of Phosphatidylinositol–3–kinase inhibitors on degranulation and gene induction in allergically triggered mouse mast cells
      828. Activation of Phosphatidylinositol 3‘-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes.
      829. Epidermal growth factor stimulates phospholipase D independent of phospholipase C, protein kinase C or Phosphatidylinositol–3 kinase activation in immortalized …
      830. … diphosphotyrosine-containing peptide that mimics activated platelet-derived growth factor receptor β induces oligomerization of Phosphatidylinositol 3–kinase
      831. Monocytic differentiation of HL-60 cells is characterized by the nuclear translocation of Phosphatidylinositol 3–kinase and of definite Phosphatidylinositol-specific …
      832. Thapsigargin-induced secretion is dependent on activation of a cholera toxin-sensitive and Phosphatidylinositol–3–kinase-regulated phospholipase D in a mast cell …
      833. Changes in the mitogen-activated protein kinase and Phosphatidylinositol 3–kinase/Akt signaling associated with the induction of apoptosis.
      834. IL-2 signaling controls actin organization through Rho-like protein family, Phosphatidylinositol 3–kinase, and protein kinase C-zeta.
      835. A role for Phosphatidylinositol 3–kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin
      836. Differential association of Phosphatidylinositol 3–kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7.
      837. Effect of wortmannin, an inhibitor of Phosphatidylinositol 3–kinase, on the first mitotic divisions of the fertilized sea urchin egg
      838. Platelet‐Derived Growth Factor Stimulates Sodium‐Dependent Pi Transport in Osteoblastic Cells via Phospholipase Cγ and Phosphatidylinositol 3′‐kinase
      839. Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen‐activated protein kinase and Phosphatidylinositol 3‐kinase
      840. Phosphatidylinositol 3–kinase and dynamics of insulin resistance in denervated slow and fast muscles in vivo
      841. Phosphatidylinositol 4-kinase, but not Phosphatidylinositol 3–kinase, is present in GLUT4-containing vesicles isolated from rat skeletal muscle
      842. Raf-1 kinase Activation by Angiotensin II in Adrenal Glomerulosa Cells: Roles of Gi, Phosphatidylinositol 3–kinase, and Ca2+ Influx
      843. The inositol polyphosphate 4-phosphatase forms a complex with Phosphatidylinositol 3–kinase in human platelet cytosol
      844. … chemokinesis in normal human neutrophils is dependent on D‐glucose concentration and sensitive to inhibitors of tyrosine kinase and Phosphatidylinositol 3‐kinase
      845. Brain‐derived neurotrophic factor stimulates interactions of Shp2 with Phosphatidylinositol 3‐kinase and Grb2 in cultured cerebral cortical neurons
      846. Phosphatidylinositol 3–kinase and focal adhesion kinase are early signals in the growth factor–like responses to thrombospondin-1 seen in human vascular smooth …
      847. Insulin stimulation of K+ uptake in 3T3-L1 fibroblasts involves Phosphatidylinositol 3–kinase and protein kinase C-zeta
      848. Phosphatidylinositol 3′-kinase and p70s6k are required for insulin but not bisperoxovanadium 1, 10-phenanthroline (bpV (phen)) inhibition of insulin-like …
      849. … secretagogues activate protein tyrosine phosphorylation and release of arachidonic acid in mast cells via a novel protein kinase C and Phosphatidylinositol 3‐kinase …
      850. Possible role for Phosphatidylinositol 3–kinase in regulating meiotic maturation of bovine oocytes in vitro
      851. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with Phosphatidylinositol 3–kinase in response to brain-derived …
      852. … C-γ1 renders platelet-derived growth factor β-receptor-expressing cells independent of the Phosphatidylinositol 3–kinase pathway for chemotaxis
      853. Activation of Phosphatidylinositol 3–kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases
      854. Potentiation of Insulin-Induced Phosphatidylinositol–3 kinase Activity by Phorbol Ester Is Mediated by Protein kinase Cϵ
      855. Phosphatidylinositol 3–kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor
      856. Signalling-competent truncated forms of ErbB2 in breast cancer cells: differential regulation by protein kinase C and Phosphatidylinositol 3–kinase
      857. Involvement of both the tyrosine kinase and the Phosphatidylinositol–3′ kinase signal transduction pathways in the regulation of lipoprotein lipase expression in J774 …
      858. Role of Phosphatidylinositol 3–kinase in degranulation induced by IgE-dependent and-independent mechanisms in rat basophilic RBL-2H3 (ml) cells
      859. PDGF-induced glycosaminoglycan synthesis is mediated via Phosphatidylinositol 3–kinase
      860. … new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-Phosphatidylinositol 3–kinase in human T …
      861. Phosphatidylinositol 3–kinase mediates heregulin-induced growth inhibition in human epithelial cells.
      862. Insulin activation of Phosphatidylinositol 3–kinase in human skeletal muscle in vivo
      863. … is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the Phosphatidylinositol 3′-kinase …
      864. Phosphatidylinositol 3–kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory …
      865. The Phosphatidylinositol 3–kinase inhibitor wortmannin sensitizes quiescent but not proliferating MG-63 human osteosarcoma cells to radiation
      866. Contrasting Signaling Pathways of α1A- and α1B-Adrenergic Receptor Subtype Activation of Phosphatidylinositol 3–kinase and Ras in Transfected NIH3T3 Cells
      867. Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and Phosphatidylinositol 3–kinase inhuman …
      868. Inositide signalling in Chlamydomonas: characterization of a Phosphatidylinositol 3–kinase gene
      869. Suppression of insulin-stimulated Phosphatidylinositol 3–kinase activity by the β3-adrenoceptor agonist CL316243 in rat adipocytes
      870. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and Phosphatidylinositol 3′-kinase in myeloid cells
      871. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by Phosphatidylinositol 3–kinase inhibitors in SH …
      872. … and protein kinase C in dibutyryl cAMP-differentiated U937 cells is dependent solely on the tyrosine-kinase activated form of Phosphatidylinositol–3–kinase
      873. … to membrane expansion during growth of cultured embryonic mouse hippocampal neurons: sensitivity to inhibitors of Phosphatidylinositol 3–kinase and other protein …
      874. LY294002-mediated inhibition of Phosphatidylinositol 3–kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos–Burkitt lymphoma B cells
      875. Oncogenic Ras-induced germinal vesicle breakdown is independent of Phosphatidylinositol 3–kinase in Xenopus oocytes
      876. The structural requirement of Phosphatidylinositols as substrate of Phosphatidylinositol 3–kinase
      877. Phosphatidylinositol 3–kinase regulates differentiation of H9c2 cardiomyoblasts mainly through the protein kinase B/Akt-independent pathway
      878. H-ras induces glucose uptake in brown adipocytes in an insulin-and Phosphatidylinositol 3–kinase-independent manner
      879. Interaction of Wild Type and Dominant-Negative p55PIK Regulatory Subunit of Phosphatidylinositol 3–kinase with Insulin-Like Growth Factor-1 Signaling Proteins
      880. Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and Phosphatidylinositol–3–kinase …
      881. EGF activates ErbB-2 and stimulates Phosphatidylinositol 3–kinase in human airway smooth muscle cells
      882. CD16‐mediated activation of Phosphatidylinositol‐3 kinase (Pl‐3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc …
      883. Retinoic acid inhibits transformation by preventing Phosphatidylinositol 3–kinase dependent activation of the c-fos promoter
      884. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the Phosphatidylinositol 3–kinase
      885. … of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, Phosphatidylinositol 3–kinase β, and protein …
      886. Insulin signalling in heart involves insulin receptor substrates-1 and-2, activation of Phosphatidylinositol 3–kinase and the JAK 2-growth related pathway
      887. Wortmannin blocks goldfish retinal Phosphatidylinositol 3–kinase and neurite outgrowth
      888. … transcription: involvement of the ligand-binding domain of the glucocorticoid receptor and independence from the Phosphatidylinositol 3–kinase and mitogen-activated …
      889. Binding of CD4 ligands induces tyrosine phosphorylation of Phosphatidylinositol–3 kinase p110 subunit.
      890. Involvement of Phosphatidylinositol 3–kinase and mitogen-activated protein kinase pathways in AII-mediated enhanced expression of Gi proteins in vascular smooth …
      891. … -1–induced cell-cycle progression: involvement of extracellular signal-regulated kinase, protein kinase C, and Phosphatidylinositol 3–kinase at distinct points
      892. Phosphatidylinositol 3–kinase in myogenesis
      893. Involvement of Phosphatidylinositol 3–kinase in the mediation of erythropoietin-induced activation of p70S6k
      894. Liver microsomal glucose-6-phosphatase is competitively inhibited by the lipid products of Phosphatidylinositol 3–kinase
      895. Interleukin-3 induces association of the protein-tyrosine phosphatase SHP2 and Phosphatidylinositol 3–kinase with a 100-kDa tyrosine-phosphorylated …
      896. Structural and biochemical evaluation of the interaction of the Phosphatidylinositol 3–kinase p85α Src homology 2 domains with phosphoinositides and …
      897. Phosphatidylinositol 3–kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth
      898. Corneal epithelial wound healing increases the expression but not long lasting activation of the p85a subunit of Phosphatidylinositol–3 kinase
      899. Wortmannin, a Phosphatidylinositol 3–kinase inhibitor, blocks the assembly of peptide-MHC class II complexes.
      900. Design of peptidomimetics that inhibit the association of Phosphatidylinositol 3–kinase with platelet-derived growth factor-β receptor and possess cellular activity
      901. Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1: regulation by Rho and Phosphatidylinositol 3–kinase
      902. Inhibition of MG‐63 cell proliferation and PDGF‐stimulated cellular processes by inhibitors of Phosphatidylinositol 3‐kinase
      903. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and Phosphatidylinositol 3–kinase
      904. JNK/SAPK activation by platelet-derived growth factor in A431 cells requires both the phospholipase C-γ and the Phosphatidylinositol 3–kinase signaling pathways of …
      905. Evidence for Phosphatidylinositol 3–kinase-dependent T cell antigen receptor (TCR) signal transduction
      906. Effects of Phosphatidylinositol 3–kinase inhibitors, wortmannin and LY294002, on germinal vesicle breakdown (GVBD) in porcine oocytes
      907. Phosphatidylinositol 3–kinase is not required for recycling of mannose 6-phosphate receptors from late endosomes to the trans-Golgi network.
      908. Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and Phosphatidylinositol 3–kinase activity in skeletal muscle and …
      909. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and Phosphatidylinositol 3‘-kinase-dependent pathway.
      910. An Insulin-like Growth Factor-mediated, Phosphatidylinositol 3′ kinase-independent Survival Signaling Pathway in β Tumor Cells
      911. … a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired Phosphatidylinositol 3–kinase activity in fibroblasts
      912. Hydrogen peroxide-induced activation of SAPK/JNK regulated by Phosphatidylinositol 3–kinase in Chinese hamster V79 cells
      913. Synergistic role of the Phosphatidylinositol 3–kinase and mitogen-activated protein kinase cascade in the regulation of insulin receptor trafficking
      914. Evidence that thrombin-stimulated DNA synthesis in pulmonary arterial fibroblasts involves Phosphatidylinositol 3–kinase-dependent p70 ribosomal S6 kinase …
      915. Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
      916. Possibility of Distinct Insulin-Signaling Pathways Beyond Phosphatidylinositol 3–kinase–Mediating Glucose Transport and Lipogenesis
      917. Insulin‐stimulated cell growth in insulin receptor substrate‐1–deficient ZR‐75‐1 cells is mediated by a Phosphatidylinositol‐3‐kinase–independent pathway
      918. Down regulation of the expression of the p110, p85 and p55 subunits of Phosphatidylinositol 3–kinase during colon cancer cell anchorage-independent growth.
      919. c-Src and Phosphatidylinositol 3–kinase are involved in NGF-dependent tyrosine phosphorylation of Shc in PC12 cells
      920. Is stimulation of class-1 Phosphatidylinositol 3–kinase activity by insulin sufficient to activate pathways involved in glucose metabolism.
      921. Phenylarsine oxide inhibits insulin activation of Phosphatidylinositol 3′-kinase
      922. Interaction of insulin receptor substrate-1 (IRS-1) with Phosphatidylinositol 3–kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation …
      923. Phosphorylation of the Grb2-and Phosphatidylinositol 3–kinase p85–binding p36/38 by Syk in Lck-Negative T Cells
      924. Tyrosine phosphorylation of Phosphatidylinositol 3–kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells
      925. … in neonatal rat ventricular myocytes by Ras is mediated by Ral guanine nucleotide dissociation stimulator (Ral. GDS) and Phosphatidylinositol 3–kinase in addition to …
      926. Effect of Ethanol on Intracellular Vesicular Transport from Golgi to the Apical Cell Membrane: Role of Phosphatidylinositol 3‐kinase and Phospholipase A2 in Golgi …
      927. Evidence that a kinase distinct from protein kinase C and Phosphatidylinositol 3–kinase mediates ligation-dependent serine/threonine phosphorylation of the T …
      928. Interleukin-4 (IL-4) induces Phosphatidylinositol 3–kinase (p85) dephosphorylation: implications for the role of SHP-1 in the IL-4-induced signals in human B …
      929. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and Phosphatidylinositol 3′-kinase
      930. Phosphatidylinositol 3–kinase is required for the regulation of hepatitis B surface antigen production and mitogen-activated protein kinase activation by insulin but not …
      931. Formation of distinct signalling complexes involving Phosphatidylinositol 3‐kinase activity with stimulation of epidermal growth factor or insulin‐like growth factor‐I in …
      932. Secretory IgA-mediated basophil activation: II. Roles of GTP-binding regulatory proteins and Phosphatidylinositol 3–kinase
      933. Identification of protein kinase B (PKB) as a Phosphatidylinositol 3, 4, 5-trisphosphate binding protein in Dictyostelium discoideum
      934. Density dependent elevation of Phosphatidylinositol–3 kinase level in rat 3Y1 cells
      935. CD40-triggered protein tyrosine phosphorylation on Vav and on Phosphatidylinositol 3–kinase correlates with survival of the Ramos–Burkitt lymphoma B cell line
      936. Phosphatidylinositol 3–kinase translocation to the nucleus is an early event in the interleukin-1 signalling mechanism in human osteosarcoma Saos-2 cells.
      937. … and insensitive intracellular signalling pathways in undifferentiated 3T3‐L1 cells stimulated by insulin converge with Phosphatidylinositol 3‐kinase upstream of the …
      938. Phosphatidylinositol 3′-kinase is associated with a serine kinase that is activated by okadaic acid
      939. Phosphatidylinositol 3–kinase in Cumulus Cells is Responsible for Meiotic Progression from MI to M II Stage in Porcine Follicular Oocytes
      940. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, Phosphatidylinositol 3′-kinase, and Grb2
      941. … Nucleotide Exchange Factor and Ha-Ras: EVIDENCES FOR A FUNCTION OF Raf-1 AND Phosphatidylinositol 3–kinase UPSTREAM TO Ras
      942. … in tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 (IRS-1) and association of p85 subunit of Phosphatidylinositol 3–kinase with IRS-1 after …
      943. Polymorphism and CH… O interaction of wortmannin, a Phosphatidylinositol 3–kinase inhibitor
      944. … stimulation lowers the activation threshold and enhances the alloreactivity of cord blood T cells by activating the Phosphatidylinositol 3–kinase pathway and inducing …
      945. … ) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires an intact phosphotyrosine binding domain but not Crk (L) or p85 Phosphatidylinositol 3–kinase …
      946. Role of Phosphatidylinositol 3–kinase in platelet aggregation
      947. Down‐regulation of LFA‐1‐mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires Phosphatidylinositol‐3‐kinase activity
      948. Phosphatidylinositol-4-phosphate 5-kinase isozymes catalyze the synthesis of 3-phosphate-containing Phosphatidylinositol signaling molecules
      949. … -(Hexadecyloxy)-3 (5)-Methoxybutanephosphonate (C4-PI), Inhibits Epithelial Cell Proliferation and is a Substrate but not an Inhibitor of Phosphatidylinositol 3–kinase
      950. Up-regulation of Phosphatidylinositol 3–kinase in psoriatic lesions
      951. … of connexin-43, gap junctional protein, in cumulus cells is regulated by mitogen-activated protein kinase and Phosphatidylinositol 3–kinase during in vitro meiotic …
      952. Inhibition of Phosphatidylinositol 3–kinase
      953. 1 , 25-Dihydroxyvitamin D 3–induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3–kinase Signaling Complex
      954. Immunocytochemical detection of Phosphatidylinositol 3 kinase in Burkitt lymphoma cells
      955. Defect in long-term activation of Phosphatidylinositol 3–kinase by insulin in vivo: studies in insulin-resistant hHTg rats
      956. Hexamethylenebisacetamide modulation of thyroglobulin and protein levels in thyroid cells is not mediated by Phosphatidylinositol–3–kinase: A study with wortmannin
      957. The regulation and function of Phosphatidylinositol 3–kinase
      958. A role for Phosphatidylinositol 3–kinase in platelet aggregation
      959. Activation of the Phosphatidylinositol 3–kinase Serine kinase by 1FN-a’
      960. Phosphatidylinositol 3–kinase mediates interleukin-l-induced activation of NFB and AP-1 Shrikanth
      961. Regulation of the p85/p110 Phosphatidylinositol 3–kinase
      962. Through Phosphatidylinositol 3–kinase in Rat Heart
      963. Cloning and characterisation of novel isoforms of Phosphatidylinositol 3–kinase
      964. REGULATION OF CHOLANGIOCYTE CL SECRETION BY Phosphatidylinositol 3–kinase
      965. Bidirectional Effect of Regulatory Subunits of Phosphatidylinositol 3–kinase Dependent Signalling Pathway
      966. Role of Phosphatidylinositol 3–kinase as an effector of Ras
      967. Mechanism of radiation sensitization by wortmannin, a Phosphatidylinositol–3 kinase inhibitor
      968. Up-regulation of Phosphatidylinositol 3–kinase in psoriatic lesions
      969. Activation of Phosphatidylinositol 3–kinase via epidermal growth factor receptor in isolated rat hepatocytes
      970. Studies of a Phosphatidylinositol 3–kinase complex linked to vesicular trafficking in human cells
      971. Comparison of insulin and platelet-derived growth factor signaling: focusing on Phosphatidylinositol 3–kinase
      972. Activation of p70S6K and ERK as well as Akt by Heat Shock and Hyperosmorality Stress is Phosphatidylinositol 3–kinase Dependent
      973. Inhibition of proliferation by wortmannin through the blokade of Phosphatidylinositol 3–kinase in mast cell line P815
      974. Antagonists of Phosphatidylinositol 3–kinase block phosphorylation-dependent activation of the leukocyte NADPH oxidase in a cell-free system
      975. Phosphatidylinositol 3–kinase AND cAMP INVOLVEMENT IN THE GROWTH HORMONE REGULATION OF ION TRANSPORT IN CACO-2 CELLS
      976. Serendipitous studies in cell signaling: The role of Phosphatidylinositol 3–kinase (PI3K) in signal transduction, identification of new PI3K targets, and the …
      977. Activation of Phosphatidylinositol 3–kinase by interleukin-13 in colonic epithelial cells: regulation of nitric oxide and apoptosis
      978. Phosphatidylinositol–3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.
      979. Beclin–Phosphatidylinositol 3–kinase complex functions at the trans-Golgi network
      980. Phosphatidylinositol 3–kinase signaling controls levels of hypoxia-inducible factor
      981. New role for Shc in activation of the Phosphatidylinositol 3–kinase/Akt pathway
      982. Regulation of B-cell activation and differentiation by the Phosphatidylinositol 3–kinase and phospholipase Cgamma pathway.
      983. Phosphatidylinositol 3–kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance
      984. Phosphatidylinositol 3–kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
      985. Tyrosine phosphorylation of p85 relieves its inhibitory activity on Phosphatidylinositol 3–kinase
      986. A Phosphatidylinositol 3–kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
      987. The Phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors
      988. Two Distinct Vps34 Phosphatidylinositol 3–kinase Complexes Function in Autophagy and Carboxypeptidase Y Sorting inSaccharomyces cerevisiae
      989. Regulation of neutrophil apoptosis: a role for protein kinase C and Phosphatidylinositol–3–kinase
      990. Ischemic preconditioning activates Phosphatidylinositol–3–kinase upstream of protein kinase C
      991. Role of Phosphatidylinositol 3–kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
      992. Phosphatidylinositol 3–kinase signaling inhibits DAF-16 DNA binding and function via 14-3–3-dependent and 14-3–3-independent pathways
      993. Phosphatidylinositol 3–kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis
      994. Phosphatidylinositol 3‐kinase mediates neuroprotection by estrogen in cultured cortical neurons
      995. Anti-apoptotic signaling by hepatocyte growth factor/Met via the Phosphatidylinositol 3–kinase/Akt and mitogen-activated protein kinase pathways
      996. Phosphatidylinositol 3–kinase regulates Raf1 through Pak phosphorylation of serine 338
      997. Transforming ability of MEN2A-RET requires activation of the Phosphatidylinositol 3–kinase/AKT signaling pathway
      998. Phosphatidylinositol 3–kinase as a mediator of TNF-induced NF-κB activation
      999. Expression of constitutively active Phosphatidylinositol 3–kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells
      1000. In Vivo and in Vitro Ovarian Carcinoma Growth Inhibition by a Phosphatidylinositol 3–kinase Inhibitor (LY294002)
      1001. Opposing actions of Phosphatidylinositol 3‐kinase and glycogen synthase kinase‐3β in the regulation of HSF‐1 activity
      1002. Phosphatidylinositol 3–kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration
      1003. Substrate specificity of αvβ3integrin-mediated cell migration and Phosphatidylinositol 3–kinase/AKT pathway activation
      1004. Role of reactive oxygen species and Phosphatidylinositol 3–kinase in cardiomyocyte differentiation of embryonic stem cells
      1005. Phosphatidylinositol 3–kinase/Akt activity regulates c-FLIP expression in tumor cells
      1006. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the Phosphatidylinositol 3–kinase/protein kinase B pathway
      1007. The Phosphatidylinositol 3–kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses
      1008. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on Phosphatidylinositol 3–kinase and Phosphatidylinositol 3-phosphate pathway
      1009. Insulin-like growth factor-mediated muscle differentiation: collaboration between Phosphatidylinositol 3–kinase-Akt-signaling pathways and myogenin
      1010. The β2-Adrenergic Receptor Delivers an Antiapoptotic Signal to Cardiac Myocytes Through Gi-Dependent Coupling to Phosphatidylinositol 3′-kinase
      1011. Phosphatidylinositol 3–kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association
      1012. The osteopontin-CD44 survival signal involves activation of the Phosphatidylinositol 3–kinase/Akt signaling pathway
      1013. Latent membrane protein 2A-mediated effects on the Phosphatidylinositol 3–kinase/Akt pathway
      1014. The p75 neurotrophin receptor activates Akt (protein kinase B) through a Phosphatidylinositol 3–kinase-dependent pathway
      1015. Pancreatic cancer cell proliferation is Phosphatidylinositol 3–kinase dependent
      1016. Lipoarabinomannan from Mycobacterium tuberculosis promotes macrophage survival by phosphorylating Bad through a Phosphatidylinositol 3–kinase/Akt …
      1017. Kit/stem cell factor receptor-induced activation of Phosphatidylinositol 3′-kinase is essential for male fertility
      1018. Hypoxia activates a platelet-derived growth factor receptor/Phosphatidylinositol 3–kinase/Akt pathway that results in glycogen synthase kinase–3 inactivation
      1019. Insulin rescues retinal neurons from apoptosis by a Phosphatidylinositol 3–kinase/Akt-mediated mechanism that reduces the activation of caspase-3
      1020. Regulation of the protein kinase Raf-1 by oncogenic Ras through Phosphatidylinositol 3–kinase, Cdc42/Rac and Pak
      1021. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the Phosphatidylinositol 3–kinase/AKT pathway
      1022. A novel role for Phosphatidylinositol 3–kinase β in signaling from G protein-coupled receptors to Akt
      1023. Platelet-derived growth factor-induced H2O2 production requires the activation of Phosphatidylinositol 3–kinase
      1024. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/Phosphatidylinositol 3–kinase/PTEN/AKT/FRAP pathway in human prostate …
      1025. Regulation of melanogenesis through Phosphatidylinositol 3–kinase-Akt pathway in human G361 melanoma cells
      1026. Hypoxia induces the activation of the Phosphatidylinositol 3–kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis
      1027. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the Phosphatidylinositol 3–kinase pathway
      1028. Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the Phosphatidylinositol 3–kinase/Akt antiapoptotic signaling …
      1029. A Phosphatidylinositol 3–kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor …
      1030. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
      1031. α7 nicotinic receptor transduces signals to Phosphatidylinositol 3–kinase to block A β-amyloid-induced neurotoxicity
      1032. The bile acid taurochenodeoxycholate activates a Phosphatidylinositol 3–kinase-dependent survival signaling cascade
      1033. The hepatitis B virus-X protein activates a Phosphatidylinositol 3–kinase-dependent survival signaling cascade
      1034. Phosphorylation of PDE3B by Phosphatidylinositol 3–kinase associated with the insulin receptor
      1035. Phosphatidylinositol 3–kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human …
      1036. A specific function for Phosphatidylinositol 3–kinase α (p85α-p110α) in cell survival and for Phosphatidylinositol 3–kinase β (p85α-p110β) in de novo DNA synthesis of …
      1037. Stimulation of Phosphatidylinositol 3–kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins
      1038. Overexpression of Phosphatidylinositol 3–kinase in human lung cancer
      1039. Angiopoietin-1 regulates endothelial cell survival through the Phosphatidylinositol 3′-kinase/Akt signal transduction pathway
      1040. Restricted accumulation of Phosphatidylinositol 3–kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis
      1041. Inhibition of mitogen-activated protein kinase and Phosphatidylinositol 3–kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis
      1042. Role of Phosphatidylinositol 3–kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest
      1043. Roles of Phosphatidylinositol 3–kinase in interferon-γ-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression
      1044. Phosphatidylinositol 3–kinase is required for insulin-like growth factor-I–induced vascular smooth muscle cell proliferation and migration
      1045. Association of Phosphatidylinositol 3–kinase with nuclear transcription sites in higher plants
      1046. A novel positive feedback loop mediated by the docking protein Gab1 and Phosphatidylinositol 3–kinase in epidermal growth factor receptor signaling
      1047. Human cytomegalovirus up-regulates the Phosphatidylinositol 3–kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling
      1048. … endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and Phosphatidylinositol 3–kinase-akt-dependent pathways in …
      1049. Signaling complexes and protein-protein interactions involved in the activation of the Ras and Phosphatidylinositol 3–kinase pathways by the c-Ret receptor …
      1050. Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of Phosphatidylinositol 3–kinase pathway
      1051. Haptotactic migration induced by midkine: involvement of protein-tyrosine phosphatase ζ, mitogen-activated protein kinase, and Phosphatidylinositol 3–kinase
      1052. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and-independent pathways: roles for Phosphatidylinositol 3–kinase and Raf
      1053. Interferon α/β promotes cell survival by activating nuclear factor κB through Phosphatidylinositol 3–kinase and Akt
      1054. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the Phosphatidylinositol 3′-kinase/Akt signal transduction pathway
      1055. A Phosphatidylinositol 3–kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human …
      1056. Induction of vascular endothelial growth factor receptors and Phosphatidylinositol 3′-kinase/Akt signaling by global cerebral ischemia in the rat
      1057. … life span of skeletal muscle satellite cells by enhancing g1/s cell cycle progression via the activation of Phosphatidylinositol 3′-kinase/akt signaling pathway
      1058. Phosphatidylinositol 3–kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells
      1059. Adrenomedullin induces endothelium-dependent vasorelaxation via the Phosphatidylinositol 3–kinase/Akt–dependent pathway in rat aorta
      1060. Association of increased Phosphatidylinositol 3–kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas
      1061. Glycogen synthase kinase–3β activity is critical for neuronal death caused by inhibiting Phosphatidylinositol 3–kinase or Akt but not for death caused by nerve …
      1062. The insulin-like growth factor-Phosphatidylinositol 3–kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in …
      1063. Phosphatidylinositol 3–kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)
      1064. Inhibition of the Phosphatidylinositol 3–kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation
      1065. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of Phosphatidylinositol 3–kinase-Akt activation pathway in …
      1066. Human SMG-1, a novel Phosphatidylinositol 3–kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the …
      1067. Redistribution of Bruton’s tyrosine kinase by activation of Phosphatidylinositol 3‐kinase and Rho‐family GTPases
      1068. Parallel and independent regulation of interleukin-3 mRNA turnover by Phosphatidylinositol 3–kinase and p38 mitogen-activated protein kinase
      1069. Phosphatidylinositol 3–kinase C2α contains a nuclear localization sequence and associates with nuclear speckles
      1070. The Phosphatidylinositol 3–kinase/AKT Signal Transduction Pathway Plays a Critical Role in the Expression of p21WAF1/CIP1/SDI1 Induced by Cisplatin and …
      1071. Amino acid-induced translation of TOP mRNAs is fully dependent on Phosphatidylinositol 3–kinase-mediated signaling, is partially inhibited by rapamycin, and is …
      1072. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and Phosphatidylinositol 3–kinase signaling pathways
      1073. Role of Phosphatidylinositol 3′ kinase and a Downstream Pleckstrin Homology Domain–Containing Protein in Controlling Chemotaxis inDictyostelium
      1074. Prevention of Phosphatidylinositol 3′-kinase-Akt survival signaling pathway during topotecan-induced apoptosis
      1075. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and Phosphatidylinositol 3–kinase/Akt controls cell migration and …
      1076. Oleate activates Phosphatidylinositol 3–kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite …
      1077. Myogenic differentiation requires signalling through both Phosphatidylinositol 3–kinase and p38 MAP kinase
      1078. Insulin-induced actin filament remodeling colocalizes actin with Phosphatidylinositol 3–kinase and GLUT4 in L6 myotubes
      1079. … up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving Phosphatidylinositol 3′-kinase and distinct from that …
      1080. Insulin Activates ATP-Sensitive K+ Channels in Pancreatic β-Cells Through a Phosphatidylinositol 3–kinase–Dependent Pathway
      1081. Interferon-α promotes survival of human primary B-lymphocytes via Phosphatidylinositol 3–kinase
      1082. … acetate induces neutrophil NADPH‐oxidase activity by two separate signal transduction pathways: dependent or independent of Phosphatidylinositol 3‐kinase
      1083. The role of genetic abnormalities of PTEN and the Phosphatidylinositol 3–kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy
      1084. Phosphatidylinositol 3–kinase inhibition enhances human sperm motility
      1085. Extracellular zinc activates p70 S6 kinase through the Phosphatidylinositol 3–kinase signaling pathway
      1086. Cooperative signaling between α6β4integrin and ErbB-2 receptor is required to promote Phosphatidylinositol 3–kinase-dependent invasion
      1087. … -inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the Phosphatidylinositol 3′-kinase/Akt signaling pathway
      1088. α5β1 integrin protects intestinal epithelial cells from apoptosis through a Phosphatidylinositol 3–kinase and protein kinase B–dependent pathway
      1089. Protein kinase C-ζ phosphorylates insulin receptor substrate-1 and impairs its ability to activate Phosphatidylinositol 3–kinase in response to insulin
      1090. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through Phosphatidylinositol 3–kinase and mammalian target of …
      1091. The EphA8 receptor regulates integrin activity through p110γ Phosphatidylinositol–3 kinase in a tyrosine kinase activity-independent manner
      1092. The tyrosine phosphatase SHP-2 is required for mediating Phosphatidylinositol 3–kinase/Akt activation by growth factors
      1093. Growth hormone induces cellular insulin resistance by uncoupling Phosphatidylinositol 3–kinase and its downstream signals in 3T3-L1 adipocytes
      1094. … : Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the Phosphatidylinositol‐3‐kinase …
      1095. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via Phosphatidylinositol 3–kinase-and AKT-dependent pathways
      1096. Cyclic AMP inhibits extracellular signal-regulated kinase and Phosphatidylinositol 3–kinase/Akt pathways by inhibiting Rap1
      1097. The classical progesterone receptor associates with p42 MAPK and is involved in Phosphatidylinositol 3–kinase signaling inXenopus oocytes
      1098. Cbl-b, a RING-type E3 ubiquitin ligase, targets Phosphatidylinositol 3–kinase for ubiquitination in T cells
      1099. The inhibition of Phosphatidylinositol‐3‐kinase induces neurite retraction and activates GSK3
      1100. Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated Phosphatidylinositol 3–kinase-dependent pathway
      1101. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by Phosphatidylinositol 3–kinase
      1102. Tec kinase signaling in T cells is regulated by Phosphatidylinositol 3–kinase and the Tec pleckstrin homology domain
      1103. Trypanosoma cruzi: Phosphatidylinositol 3–kinase and protein kinase B activation is associated with parasite invasion
      1104. A Phosphatidylinositol 3–kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced …
      1105. Phosphatidylinositol 3‐kinase and mTOR mediate lipopolysaccharide‐stimulated nitric oxide production in macrophages via interferon‐β
      1106. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving Phosphatidylinositol–3 kinase activation
      1107. L-leucine availability regulates Phosphatidylinositol 3–kinase, p70 S6 kinase and glycogen synthase kinase–3 activity in L6 muscle cells: evidence for the involvement …
      1108. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through Phosphatidylinositol 3–kinase/Akt phosphorylation and Bcl-xL/caspase …
      1109. Role of extracellular signal-regulated kinase and Phosphatidylinositol–3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis
      1110. TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a Phosphatidylinositol 3–kinase/Akt pathway in human hepatocytes
      1111. Activation of Phosphatidylinositol 3–kinase and Akt bytert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells
      1112. Erythropoietin regulates vascular smooth muscle cell apoptosis by a Phosphatidylinositol 3 kinase-dependent pathway
      1113. S338 phosphorylation of Raf-1 is independent of Phosphatidylinositol 3–kinase and Pak3
      1114. … factor rapidly increases activity and cell surface expression of the EAAC1 subtype of glutamate transporter through activation of Phosphatidylinositol 3–kinase
      1115. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of Phosphatidylinositol 3–kinase
      1116. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon Phosphatidylinositol–3 kinase and mitogen-activated protein …
      1117. TEL-JAK2 mediates constitutive activation of the Phosphatidylinositol 3′-kinase/protein kinase B signaling pathway
      1118. An inhibitory role of the Phosphatidylinositol 3–kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression
      1119. … fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and Phosphatidylinositol 3–kinase intracellular signalling pathways …
      1120. c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a Phosphatidylinositol–3 kinase (PI-3K)-dependent …
      1121. … neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a Phosphatidylinositol–3 kinase …
      1122. Urokinase stimulates human vascular smooth muscle cell migration via a Phosphatidylinositol 3–kinase-Tyk2 interaction
      1123. Phosphatidylinositol 3‐kinase and ERK are required for NF‐κB activation but not for phagocytosis
      1124. Phosphatidylinositol 3–kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor
      1125. Quercetin inhibits Shc-and Phosphatidylinositol 3–kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells
      1126. Differential effects of Phosphatidylinositol 3–kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport
      1127. Regulation of gene expression by glucose in pancreatic β-cells (MIN6) via insulin secretion and activation of Phosphatidylinositol 3′-kinase
      1128. The essential role of Phosphatidylinositol 3–kinase and of p38 mitogen-activated protein kinase activation in the antioxidant response element-mediated rGSTA2 …
      1129. Phosphatidylinositol 3–kinase signaling is important for smooth muscle cell replication after arterial injury
      1130. Trypanosoma cruzi trans-sialidase: A potent and specific survival factor for human Schwann cells by means of Phosphatidylinositol 3–kinase/Akt signaling
      1131. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through Phosphatidylinositol 3–kinase/Akt pathway
      1132. Putative role of the Phosphatidylinositol 3–kinase—Akt signaling pathway in the survival of granulosa cells
      1133. Activation of Phosphatidylinositol–3 kinase (PI-3K) and extracellular regulated kinases (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural …
      1134. Insulin accelerates inter-endosomal GLUT4 traffic via Phosphatidylinositol 3–kinase and protein kinase B
      1135. The Ras/Phosphatidylinositol 3–kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling …
      1136. A Novel B Lymphocyte–associated Adaptor Protein, Bam32, Regulates Antigen Receptor Signaling Downstream of Phosphatidylinositol 3–kinase
      1137. Involvement of the pathway Phosphatidylinositol–3–kinase/AKT-1 in the establishment of the survival response to ionizing radiation
      1138. Reduction of potassium currents and Phosphatidylinositol 3–kinase-dependent AKT phosphorylation by tumor necrosis factor-α rescues axotomized retinal ganglion …
      1139. Novel role of Phosphatidylinositol 3–kinase in CD28-mediated costimulation
      1140. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the Phosphatidylinositol‐3 kinase/Akt pathway
      1141. Halenaquinone, a novel Phosphatidylinositol 3–kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells
      1142. Stem cell factor induces Phosphatidylinositol 3′-kinase–dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells
      1143. X-linked inhibitor of apoptosis protein activates the Phosphatidylinositol 3–kinase/Akt pathway in rat granulosa cells during follicular development
      1144. Phosphatidylinositol–3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic …
      1145. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of Phosphatidylinositol–3 kinase
      1146. Phosphatidylinositol 3–kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary …
      1147. Specific requirement for the p85-p110α Phosphatidylinositol 3–kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells
      1148. Cooperative regulation of Mcl-1 by Janus kinase/stat and Phosphatidylinositol 3–kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed …
      1149. Phosphatidylinositol–3 kinase acts in parallel to the ERK MAP kinase in the FGF pathway during Xenopus mesoderm induction
      1150. Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis
      1151. Neuregulin rescues PC12-ErbB4 cells from cell death induced by H2O2: regulation of reactive oxygen species levels by Phosphatidylinositol 3–kinase
      1152. Apoptosis suppression by Raf-1 and MEK1 requires MEK-and Phosphatidylinositol 3–kinase-dependent signals
      1153. Insulin regulates alternative splicing of protein kinase C βII through a Phosphatidylinositol 3–kinase-dependent pathway involving the nuclear serine/arginine …
      1154. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: the role of Phosphatidylinositol 3–kinase
      1155. Retention of PDGFR-β function in mice in the absence of Phosphatidylinositol 3′-kinase and phospholipase Cγ signaling pathways
      1156. Activation of the Ral and Phosphatidylinositol 3′ kinase signaling pathways by the ras-related protein TC21
      1157. The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via Phosphatidylinositol 3–kinase
      1158. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated Phosphatidylinositol 3–kinase activity by ceramide
      1159. Phosphatidylinositol 3–kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial …
      1160. Targets of B-cell antigen receptor signaling: the Phosphatidylinositol 3–kinase/Akt/glycogen synthase kinase–3 signaling pathway and the Rap1 GTPase.
      1161. Regulation of Cyclin D1 Expression and DNA Synthesis by Phosphatidylinositol 3–kinase in Airway Smooth Muscle Cells
      1162. Interleukin‐6 activates Phosphatidylinositol‐3 kinase, which inhibits apoptosis in human prostate cancer cell lines
      1163. Cooperation between STAT5 and Phosphatidylinositol 3–kinase in the IL-3-dependent survival of a bone marrow derived cell line
      1164. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and Phosphatidylinositol–3 kinase activation
      1165. Phosphatidylinositol 3–kinase-dependent stabilization of α1(I) collagen mRNA in human lung fibroblasts
      1166. GTPases and Phosphatidylinositol 3–kinase are critical for insulin-like growth factor-I-mediated Schwann cell motility
      1167. The role of Phosphatidylinositol 3–kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells
      1168. Thrombopoietin potentiates collagen receptor signaling in platelets through a Phosphatidylinositol 3–kinase–dependent pathway
      1169. Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of Phosphatidylinositol 3–kinase activity
      1170. NK cell‐mediated lysis of autologous antigen‐presenting cells is triggered by the engagement of the Phosphatidylinositol 3‐kinase upon ligation of the natural …
      1171. Role of Gab proteins in Phosphatidylinositol 3–kinase activation by thrombopoietin (Tpo)
      1172. Phosphatidylinositol 3–kinase and NF-κB/Rel are at the divergence of CD40-mediated proliferation and survival pathways
      1173. Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and Phosphatidylinositol 3–kinase in the regulation of Mcl-1 …
      1174. … vascular endothelial cells by a phosphatase inhibitor: possible involvement of extracellular signal-regulated kinase and Phosphatidylinositol 3–kinase
      1175. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-κB and Phosphatidylinositol 3–kinase
      1176. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, Phosphatidylinositol 3–kinase, and Rac
      1177. … agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on Phosphatidylinositol 3–kinase and transcription factor NF …
      1178. Both src-dependent and-independent mechanisms mediate Phosphatidylinositol 3–kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein …
      1179. Regulation of nuclear factor κB transactivation: implication of Phosphatidylinositol 3–kinase and protein kinase C ζ in c-Rel activation by tumor necrosis factor α
      1180. Phosphatidylinositol 3‐kinase and the control of endosome dynamics: new players defined by structural motifs
      1181. … of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of Phosphatidylinositol 3–kinase and cell proliferation
      1182. Tyr612 and Tyr632 in human insulin receptor substrate-1 are important for full activation of insulin-stimulated Phosphatidylinositol 3–kinase activity and translocation of …
      1183. … of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and Phosphatidylinositol 3–kinase activation
      1184. 1α, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by Phosphatidylinositol 3–kinase and mediated by the NADPH …
      1185. … effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and Phosphatidylinositol 3–kinase (PI3 …
      1186. Phosphatidylinositol 3–kinase–dependent translocation of phospholipase Cγ2 in mouse megakaryocytes is independent of Bruton tyrosine kinase translocation
      1187. Phosphatidylinositol 3–kinase-dependent extracellular calcium influx is essential for CX3CR1-mediated activation of the mitogen-activated protein kinase …
      1188. Up-regulation of endothelial nitric-oxide synthase promoter by the Phosphatidylinositol 3–kinase γ/Janus kinase 2/MEK-1-dependent pathway
      1189. … domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent Phosphatidylinositol 3′-kinase activation and endothelial cell …
      1190. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the Phosphatidylinositol 3–kinase signaling pathway in anchorage …
      1191. Regulatory role of Phosphatidylinositol 3–kinase on TNF-α–Induced cyclooxygenase 2 expression in colonic epithelial cells
      1192. Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and Phosphatidylinositol 3–kinase pathways in a new …
      1193. The Gab1 docking protein links the b cell antigen receptor to the Phosphatidylinositol 3–kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase
      1194. Phosphatidylinositol 3–kinase mediates integrin-dependent NF-(κ) B and MAPK activation through separate signaling pathways
      1195. Diversification of cardiac insulin signaling involves the p85α/β subunits of Phosphatidylinositol 3–kinase
      1196. The expression of the p85α subunit of Phosphatidylinositol 3–kinase is induced by activation of the peroxisome proliferator-activated receptor γ in human adipocytes
      1197. Stimulation of human neutrophils by chemotactic factors is associated with the activation of Phosphatidylinositol 3–kinase γ
      1198. Roles of insulin receptor substrate-1, Phosphatidylinositol 3–kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in β-cells
      1199. Differential regulation of the Phosphatidylinositol 3–kinase/Akt and p70 S6 kinase pathways by the α1A-adrenergic receptor in rat-1 fibroblasts
      1200. Phosphatidylinositol 3–kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the …
      1201. Src transduces erythropoietin-induced differentiation signals through Phosphatidylinositol 3–kinase
      1202. Glial cell line-derived neurotrophic factor-stimulated Phosphatidylinositol 3–kinase and Akt activities exert opposing effects on the ERK pathway: importance …
      1203. The bile acid–activated Phosphatidylinositol 3–kinase pathway inhibits Fas apoptosis upstream of bid in rodent hepatocytes
      1204. Cross-talk between Phosphatidylinositol 3–kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions
      1205. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving Phosphatidylinositol–3 kinase and protein phosphatase-1 in HepG2 cells
      1206. Stimulation of tetrahydrobiopterin synthesis induced by insulin: possible involvement of Phosphatidylinositol 3–kinase
      1207. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the Phosphatidylinositol–3–kinase pathway and is associated with …
      1208. Glut-1 Translocation in FRTL-5 Thyroid Cells: Role of Phosphatidylinositol 3–kinase and N-Glycosylation
      1209. Persistent activation of Phosphatidylinositol 3–kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 …
      1210. Five isoforms of the Phosphatidylinositol 3‐kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations
      1211. Phosphatidylinositol–3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils
      1212. Ceramide regulates lipopolysaccharide-induced Phosphatidylinositol 3–kinase and Akt activity in human alveolar macrophages
      1213. Insulin stimulates NHE1 activity by sequential activation of Phosphatidylinositol 3‐kinase and protein kinase C ζ in human erythrocytes
      1214. Evidence for a Functional Association between Phosphatidylinositol 3–kinase and c-src in the Spreading Response of Osteoclasts to Colony-Stimulating Factor-1
      1215. A Specific Role of Phosphatidylinositol 3–kinase γ: A Regulation of Autonomic Ca2+ Oscillations in Cardiac Cells
      1216. Stabilization of cyclin D1 mRNA via the Phosphatidylinositol 3–kinase pathway in MCF-7 human breast cancer cells
      1217. Protein phosphatase 2A and Phosphatidylinositol 3–kinase regulate the activity of Sp1-responsive promoters
      1218. Tyrosine phosphorylation of the p85 subunit of Phosphatidylinositol 3–kinase correlates with high proliferation rates in sublines derived from the Jurkat leukemia
      1219. Constitutively active Phosphatidylinositol 3–kinase and AKT are sufficient to stimulate the epithelial Na+/H+ exchanger 3
      1220. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via Phosphatidylinositol 3–kinase and extracellular signal …
      1221. … protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and Phosphatidylinositol–3–kinase-dependent signaling pathways
      1222. Phosphatidylinositol 3′-kinase blocks CD95 aggregation and caspase-8 cleavage at the death-inducing signaling complex by modulating lateral diffusion of CD95
      1223. Platelet-derived growth factor activates porcine thecal cell Phosphatidylinositol–3–kinase-Akt/PKB and Ras-extracellular signal-regulated kinase-1/2 kinase signaling …
      1224. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by Phosphatidylinositol 3′-kinase …
      1225. 15-Deoxy-Δ12, 14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through Phosphatidylinositol 3–kinase in vascular smooth muscle …
      1226. Association of Phosphatidylinositol 3–kinase composed of p110β-catalytic and p85-regulatory subunits with the small GTPase Rab5
      1227. Interleukins 4 and 13 increase intestinal epithelial permeability by a Phosphatidylinositol 3–kinase pathway: lack of evidence for STAT 6 involvement
      1228. ERK regulates the hepatocyte growth factor-mediated interaction of Gab1 and the Phosphatidylinositol 3–kinase
      1229. Intracellular signals that control cell proliferation in mammalian balance epithelia: key roles for Phosphatidylinositol–3 kinase, mammalian target of rapamycin, and S6 …
      1230. Cutting edge: gab2 mediates an inhibitory Phosphatidylinositol 3′-kinase pathway in T cell antigen receptor signaling
      1231. Brain‐derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the Phosphatidylinositol 3‐kinase …
      1232. Phosphatidylinositol 3–kinase signaling to Akt mediates survival in isolated canine islets of Langerhans
      1233. … (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through Phosphatidylinositol 3–kinase …
      1234. Involvement of a Phosphatidylinositol 3–kinase–p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells
      1235. … growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen‐activated protein kinase and Phosphatidylinositol 3‐kinase/Akt …
      1236. Nerve Growth Factor Uses Ras/ERK and Phosphatidylinositol 3–kinase Cascades to Up-regulate theN-Methyl-d-aspartate Receptor 1 Promoter
      1237. Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the Phosphatidylinositol 3–kinase and mitogen-activated protein kinase …
      1238. A Phosphatidylinositol 3–kinase of Candida albicans influences adhesion, filamentous growth and virulence
      1239. A link between insulin resistance and hyperinsulinemia: inhibitors of Phosphatidylinositol 3–kinase augment glucose-induced insulin secretion from islets of lean, but …
      1240. Requirement of Phosphatidylinositol 3–kinase activity for translocation of exogenous aFGF to the cytosol and nucleus
      1241. In vitro hormone induction of final oocyte maturation in striped bass (Morone saxatilis) follicles is inhibited by blockers of Phosphatidylinositol 3–kinase activity
      1242. Tyrosine kinase-dependent, Phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma …
      1243. … preproinsulin gene expression and nucleartrans-location of pancreatic duodenum homeobox-1 require activation of Phosphatidylinositol 3–kinase but not p38 …
      1244. Activation of Phosphatidylinositol 3‐kinase by a complex of p59fyn and the receptor tyrosine kinase Xmrk is involved in malignant transformation of pigment cells
      1245. … protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of Phosphatidylinositol 3′-kinase …
      1246. Dual Signaling via Protein kinase C and Phosphatidylinositol 3′-kinase/Akt Contributes to Bradykinin B2Receptor-induced Cardioprotection in Guinea Pig Hearts
      1247. Insulin-like growth factor I potentiates kainate receptors through a Phosphatidylinositol 3–kinase dependent pathway
      1248. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by Phosphatidylinositol 3–kinase
      1249. Basic fibroblast growth factor stimulates surface expression and activity of Na+/H+ exchanger NHE3 via mechanism involving Phosphatidylinositol 3–kinase
      1250. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin α2β1 and GPIb in a Phosphatidylinositol 3–kinase independent pathway
      1251. A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and Phosphatidylinositol 3‐kinase binding
      1252. Regulation of oxidative stress-induced calcium release by Phosphatidylinositol 3–kinase and Bruton’s tyrosine kinase in B cells
      1253. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1. 0 cells: involvement of Phosphatidylinositol 3–kinase …
      1254. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished Phosphatidylinositol 3–kinase activation
      1255. … and luteinizing hormone in cultured porcine granulosa-luteal cells: possible convergence of protein kinase a, Phosphatidylinositol 3–kinase, and mitogen-activated …
      1256. Role of Phosphatidylinositol 3–kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase
      1257. The expression of the γ subunit of Na-K-ATPase is regulated by osmolality via C-terminal Jun kinase and Phosphatidylinositol 3–kinase-dependent mechanisms
      1258. Ras activation of Phosphatidylinositol 3–kinase and Akt
      1259. Involvement of Phosphatidylinositol 3–kinase and mitogen-activated protein kinases in glycine-extended gastrin-induced dissociation and migration of gastric …
      1260. Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85α activates Phosphatidylinositol 3–kinase in C2C12 cells
      1261. Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of Phosphatidylinositol 3–kinase
      1262. The insulin receptor substrate (IRS)-1 recruits Phosphatidylinositol 3–kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret
      1263. Activation of the Phosphatidylinositol 3–kinase-Akt/protein kinase B signaling pathway in arachidonic acid-stimulated human myeloid and endothelial cells …
      1264. An SH2-domain-containing kinase negatively regulates the Phosphatidylinositol–3 kinase pathway
      1265. The Phosphatidylinositol 3–kinase pathway selectively controls sIL-1RA not interleukin-1β production in the septic leukocytes
      1266. T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of Phosphatidylinositol 3–kinase (p85) via a complex mechanism …
      1267. Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of Phosphatidylinositol 3–kinase and Akt in Chinese hamster ovary cells …
      1268. The T cell antigen receptor activates Phosphatidylinositol 3‐kinase‐regulated serine kinases protein kinase B and ribosomal S6 kinase 1
      1269. Rac and Phosphatidylinositol 3–kinase regulate the protein kinase B in FcεRI signaling in RBL 2H3 mast cells
      1270. Activation of Phosphatidylinositol 3 kinase by muscarinic receptors in astrocytoma cells
      1271. … with Thyrotropin-induced G1-S Transition Mediated by cAMP-dependent Protein kinase and Phosphatidylinositol 3–kinase: INVOLVEMENT OF RhoA AND …
      1272. Expression of a constitutively active form of Phosphatidylinositol 3–kinase inhibits the induction of nitric oxide synthase in human astrocytes
      1273. Role of Phosphatidylinositol 3–kinase in anti-IgM-and anti-IgD-induced apoptosis in B cell lymphomas
      1274. Insulin-mediated cell proliferation and survival involve inhibition of c-Jun N-terminal kinases through a Phosphatidylinositol 3–kinase-and mitogen-activated protein …
      1275. Enteric neuroblasts require the Phosphatidylinositol 3‐kinase pathway for GDNF‐stimulated proliferation
      1276. The CK2 phosphorylation of vitronectin: Promotion of cell adhesion via the αvβ3–Phosphatidylinositol 3–kinase pathway
      1277. β-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of Phosphatidylinositol 3–kinase
      1278. … 1 fusion protein of the t (6; 8) translocation induces cell survival mediated by mitogen-activated protein kinase and Phosphatidylinositol 3–kinase/Akt/mTOR pathways
      1279. Ca2+-and Phosphatidylinositol 3–kinase-dependent nitric oxide generation in lung endothelial cells in situ with ischemia
      1280. Compartmentalization and insulin-induced translocations of insulin receptor substrates, Phosphatidylinositol 3–kinase, and protein kinase B in rat liver
      1281. Sites of action of protein kinase C and Phosphatidylinositol 3–kinase are distinct in oxidized low density lipoprotein-induced macrophage proliferation
      1282. Role of Phosphatidylinositol–3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function
      1283. Heregulin‐β is especially potent in activating Phosphatidylinositol 3‐kinase in nontransformed human mammary epithelial cells
      1284. Interaction of the insulin receptor β-subunit with Phosphatidylinositol 3–kinase in bovine ROS
      1285. IL‐12 selectively regulates STAT4 via Phosphatidylinositol 3‐kinase and Ras‐independent signal transduction pathways
      1286. Phosphatidylinositol 3–kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase
      1287. … rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of Phosphatidylinositol 3–kinase and Akt kinase …
      1288. Epidermal growth factor-induced Phosphatidylinositol 3–kinase activation and DNA synthesis: identification of Grb2-associated binder 2 as the major mediator …
      1289. Platelet‐activating factor activates mitogen‐activated protein kinases through the activation of Phosphatidylinositol 3‐kinase and tyrosine kinase in human eosinophils
      1290. Phosphatidylinositol 3–kinase is required for the trophic, but not the survival-promoting, actions of NGF on sympathetic neurons
      1291. HIV‐1 Tat protein down‐regulates CREB transcription factor expression in PC12 neuronal cells through a Phosphatidylinositol 3‐kinase/AKT/cyclic nucleoside …
      1292. LY 294002, an inhibitor of Phosphatidylinositol 3–kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes
      1293. Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cbl and Phosphatidylinositol 3–kinase
      1294. … apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and Phosphatidylinositol 3–kinase/Akt pathways up …
      1295. Phosphatidylinositol 3–kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream …
      1296. Regulation of p85α Phosphatidylinositol–3–kinase expression by peroxisome proliferator-activated receptors (PPARs) in human muscle cells
      1297. The Rho/Rho‐kinase and the Phosphatidylinositol 3‐kinase pathways are essential for spontaneous locomotion of Walker 256 carcinosarcoma cells
      1298. Interactions between Phosphatidylinositol 3–kinase and nitric oxide: explaining the paradox
      1299. The roles of Phosphatidylinositol 3–kinase and protein kinase Cζ for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine …
      1300. Inhibition of Phosphatidylinositol–3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-α cytotoxicity
      1301. Activation of the Phosphatidylinositol 3–kinase/Akt pathway protects against interleukin-3 starvation but not DNA damage-induced apoptosis
      1302. Enhanced cell killing by overexpression of dominant‐negative Phosphatidylinositol 3‐kinase subunit, Δp85, following genotoxic stresses
      1303. … is required for efficient induction of chronic myeloid leukemia–like disease in mice but not for lymphoid leukemogenesis or activation of Phosphatidylinositol 3–kinase
      1304. Phosphatidylinositol 3–kinase activity regulates α-thrombin-stimulated G1 progression by its effect on cyclin D1 expression and cyclin-dependent kinase 4 …
      1305. … promotes the expression of peroxisome proliferator-activated receptor γ in vascular smooth muscle cells by a Phosphatidylinositol 3–kinase/Akt signaling pathway
      1306. Mechanism of Phosphatidylinositol 3–kinase-dependent increases in BAC1. 2F5 macrophage-like cell density in response to M-CSF: Phosphatidylinositol 3–kinase …
      1307. … effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for Phosphatidylinositol 3–kinase …
      1308. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the Phosphatidylinositol 3–kinase and STAT3 pathways
      1309. Phosphatidylinositol 3–kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene …
      1310. Tyrosine kinase and Phosphatidylinositol 3–kinase activation are required for cyclic adenosine 3′, 5′-monophosphate-dependent potentiation of deoxyribonucleic …
      1311. LFA-1-mediated costimulation of CD8+ T cell proliferation requires Phosphatidylinositol 3–kinase activity
      1312. Phosphatidylinositol–3′ kinase-dependent vesicle formation in macrophages in response to macrophage colony stimulating factor
      1313. A Phosphatidylinositol 3‐kinase of Candida albicans: molecular cloning and characterization
      1314. Tyrosine phosphorylation is involved in Phosphatidylinositol 3–kinase activation in bovine rod outer segments
      1315. Phosphatidylinositol 3–kinase-dependent pathways oppose fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells: implications …
      1316. Phosphatidylinositol 3‐kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP‐dependent induction of differentiation in rat C6 glioma
      1317. Phosphatidylinositol 3–kinase in cumulus cells and oocytes is responsible for activation of oocyte mitogen-activated protein kinase during meiotic progression beyond …
      1318. Neurotrophic factor protection against ethanol toxicity in rat cerebellar granule cell cultures requires Phosphatidylinositol 3–kinase activation
      1319. Phosphatidylinositol 3–kinase activity in murine motoneuron disease: the progressive motor neuropathy mouse
      1320. Phosphatidylinositol 3‐kinase Translocates to the Nucleus of Osteoblast‐Like MC3T3‐E1 Cells in Response to Insulin‐Like Growth Factor I and Platelet‐Derived …
      1321. … a combined treatment with epidermal growth factor and transforming growth factor-β in rat hepatocytes: role of Phosphatidylinositol 3–kinase-induced AP-1 …
      1322. Phosphatidylinositol 3–kinase is required for adherens junction-dependent mammary epithelial cell spheroid formation
      1323. Role of Phosphatidylinositol 3–kinase in acetylcholine-induced dilatation of rat basilar artery
      1324. … growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition: Role of Grb2, Phosphatidylinositol 3‐kinase, Src tyrosine kinase …
      1325. Effect of long-term caloric restriction on GLUT4, Phosphatidylinositol–3 kinase p85 subunit, and insulin receptor substrate-1 protein levels in rhesus monkey skeletal …
      1326. Phosphatidylinositol 3–kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after γ-irradiation by stabilization of the protein
      1327. Further evidence for the involvement of insulin receptor substrates in epidermal growth factor‐induced activation of Phosphatidylinositol 3‐kinase
      1328. Rosiglitazone (BRL 49653) enhances insulin secretory response via Phosphatidylinositol 3–kinase pathway
      1329. Anchorage-independent activation of mitogen-activated protein kinase through Phosphatidylinositol–3 kinase by insulin-like growth factor I
      1330. Regulation of gene expression during severe caloric restriction: lack of induction of p85alpha Phosphatidylinositol 3–kinase mRNA in skeletal muscle of patients with …
      1331. Tyrosine phosphorylation of the catalytic subunit p110 of Phosphatidylinositol–3 kinase induced by HMG-CoA reductase inhibitor inhibits its kinase activity in …
      1332. Hepatocyte growth factor-induced differential activation of phospholipase Cγ1 and Phosphatidylinositol 3–kinase is regulated by tyrosine phosphatase SHP-1 …
      1333. MIP-1α induces activation of Phosphatidylinositol–3 kinase that associates with Pyk-2 and is necessary for B-cell migration
      1334. Phosphatidylinositol–3–kinase activation and atypical protein kinase C ζ phosphorylation characterize the DMSO signalling in erythroleukemia cells
      1335. Inhibition of Phosphatidylinositol 3–kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis
      1336. Phosphatidylinositol 3‐kinase inhibitors prevent mouse cytotoxic T‐cell development in vitro
      1337. Phosphatidylinositol 3′-kinase-mediated calcium mobilization regulates chemotaxis in phosphatidic acid-stimulated human neutrophils
      1338. Membrane depolarization-mediated survival of sympathetic neurons occurs through both Phosphatidylinositol 3–kinase-and CaM kinase II-dependent pathways
      1339. Involvement of insulin receptor substrates in epidermal growth factor induced activation of Phosphatidylinositol 3‐kinase in rat hepatocyte primary culture
      1340. Surfactant protein A regulates pulmonary surfactant secretion via activation of Phosphatidylinositol 3–kinase in type II alveolar cells
      1341. Subcellular localization of insulin receptor substrate family proteins associated with Phosphatidylinositol 3–kinase activity and alterations in lipolysis in primary mouse …
      1342. Phosphatidylinositol 3–kinase in zymosan-and bacteria-induced signalling to mobilisation of arachidonic acid in macrophages
      1343. A human class II MHC–derived peptide antagonizes Phosphatidylinositol 3–kinase to block IL-2 signaling
      1344. Induction of Phosphatidylinositol 3–kinase and serine-threonine kinase-like immunoreactivity in rabbit spinal cord after transient ischemia
      1345. Phosphorylation of unnatural Phosphatidylinositols with Phosphatidylinositol 3–kinase
      1346. Hepatic glutamine transporter activation in burn injury: role of amino acids and Phosphatidylinositol–3–kinase
      1347. VCAM-1 activates Phosphatidylinositol 3–kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells
      1348. Inhibition of Phosphatidylinositol 3–kinase or Mitogen-Activated Protein kinase kinase Leads to Suppression of p34cdc2 kinase Activity and Meiotic Progression …
      1349. DNA Damage-Induced G1 Arrest in Hematopoietic Cells Is Overridden following Phosphatidylinositol 3–kinase-Dependent Activation of Cyclin-Dependent kinase 2
      1350. Phosphatidylinositol 3–kinase and trypsin activation in pancreatitis
      1351. Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active Phosphatidylinositol 3–kinase and protein kinase B
      1352. … induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and Phosphatidylinositol 3–kinase …
      1353. Interaction of oestrogen receptor with the regulatory subunit of Phosphatidylinositol–3-OH kinase
      1354. A direct interaction between oncogenic Ha-Ras and Phosphatidylinositol 3–kinase is not required for Ha-Ras-dependent transformation of epithelial cells
      1355. … IV Collagen Interacts with a Novel Binding Site on the β3Subunit of Integrin αvβ3 and Stimulates Focal Adhesion kinase and Phosphatidylinositol 3–kinase …
      1356. … 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the Phosphatidylinositol 3–kinase inhibitor 2-(4 …
      1357. The protein-tyrosine kinase fer associates with signaling complexes containing insulin receptor substrate-1 and Phosphatidylinositol 3–kinase
      1358. Regulation of human neutrophil‐mediated cartilage proteoglycan degradation by Phosphatidylinositol‐3‐kinase
      1359. … of the C/EBP homologous protein (CHOP) by amino acid deprivation requires insulin-like growth factor I, Phosphatidylinositol 3–kinase, and mammalian target of …
      1360. Modulation of the basal activity of Phosphatidylinositol–3–kinase/protein kinase B signaling pathway in human hepatocarcinoma cells.
      1361. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on Phosphatidylinositol 3–kinase and p70S6K: implications for rheumatoid …
      1362. Phosphatidylinositol 3–kinase in bovine lens and its stimulation by insulin and IGF-1
      1363. Insulin activation of mitogen-activated protein (MAP) kinase and Akt is Phosphatidylinositol 3–kinase-dependent in rat adipocytes
      1364. Inhibition of basophil histamine release by tyrosine kinase and Phosphatidylinositol 3–kinase inhibitors
      1365. Stimulation of glycogen synthesis by insulin requires S6 kinase and Phosphatidylinositol‐3‐kinase in HTC‐IR cells
      1366. Thrombin‐stimulated Phosphatidylinositol 3‐kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation …
      1367. HIV-Nef enhances interleukin-2 production and Phosphatidylinositol 3–kinase activity in a human T cell line
      1368. Exercise training prevents maturation-induced decreases in insulin receptor substrate-1 and Phosphatidylinositol 3–kinase in rat skeletal muscle
      1369. Involvement of both Phosphatidylinositol 3–kinase and p44/p42 mitogen-activated protein kinase pathways in the short-term regulation of pyruvate kinase L by insulin
      1370. Induction of Akt phosphorylation in rat primary astrocytes by H2O2 occurs upstream of Phosphatidylinositol 3–kinase: no evidence for oxidative inhibition of PTEN
      1371. Gene encoding the catalytic subunit p110beta of human Phosphatidylinositol 3–kinase: cloning, genomic structure, and screening for variants in patients with type 2 …
      1372. CD19 signal transduction in normal human B cells: linkage to downstream pathways requires Phosphatidylinositol 3‐kinase, protein kinase C and Ca2+
      1373. Activation of Phosphatidylinositol 3–kinase by oxidative stress leads to the induction of microsomal epoxide hydrolase in H4IIE cells
      1374. Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates Phosphatidylinositol 3′-kinase binding
      1375. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and Phosphatidylinositol–3-OH kinase
      1376. Phosphatidylinositol 3–kinase and protein kinase C contribute to the inhibition by interleukin 6 of phosphoenolpyruvate carboxykinase gene expression in cultured rat …
      1377. Protein tyrosine kinase‐dependent regulation of adenylate cyclase and Phosphatidylinositol 3‐kinase activates the expression of glial fibrillary acidic protein upon …
      1378. Odor-stimulated Phosphatidylinositol 3–kinase in lobster olfactory receptor cells
      1379. 3-Deoxy-3-substituted-D-myo-inositol imidazolyl ether lipid phosphates and carbonate as inhibitors of the Phosphatidylinositol 3–kinase pathway and cancer cell …
      1380. IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and Phosphatidylinositol 3′-kinase
      1381. Roles of Phosphatidylinositol 3‐kinase and phospholipase D in temporal activation of superoxide production in FMLP‐stimulated human neutrophils
      1382. Association of Phosphatidylinositol 3–kinase with the insulin receptor: compartmentation in rat liver
      1383. Prolactin signaling to pim-1 expression: a role for Phosphatidylinositol 3–kinase
      1384. IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, Phosphatidylinositol–3 kinase pathway and plasmin …
      1385. Interleukin‐10 and interleukin‐13 inhibit proinflammatory cytokine‐induced ceramide production through the activation of Phosphatidylinositol 3‐kinase
      1386. Eicosanoid 12 (S)-HETE activates Phosphatidylinositol 3–kinase
      1387. … receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with Phosphatidylinositol 3 kinase
      1388. Expression of Phosphatidylinositol–3 kinase in lung cancer
      1389. Ca2+-evoked serotonin secretion by parafollicular cells: roles in signal transduction of Phosphatidylinositol 3′-kinase, and the γ and ζ isoforms of protein kinase C
      1390. Activation of Phosphatidylinositol 3–kinase is required for transcriptional activity of F-type 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: assessment of the …
      1391. Dynamin inhibits Phosphatidylinositol 3–kinase in hematopoietic cells
      1392. Evidence for the involvement of Phosphatidylinositol 3–kinase in fMLP-stimulated neutrophil adhesion to ICAM-1-transfected cells
      1393. CRKII participation in the cellular effects of growth hormone and insulin-like growth factor-1: Phosphatidylinositol–3 kinase dependent and independent effects
      1394. … library to identify basic residues in A-Raf required to mediate binding to the Src homology 2 domains of the p85 subunit of Phosphatidylinositol 3′-kinase
      1395. Structural organization of the mouse Phosphatidylinositol 3–kinase p110d gene
      1396. Involvement of tyrosine kinase and Phosphatidylinositol 3–kinase in phagocytosis by ascidian hemocytes
      1397. Phosphatidylinositol 3–kinase modulates IL-18-induced nuclear factor-kappa B activation.
      1398. … -induced glucose transport pathway in 3T3-L1 adipocytes is mediated by gab-1 and requires Gab-1-associated Phosphatidylinositol 3–kinase activity for full …
      1399. Protein kinase C and Phosphatidylinositol 3–kinase independently contribute to P-glycoprotein-mediated drug secretion in the mouse proximal tubule
      1400. Activation of NF-κB binding in HT-29 colon cancer cells by inhibition of Phosphatidylinositol 3–kinase
      1401. Involvement of sphingomyelinase in insulin‐induced Phosphatidylinositol 3‐kinase activation
      1402. Mitogenic signaling by cyclic adenosine monophosphate in chromaffin cells involves Phosphatidylinositol 3‐kinase activation
      1403. … induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca2+-dependent pathway independent of Phosphatidylinositol 3–kinase/Akt
      1404. … cascades initiated by fibroblast growth factor 1 on Xenopus oocytes expressing MDA-MB-231 mRNAs: role of Grb2, Phosphatidylinositol 3–kinase, Src tyrosine kinase …
      1405. Activation of phospholipase D in porcine tracheal smooth muscle: role of Phosphatidylinositol 3–kinase and RhoA activation
      1406. Role of the conserved acidic residue Asp21 in the structure of Phosphatidylinositol 3–kinase Src homology 3 domain: circular dichroism and nuclear magnetic …
      1407. Inhibition of Phosphatidylinositol 3–kinase does not alter forskolin-stimulated Cl− secretion by T84 cells
      1408. Modulation of the basal activity of N-acetylglucosaminyltransferase V by Phosphatidylinositol–3–kinase/protein kinase B signaling pathway in human hepatocarcinoma …
      1409. … of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of Phosphatidylinositol 3–kinase.
      1410. Regulation of the very late antigen‐4‐mediated adhesive activity of normal and nonreleaser basophils: roles for Src, Syk, and Phosphatidylinositol 3‐kinase
      1411. Phosphatidylinositol 3–kinase and prostaglandylinositol cyclic phosphate (cyclic PIP), a mediator of insulin action, in the signal transduction of insulin
      1412. Association of impaired Phosphatidylinositol 3–kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of …
      1413. Interactions of Phosphatidylinositol 3‐kinase Src homology 3 domain with its ligand peptide studied by absorption, circular dichroism, and UV resonance Raman …
      1414. Cardiac insulin resistance is associated with an impaired recruitment of Phosphatidylinositol 3–kinase to GLUT4 vesicles.
      1415. Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via Phosphatidylinositol 3–kinase pathway in rat aortic smooth muscle cells
      1416. Phosphatidylinositol‐3‐OH kinase regulatory subunits are differentially expressed during development of the rat cerebellum
      1417. Grb-2-Associated Binder-1 Is Involved in Insulin-Induced egr-1 Gene Expression through its Phosphatidylinositol 3′-kinase Binding Site
      1418. Identification of tyrosine residues involved in ligand recognition by the Phosphatidylinositol 3–kinase Src homology 3 domain: Circular dichroism and UV resonance …
      1419. Sensitizing effect of the Phosphatidylinositol 3–kinase inhibitor wortmannin on thermal neutron irradiation with or without boron compound.
      1420. Interleukin-1β Induced Synthesis of Protein kinase C-δ and Protein kinase C-ε in EL4 Thymoma Cells: Possible Involvement of Phosphatidylinositol 3–kinase
      1421. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires Phosphatidylinositol–3-OH-kinase-dependent and mitogen-activated …
      1422. Ultrastructural modifications and Phosphatidylinositol–3–kinase expression and activity in myocardial tissue deriving from rats in different experimental conditions
      1423. Troglitazone Enhances Glucose Uptake Induced By α‐Adrenoceptor Stimulation Via Phosphatidylinositol 3‐kinase In Rat Heart
      1424. Involvement of regulating the Phosphatidylinositol 3–kinase signaling pathway in the process of herbimycin A-induced erythroid cell differentiation in the K562 …
      1425. Phosphatidylinositol 3–kinase regulates proliferation of RAW 264.7 macrophages
      1426. Regulation of cellular differentiation and cellular function by Phosphatidylinositol 3–kinase
      1427. Up-regulation of Phosphatidylinositol–3 kinase Signaling in plcg1 Gene Null Fibroblasts.
      1428. Tumor Necrosis Factor-α, Sphingomyelinase and Ceramides Activate Tyrosine kinase, P21ras and Phosphatidylinositol 3–kinase: Implications for Glucose Transport …
      1429. Arginine-specific ADP-ribosyltransferase on the surface of gizzard smooth muscle cells and the involvement of Phosphatidylinositol 3–kinase in maintaining the activity …
      1430. Casein kinase I associates with members of the centaurin-α family of Phosphatidylinositol 3, 4, 5-trisphosphate-binding proteins
      1431. Glucose-induced insulin resistance of Phosphatidylinositol 3′-OH kinase and AKT/PKB is mediated by the hexosamine biosynthesis pathway
      1432. TPO regulates Bcl-xL gene expression through Stat5 and Phosphatidylinositol–3–kinase activation pathways
      1433. Wortmannin, A Specific Phosphatidylinositol 3–kinase Inhibitor, Blocks In Vitro Fertilization and Embryonic Development of Bovine Oocytes Matured In Vitro with …
      1434. Activation of Phosphatidylinositol 3–kinase (PI3K) as a predictor of clinical outcome in breast cancer patients
      1435. Phosphatidylinositol 3–kinase and NF
      1436. The cloning and functional characterisation of murine Phosphatidylinositol 3–kinase gamma
      1437. Phosphatidylinositol 3–kinase is involved in IL-18-stimulated AP-1 activation
      1438. Investigation of Phosphatidylinositol–3–kinase (PI3K) and extracellular signal-regulated kinase 1/2 (ERK1/2) activation
      1439. A novel mechanism of regulation of Phosphatidylinositol 3–kinase: Tyrosine phosphorylation of p85 residue 688
      1440. A Role of Phosphatidylinositol 3–kinase (PI3K) on H-ras-lnduced Invasive phenotype
      1441. The role and regulation of Phosphatidylinositol–3 kinase, PTEN, and AKT in tumorigenesis
      1442. Rac and Phosphatidylinositol 3–kinase
      1443. A Role of Phosphatidylinositol 3–kinase (PI3K) on H-ras-Induced Invasive phenotype
      1444. The relationship of Met326Ile variant of p85? regulatory subunit of Phosphatidylinositol 3–kinase (PI3-K) with type 2 diabetes
      1445. Phosphatidylinositol 3-OH kinase–Akt/protein kinase B pathway mediates Gas6 induction of scavenger receptor a in immortalized human vascular smooth muscle cell …
      1446. Activation of Phosphatidylinositol 3–kinase (PI3K) is Required for Invasiveness and Motility in H-ras MCE10A Cells
      1447. The Role of Nuclear Factor kB and Phosphatidylinositol 3–kinase in Trypsinogen Activation in Cerulein-Stimulated Rat Pancreatic Acini
      1448. Phosphatidylinositol 3–kinase BUT NOT TUBERIN IS REQUIRED FOR PDGF-INDUCED CELL MIGRATION
      1449. THE ESSENTIAL ROLE OF Phosphatidylinositol 3–kinase IN THE INDUCTION OF MICROSOMAL EPOXIDE HYDROLASE
      1450. Role of Conserved Acidic Residue Asp21 in the Structure of Phosphatidylinositol 3–kinase Src Homology 3 Domain: Circular Dichroism and Nuclear Magnetic …
      1451. Retinoic acid inhibits transformation by modulating Phosphatidylinositol 3–kinase signaling to the nucleus
      1452. Regulation of hematopoietic cell proliferation by cytokine-activated Phosphatidylinositol 3–kinase
      1453. Involvement of Phosphatidylinositol 3–kinase in the Insulin Signaling in Preimplantation Mouse Embryos
      1454. Regulation of FRTL-5 thyroid cell growth by Phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling
      1455. Expression of Phosphatidylinositol 3–kinase during the proliferation of the hypoxic rat pulmonary arterial smooth muscle cells
      1456. Regulation of lysosomal pH in macrophages via Phosphatidylinositol 3–kinase and protein kinase C
      1457. Activation of Phosphatidylinositol 3–kinase-protein kinase B (PI3K-PKB) induced by 17?-estradiol in endometrial carcinoma cell (Ishikawa)
      1458. Cytokines Prevent Dexamethasone-induced Apoptosis via the Activation of Mitogen-activated Protein kinase and Phosphatidylinositol 3–kinase Pathways in a …
      1459. An Inhibitory Role of the Phosphatidylinositol 3–kinase-signaling Pathway in Vascular Endothelial Growth Factor-induced Tissue Factor Expression
      1460. c-CBL is the bridge molecule linking BCR/ABL to Phosphatidylinositol–3 kinase
      1461. Fas and ceramide inhibition of the Phosphatidylinositol–3–kinase (PI3K) cell survival pathway in human granulosa luteal cells (hGLC).
      1462. The Link between Insulin Resistance and Hyperinsulinemia: Inhibition of Phosphatidylinositol 3–kinase (PI3K) by Wortmannin Augments Glucose (G)-Induced Insulin …
      1463. Wortmannin, A Specific Phosphatidylinositol 3–kinase Inhibitor, Blocks In Vitro Fertilization and Embryonic Development of Bovine Oocytes Matured In Vitro with …
      1464. Lysophosphatidylcholine generates superoxide anions through activation of Phosphatidylinositol 3–kinase in human neutrophils
      1465. Coincident signaling of cAMP with Phosphatidylinositol 3‘kinase and mitogen-activated protein kinase signal transduction cascades: A role in regulating gene …
      1466. The role of nucleoside diphosphate kinase and Phosphatidylinositol 3–kinase in the expression and cellular localization of the glial fibrillary acidic protein …
      1467. Insulin Regulates Alternative Splicing of Protein kinase C ßII through a Phosphatidylinositol 3–kinase-dependent Pathway Involving the Nuclear Serine …
      1468. Evidence for Involvement of Gab-1 Associated Phosphatidylinositol 3–kinase in Osmotic Shock Induced Glucose Transport in 3T3-L1 Adipocytes
      1469. Human SMG-1, a novel Phosphatidylinositol 3–kinase-related protein kinase, associates with components of the mRNA surveillance complex and involved in the …
      1470. Aggretin, a C-Type Lectin Protein, Induces Platelet Aggregation Via Integrin 21 and Gpib in a Phosphatidylinositol 3–kinase Independent Pathway
      1471. Interleukin-1 receptor associated kinase 1 and Phosphatidylinositol 3 kinase regulate the NF-kappaB activation induced by IL-1
      1472. AtPIP5K1, an Arabidopsis thaliana Phosphatidylinositol phosphate kinase, synthesizes PtdIns (3, 4) P2 and PtdIns (4, 5) P2 in vitro and is inhibited by phosphorylation
      1473. Role of the Phosphatidylinositol (PI) 3–kinase/Akt protein kinase signaling pathway in the survival of rat sympathetic neurons
      1474. The Phosphatidylinositol 3–kinase–AKT pathway in human cancer
      1475. Leading the way: directional sensing through Phosphatidylinositol 3–kinase and other signaling pathways
      1476. Prostanoid receptors and Phosphatidylinositol 3–kinase: a pathway to cancer?
      1477. Analysis of the Phosphatidylinositol 3′-kinase Signaling Pathway in Glioblastoma Patients in Vivo
      1478. A crucial role for the p110δ subunit of Phosphatidylinositol 3–kinase in B cell development and activation
      1479. Phosphatidylinositol–3 kinase inhibitors enhance the anti-leukemia effect of STI571
      1480. The Phosphatidylinositol 3–kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation
      1481. Rapid accumulation of Akt in mitochondria following Phosphatidylinositol 3‐kinase activation
      1482. Inhibition of Phosphatidylinositol 3–kinase enhances mitogenic actions of insulin in endothelial cells
      1483. The Phosphatidylinositol 3–kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria
      1484. Role of the Phosphatidylinositol 3–kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma
      1485. Role of the Phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide
      1486. Anti-cancer alkyl-lysophospholipids inhibit the Phosphatidylinositol 3–kinase–Akt/PKB survival pathway
      1487. The Phosphatidylinositol 3–kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human …
      1488. Inhibition of Phosphatidylinositol 3′-kinase Increases Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models
      1489. Phosphatidylinositol 3–kinase/Akt signaling in the response of vascular endothelium to ionizing radiation
      1490. Role of the Phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells
      1491. Receptor-specific regulation of Phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2
      1492. A Phosphatidylinositol 3–kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding
      1493. Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages
      1494. Src kinase mediates Phosphatidylinositol 3–kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen
      1495. The role of focal adhesion kinase–Phosphatidylinositol 3–kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression
      1496. Inhibition of the Phosphatidylinositol 3′-kinase-AKT Pathway Induces Apoptosis in Pancreatic Carcinoma Cells in Vitro and in Vivo
      1497. Phosphatidylinositol 3–kinase mediates proliferative signals in intestinal epithelial cells
      1498. Phosphatidylinositol 3–kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin
      1499. Role of Phosphatidylinositol 3–kinase in oxidative stress-induced disruption of tight junctions
      1500. Targeting the Phosphatidylinositol 3–kinase/Akt pathway for enhancing breast cancer cells to radiotherapy
      1501. Phosphorylation of glycogen synthase kinase–3β during preconditioning through a Phosphatidylinositol–3–kinase–dependent pathway is cardioprotective
      1502. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and Phosphatidylinositol 3–kinase
      1503. Human mammary epithelial cell transformation through the activation of Phosphatidylinositol 3–kinase
      1504. Phosphatidylinositol 3–kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms
      1505. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the Phosphatidylinositol 3–kinase/Akt/glycogen synthase kinase 3β …
      1506. Role of translation initiation factor 2B in control of cell survival by the Phosphatidylinositol 3–kinase/Akt/glycogen synthase kinase 3β signaling pathway
      1507. Constitutively activated Phosphatidylinositol–3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ
      1508. Activation of the Phosphatidylinositol 3–kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis
      1509. Involvement of protein kinase C and Phosphatidylinositol 3–kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells
      1510. Phosphatidylinositol 3–kinase/Akt stimulates androgen pathway through GSK3β inhibition and nuclear β-catenin accumulation
      1511. Suppression versus induction of androgen receptor functions by the Phosphatidylinositol 3–kinase/Akt pathway in prostate cancer LNCaP cells with different …
      1512. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the Phosphatidylinositol 3–kinase/Akt pathway in glioblastomas
      1513. Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the Phosphatidylinositol 3–kinase pathway
      1514. Effects of deguelin on the Phosphatidylinositol 3–kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells
      1515. Native group‐III metabotropic glutamate receptors are coupled to the mitogen‐activated protein kinase/Phosphatidylinositol‐3‐kinase pathways
      1516. … factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and Phosphatidylinositol 3–kinase signaling in colon …
      1517. Phosphatidylinositol 3–kinase Functionally Compartmentalizes the Concurrent Gs Signaling During β2-Adrenergic Stimulation
      1518. Modulation of Rab5 and Rab7 recruitment to phagosomes by Phosphatidylinositol 3–kinase
      1519. Immunocytochemical detection of Phosphatidylinositol 3–kinase activation by insulin and leptin
      1520. Activation of Phosphatidylinositol 3–kinase/Akt pathway by androgen through interaction of p85α, androgen receptor, and Src
      1521. The endothelial receptor tyrosine kinase Tie1 activates Phosphatidylinositol 3–kinase and Akt to inhibit apoptosis
      1522. Phosphatidylinositol 3–kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination
      1523. Phosphatidylinositol 3–kinase: a molecule mediating BDNF-dependent spatial memory formation
      1524. Phosphatidylinositol 3–kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress
      1525. Endurance training improves responsiveness to insulin and modulates insulin signal transduction through the Phosphatidylinositol 3–kinase/Akt-1 pathway
      1526. Activation of the Phosphatidylinositol 3–kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma …
      1527. Inhibition of Phosphatidylinositol 3–kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy
      1528. Src family protein-tyrosine kinases alter the function of PTEN to regulate Phosphatidylinositol 3–kinase/AKT cascades
      1529. Herceptin-induced inhibition of Phosphatidylinositol–3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action
      1530. Microphthalmia associated transcription factor is a target of the Phosphatidylinositol–3–kinase pathway
      1531. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and Phosphatidylinositol–3 kinase/Akt signaling
      1532. E-cadherin homophilic ligation directly signals through Rac and Phosphatidylinositol 3–kinase to regulate adhesive contacts
      1533. Phosphatidylinositol 3–kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region
      1534. Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the Phosphatidylinositol 3–kinase signaling …
      1535. Phosphatidylinositol 3–kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1α nor sufficient for HIF-1-dependent target gene transcription
      1536. Phosphatidylinositol 3–kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus
      1537. Phosphatidylinositol 3‐kinase is a central mediator of NMDA receptor signalling to MAP kinase (Erk1/2), Akt/PKB and CREB in striatal neurones
      1538. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the Phosphatidylinositol 3–kinase …
      1539. Requirement of BMP-2-induced Phosphatidylinositol 3–kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene …
      1540. Phosphatidylinositol 3–kinase regulates the CD4/CD8 T cell differentiation ratio
      1541. Endocytosed transferrin receptors recycle via distinct dynamin and Phosphatidylinositol 3–kinase-dependent pathways
      1542. Insulin activation of Phosphatidylinositol 3–kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia
      1543. Regulation of TRAIL expression by the Phosphatidylinositol 3–kinase/Akt/GSK-3 pathway in human colon cancer cells
      1544. RANKL regulates endothelial cell survival through the Phosphatidylinositol 3′‐kinase/Akt signal transduction pathway
      1545. Characterization of the Met326Ile variant of Phosphatidylinositol 3–kinase p85α
      1546. Caveolin-induced activation of the Phosphatidylinositol 3–kinase/Akt pathway increases arsenite cytotoxicity
      1547. Protective effect of dopamine D2 agonists in cortical neurons via the Phosphatidylinositol 3 kinase cascade
      1548. Regulation of rat Sertoli cell function by FSH: possible role of Phosphatidylinositol 3–kinase/protein kinase B pathway
      1549. Protective effects of docosahexaenoic acid in staurosporine‐induced apoptosis: involvement of Phosphatidylinositol‐3 kinase pathway
      1550. Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a Phosphatidylinositol 3–kinase-dependent pathway
      1551. Role of the Phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell …
      1552. Aldosterone regulates vascular reactivity: short-term effects mediated by Phosphatidylinositol 3–kinase–dependent nitric oxide synthase activation
      1553. ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the Phosphatidylinositol 3–kinase
      1554. Vanadate-induced expression of hypoxia-inducible factor 1α and vascular endothelial growth factor through Phosphatidylinositol 3–kinase/Akt pathway and …
      1555. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the Phosphatidylinositol 3–kinase pathway
      1556. Critical involvement of the Phosphatidylinositol 3–kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer
      1557. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the Phosphatidylinositol 3–kinase/protein kinase B pathway
      1558. Molecular basis of cell membrane estrogen receptor interaction with Phosphatidylinositol 3–kinase in endothelial cells
      1559. … lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a Phosphatidylinositol 3–kinase/Akt-dependent process
      1560. Kaposi’s sarcoma-associated herpesvirus induces the Phosphatidylinositol 3–kinase-PKC-ζ-MEK-ERK signaling pathway in target cells early during infection …
      1561. C5a delays apoptosis of human neutrophils by a Phosphatidylinositol 3–kinase-signaling pathway
      1562. Phosphatidylinositol 3–kinase activity negatively regulates stability of cyclooxygenase 2 mRNA
      1563. CD40 induces human multiple myeloma cell migration via Phosphatidylinositol 3–kinase/AKT/NF-κB signaling
      1564. Ras mediates radioresistance through both Phosphatidylinositol 3–kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal …
      1565. β1 integrin regulates fibroblast viability during collagen matrix contraction through a Phosphatidylinositol 3–kinase/Akt/protein kinase B signaling pathway
      1566. … growth factor-induced migration of multiple myeloma cells is associated with β1 integrin-and Phosphatidylinositol 3–kinase-dependent PKCα activation
      1567. Activated Gαq inhibits p110α Phosphatidylinositol 3–kinase and Akt
      1568. Regulation of Fas expression by STAT3 and c-Jun is mediated by Phosphatidylinositol 3–kinase-AKT signaling
      1569. Ureteric bud outgrowth in response to RET activation is mediated by Phosphatidylinositol 3–kinase
      1570. … tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive Phosphatidylinositol 3′-kinase/Akt pathway signaling
      1571. The role of Phosphatidylinositol 3‐kinase in neural cell adhesion molecule‐mediated neuronal differentiation and survival
      1572. Reduced activation of Phosphatidylinositol–3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle …
      1573. IL-12 provides proliferation and survival signals to murine CD4+ T cells through Phosphatidylinositol 3–kinase/Akt signaling pathway
      1574. Regulation of Phosphatidylinositol 3–kinase activity and Phosphatidylinositol 3, 4, 5-trisphosphate accumulation by neutrophil priming agents
      1575. Implication of Phosphatidylinositol 3–kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt
      1576. Phosphatidylinositol 3–kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation
      1577. Phosphatidylinositol 3–kinase Regulates Human Immunodeficiency Virus Type 1 Replication following Viral Entry in Primary CD4+ T Lymphocytes and Macrophages
      1578. CD40-dependent activation of Phosphatidylinositol 3–kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis
      1579. The phospholipase Cγ1-dependent pathway of FcϵRI-mediated mast cell activation is regulated independently of Phosphatidylinositol 3–kinase
      1580. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 Phosphatidylinositol 3–kinase
      1581. IKKβ and Phosphatidylinositol 3–kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-κB activation …
      1582. The Phosphatidylinositol 3‐kinase inhibitor LY294002 potently blocks Kv currents via a direct mechanism
      1583. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the Phosphatidylinositol 3–kinase-mediated pathway but …
      1584. … cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through Phosphatidylinositol 3–kinase/Akt signaling pathways …
      1585. Expression of a mutated form of the p85α regulatory subunit of Phosphatidylinositol 3–kinase in a Hodgkin’s lymphoma-derived cell line (CO)
      1586. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via Phosphatidylinositol 3′-kinase pathway
      1587. … of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, Phosphatidylinositol 3′-kinase-AKT-dependent pathway
      1588. … gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the Phosphatidylinositol–3 kinase domain and is …
      1589. Inactivation of the antiapoptotic Phosphatidylinositol 3–kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition
      1590. … -1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/Phosphatidylinositol 3–kinase and MAPK signaling …
      1591. Phosphatidylinositol 3‐kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival
      1592. Negative regulation of Phosphatidylinositol 3–kinase and Akt signalling pathway by PKC
      1593. The role of Phosphatidylinositol 3–kinase, rho family GTPases, and STAT3 in Ros-induced cell transformation
      1594. Dysregulation of Phosphatidylinositol 3‐kinase and downstream effectors in human breast cancer
      1595. Insulin down-regulates insulin receptor substrate-2 expression through the Phosphatidylinositol 3–kinase/Akt pathway
      1596. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and Phosphatidylinositol 3–kinase/AKT by saturated and polyunsaturated …
      1597. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and Phosphatidylinositol 3–kinase in the adult rat …
      1598. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/Phosphatidylinositol 3′-kinase/protein kinase B in prostate …
      1599. A Phosphatidylinositol 3–kinase-independent insulin signaling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling
      1600. Hepatocyte growth factor induced human trophoblast motility involves Phosphatidylinositol–3–kinase, mitogen-activated protein kinase, and inducible nitric oxide …
      1601. Evidence that SHIP-1 contributes to Phosphatidylinositol 3, 4, 5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3–kinase …
      1602. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the Phosphatidylinositol 3–kinase/Akt/mammalian target of rapamycin …
      1603. … hormone-treated astrocytes is mediated by epidermal growth factor/mitogen-activated protein kinase–Phosphatidylinositol 3–kinase pathways and involves …
      1604. Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of Phosphatidylinositol 3–kinase and Akt activity mediating neuronal survival
      1605. Interaction between Nef and Phosphatidylinositol–3–kinase leads to activation of p21-activated kinase and increased production of HIV
      1606. Potential role of Phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA–induced immune activation
      1607. p38 Mitogen‐activated protein kinase and Phosphatidylinositol 3‐kinase activities have opposite effects on human neutrophil apoptosis
      1608. Activation of Phosphatidylinositol 3–kinase is important for erythropoietin-induced erythropoiesis from CD34+ hematopoietic progenitor cells
      1609. PTEN and Phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial …
      1610. Phosphatidylinositol 3–kinase and NF-κB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen …
      1611. The Role of Novel Oncogenes Squamous Cell Carcinoma-related Oncogene and Phosphatidylinositol 3–kinase p110α in Squamous Cell Carcinoma of the Oral …
      1612. Signal transduction from N-cadherin increases Bcl-2: regulation of the Phosphatidylinositol 3–kinase/Akt pathway by homophilic adhesion and actin …
      1613. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and Phosphatidylinositol 3–kinase activation pathways
      1614. Parallel Phosphatidylinositol–3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like …
      1615. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of Phosphatidylinositol 3–kinase, Bcl-xL, and IL-2 expression in …
      1616. TAPP1 and TAPP2 are targets of Phosphatidylinositol 3–kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor
      1617. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine‐activated T cells: involvement of Phosphatidylinositol 3‐kinase and nuclear factor κB …
      1618. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the Phosphatidylinositol 3–kinase/Akt pathway to promote cell survival and induce actin filament …
      1619. Ephrin-B2 induces migration of endothelial cells through the Phosphatidylinositol–3 kinase pathway and promotes angiogenesis in adult vasculature
      1620. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated Phosphatidylinositol 3–kinase activity in muscle
      1621. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-integrin and Phosphatidylinositol 3′-kinase/AKT …
      1622. Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-Phosphatidylinositol 3–kinase/Akt signaling pathway by disrupting the association of IRS-1 …
      1623. Synchronous activation of ERK and Phosphatidylinositol 3–kinase pathways is required for collagen and extracellular matrix production in keloids
      1624. EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for Phosphatidylinositol 3–kinase and Vav2
      1625. Epidermal growth factor receptor-dependent, NF-κB-independent activation of the Phosphatidylinositol 3–kinase/Akt pathway inhibits ultraviolet irradiation …
      1626. Sustained Production of H2O2Activates Pro-matrix Metalloproteinase-2 through Receptor Tyrosine kinases/Phosphatidylinositol 3–kinase/NF-κB Pathway
      1627. Insulin stimulates hypoxia-inducible factor 1 through a Phosphatidylinositol 3–kinase/target of rapamycin-dependent signaling pathway
      1628. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-β by Phosphatidylinositol 3–kinase/Akt-dependent suppression of the …
      1629. … lucidum inhibits spontaneous and Fas‐mediated apoptosis in human neutrophils through activation of the Phosphatidylinositol 3 kinase/Akt signaling pathway
      1630. Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression
      1631. Phosphatidylinositol–3–kinase–Akt kinase and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of …
      1632. … induces an autocrine‐paracrine survival pathway via platelet‐derived growth factor (PDGF)‐B/PDGF‐β receptor/Phosphatidylinositol 3‐kinase/Akt signaling in RN46A …
      1633. Characterization of Phosphatidylinositol 3–kinase-dependent phosphorylation of the hydrophobic motif site Thr389 in p70 S6 kinase 1
      1634. Insulin-Like Growth Factor-1–Induced Phosphorylation of Transcription Factor FKHRL1 Is Mediated by Phosphatidylinositol 3–kinase/Akt kinase and Role of This …
      1635. Selective PDZ protein-dependent stimulation of Phosphatidylinositol 3–kinase by the adenovirus E4-ORF1 oncoprotein
      1636. … endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and Phosphatidylinositol 3′-kinase-mediated PKCδ phosphorylation: role of …
      1637. Augmentation of sodium butyrate-induced apoptosis by Phosphatidylinositol 3′-kinase inhibition in the KM20 human colon cancer cell line
      1638. Phosphatidylinositol 3–kinase regulates PMA-induced differentiation and superoxide production in HL-60 cells
      1639. … of FcϵRI‐and FcγRI‐mediated degranulation and TNF‐α synthesis in human mast cells: selective utilization of Phosphatidylinositol‐3‐kinase for FcγRI‐induced …
      1640. The oncogene Phosphatidylinositol 3′-kinase catalytic subunit α promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma
      1641. Tauroursodeoxycholic acid prevents amyloid-β peptide-induced neuronal death via a Phosphatidylinositol 3–kinase-dependent signaling pathway
      1642. Functional cooperation among Ras, STAT5, and Phosphatidylinositol 3–kinase is required for full oncogenic activities of BCR/ABL in K562 cells
      1643. … expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1α stabilization: a role for Phosphatidylinositol 3′-kinase
      1644. Involvement of Phosphatidylinositol 3–kinase γ in neutrophil apoptosis
      1645. Activation of Phosphatidylinositol 3–kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic β-cell death
      1646. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of Phosphatidylinositol 3–kinase, independent of insulin …
      1647. The Phosphatidylinositol 3–kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells
      1648. Src and Phosphatidylinositol 3–kinase mediate soluble E-selectin–induced angiogenesis
      1649. Dietary cod protein restores insulin-induced activation of Phosphatidylinositol 3–kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed …
      1650. Phosphatidylinositol 3–kinase but not tuberin is required for PDGF-induced cell migration
      1651. Inhibition of Phosphatidylinositol 3–kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis
      1652. The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a Phosphatidylinositol 3–kinase-dependent pathway
      1653. Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves Phosphatidylinositol 3–kinase and reactive oxygen species in …
      1654. The in Vitro and in Vivo Effects of 2-(4-Morpholinyl)-8-phenyl-chromone (LY294002), a Specific Inhibitor of Phosphatidylinositol 3′-kinase, in Human Colon Cancer …
      1655. Essential Role of Phosphatidylinositol 3–kinase-Dependent CCAAT/Enhancer Binding Protein β Activation in the Induction of Glutathione S-Transferase by Oltipraz
      1656. Betacellulin induces angiogenesis through activation of mitogen‐activated protein kinase and Phosphatidylinositol 3‘‐kinase in endothelial cells
      1657. Oncogenic H-Ras Enhances DNA Repair through the Ras/Phosphatidylinositol 3–kinase/Rac1 Pathway in NIH3T3 Cells: Evidence for association with …
      1658. Evidence for Phosphatidylinositol 3–kinase—Akt—p70S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in human …
      1659. Laminin-10/11 and fibronectin differentially prevent apoptosis induced by serum removal via Phosphatidylinositol 3–kinase/Akt-and MEK1/ERK-dependent …
      1660. The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3–kinase/Akt Signaling Pathway
      1661. … expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the Phosphatidylinositol 3–kinase and extracellular signal …
      1662. Phosphatidylinositol 3–kinase Suppresses Glucose-Stimulated Insulin Secretion by Affecting Post-Cytosolic [Ca2+] Elevation Signals
      1663. Requirement for Phosphatidylinositol–3 kinase activity during progression through S-phase and entry into mitosis
      1664. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a Phosphatidylinositol 3–kinase–dependent pathway in rats
      1665. The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and Phosphatidylinositol 3–kinase
      1666. β-Arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of Phosphatidylinositol 3–kinase (PI3K) and anti-apoptosis
      1667. Phosphatidylinositol 3–kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites
      1668. Tumor necrosis factor alpha-induced interleukin-8 production via NF-κB and Phosphatidylinositol 3–kinase/Akt pathways inhibits cell apoptosis in human hepatocytes
      1669. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and Phosphatidylinositol 3–kinase regulation
      1670. … -cytokine cross-talk: the ELR+ CXC chemokine LIX (CXCl5) amplifies a proinflammatory cytokine response via a Phosphatidylinositol 3–kinase-NF-κB pathway
      1671. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the Phosphatidylinositol 3–kinase pathway in endothelial …
      1672. Nerve growth factor signals through TrkA, Phosphatidylinositol 3–kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 …
      1673. Semaphorin 3F antagonizes neurotrophin-induced Phosphatidylinositol 3–kinase and mitogen-activated protein kinase kinase signaling: a mechanism for growth cone …
      1674. Phosphatidylinositol 3–kinase: a key regulator of vascular tone?
      1675. Estrogen regulation of c-fos gene expression through Phosphatidylinositol–3–kinase-dependent activation of serum response factor in MCF-7 breast cancer cells
      1676. Synapsin I-associated Phosphatidylinositol 3–kinase mediates synaptic vesicle delivery to the readily releasable pool
      1677. Putative Phosphatidylinositol 3–kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt …
      1678. Phosphatidylinositol 3–kinase is essential for the proliferation of lymphoblastoid cells
      1679. Taurolithocholic acid exerts cholestatic effects via Phosphatidylinositol 3–kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets
      1680. The Phosphatidylinositol‐3 kinase (PI3K)‐Akt pathway suppresses neurite branch formation in NGF‐treated PC12 cells
      1681. Involvement of Phosphatidylinositol 3–kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation
      1682. Interferon beta promotes survival in primary astrocytes through Phosphatidylinositol 3–kinase
      1683. Role of Phosphatidylinositol 3–kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells
      1684. Acetylcholine leads to free radical production dependent on KATP channels, Gi proteins, Phosphatidylinositol 3–kinase and tyrosine kinase
      1685. Hepatitis B virus X protein activates a survival signaling by linking SRC to Phosphatidylinositol 3–kinase
      1686. … sugar absorption is regulated by phosphorylation and turnover of protein kinase C βII mediated by Phosphatidylinositol 3–kinase-and mammalian target of …
      1687. The α5β1 integrin selectively enhances epidermal growth factor signaling to the Phosphatidylinositol–3–kinase/Akt pathway in intestinal epithelial cells
      1688. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and Phosphatidylinositol 3–kinase pathways
      1689. Phosphatidylinositol 3–kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation
      1690. Estrogen enhances depolarization-induced glutamate release through activation of Phosphatidylinositol 3–kinase and mitogen-activated protein kinase in cultured …
      1691. Regulatory role for SRC and Phosphatidylinositol 3–kinase in initiation of fibronectin matrix assembly
      1692. TC21 mediates transformation and cell survival via activation of Phosphatidylinositol 3–kinase/Akt and NF-κB signaling pathway
      1693. … CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and Phosphatidylinositol 3–kinase signaling leading to …
      1694. Necessary role of Phosphatidylinositol 3‐kinase in transforming growth factor β–mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts
      1695. … motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator by inhibiting the Phosphatidylinositol 3′-kinase activity in breast …
      1696. Attenuated 5‐HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, Phosphatidylinositol 3‐kinase, Akt and mitogen‐activated protein …
      1697. … nitric-oxide synthase by tumor necrosis factor-α: a novel pathway involving sequential activation of neutral sphingomyelinase, Phosphatidylinositol–3′ kinase, and …
      1698. … cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, Phosphatidylinositol 3–kinase, and mitogen-activated protein …
      1699. Phosphatidylinositol 3–kinase is a key regulator of early phase differentiation in keratinocytes
      1700. Activation of Protein kinase C-ζ by Insulin and Phosphatidylinositol–3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose Tolerance …
      1701. Evidence that Phosphatidylinositol 3–kinase-and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent pathways cooperate to …
      1702. Interleukin-3-mediated cell survival signals include Phosphatidylinositol 3–kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface
      1703. … growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and Phosphatidylinositol 3′-kinase-Akt signaling pathways
      1704. Requirement of Phosphatidylinositol 3–kinase activation and calcium influx for leukotriene B4-induced enzyme release
      1705. Studies of the mitogen-activated protein kinases and Phosphatidylinositol–3 kinase in the lens. 1. The mitogenic and stress responses
      1706. The cross-talk between angiotensin and insulin differentially affects Phosphatidylinositol 3–kinase-and mitogen-activated protein kinase-mediated signaling in rat heart …
      1707. Impaired insulin action on Phosphatidylinositol 3–kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients
      1708. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits Phosphatidylinositol 3–kinase to mediate the tumor necrosis factor-induced angiogenic …
      1709. Phosphatidylinositol 3′-kinase is required for growth of mast cells expressing the kit catalytic domain mutant
      1710. Cell cycle activation in lung adenocarcinoma cells by the ErbB3/Phosphatidylinositol 3–kinase/Akt pathway
      1711. HIV-1-Tat protein activates Phosphatidylinositol 3–kinase/AKT-dependent survival pathways in Kaposi’s sarcoma cells
      1712. Activation of CR3‐mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, Phosphatidylinositol 3‐kinase, and protein kinase C ζ
      1713. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the Phosphatidylinositol 3–kinase pathway in vascular …
      1714. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via Phosphatidylinositol–3–kinase–dependent pathway
      1715. 1α,25-Dihydroxyvitamin D3 Induces Vascular Smooth Muscle Cell Migration via Activation of Phosphatidylinositol 3–kinase
      1716. Phosphatidylinositol 3′-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products
      1717. … -like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the Phosphatidylinositol 3 kinase/Akt signaling pathway
      1718. Phosphatidylinositol 3–kinase controls antineutrophil cytoplasmic antibodies—induced respiratory burst in human neutrophils
      1719. Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via Phosphatidylinositol 3–kinase in porcine granulosa cells
      1720. Role of Phosphatidylinositol 3‐kinase in neuronal survival and axonal outgrowth of adult mouse dorsal root ganglia explants
      1721. μ-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via Phosphatidylinositol 3–kinase
      1722. Minimal mutation of the cytoplasmic tail inhibits the ability of E-cadherin to activate Rac but not Phosphatidylinositol 3–kinase: direct evidence of a role for …
      1723. Dexamethasone impairs insulin signalling and glucose transport by depletion of insulin receptor substrate-1, Phosphatidylinositol 3–kinase and protein kinase B in …
      1724. Regulation of the Phosphatidylinositol 3–kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways …
      1725. The role of Phosphatidylinositol 3′-kinase and its downstream signals in erbB-2-mediated transformation
      1726. Distinct role of Phosphatidylinositol 3–kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes
      1727. … -like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A-and a Phosphatidylinositol 3–kinase …
      1728. Phosphatidylinositol 3–kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling
      1729. Early stage-specific inhibitions of cardiomyocyte differentiation and expression of Csx/Nkx-2.5 and GATA-4 by Phosphatidylinositol 3–kinase inhibitor LY294002
      1730. Role of the insulin receptor substrate 1 and Phosphatidylinositol 3–kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein …
      1731. High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated Phosphatidylinositol 3–kinase activity and glucose transport
      1732. … of interferon-γ-inducible GTPase inhibits coxsackievirus B3-induced apoptosis through the activation of the Phosphatidylinositol 3–kinase/Akt pathway and …
      1733. Transformation of mouse fibroblasts by Jaagsiekte sheep retrovirus envelope does not require Phosphatidylinositol 3–kinase
      1734. Y box-binding protein 1 induces resistance to oncogenic transformation by the Phosphatidylinositol 3–kinase pathway
      1735. … growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a Phosphatidylinositol 3–kinase …
      1736. Phosphatidylinositol 3‐kinase is essential for kit ligand‐mediated survival, whereas interleukin‐3 and flt3 ligand induce expression of antiapoptotic Bcl‐2 family …
      1737. Insulin Resistance, Defective Insulin Receptor Substrate 2—Associated Phosphatidylinositol–3′ kinase Activation, and Impaired Atypical Protein kinase C (ζ/λ) …
      1738. Phosphatidylinositol 3–kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide production
      1739. Inhibition of activator protein-1 binding activity and Phosphatidylinositol 3–kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue …
      1740. B cell receptor-mediated Syk-independent activation of Phosphatidylinositol 3–kinase, Ras, and mitogen-activated protein kinase pathways
      1741. High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to Phosphatidylinositol (3, 4, 5)-trisphosphate
      1742. Phosphatidylinositol 3–kinase activity is required for epidermal growth factor to suppress proteolysis
      1743. A new role for the p85-Phosphatidylinositol 3–kinase regulatory subunit linking FRAP to p70 S6 kinase activation
      1744. Phosphatidylinositol 3‐kinase and extracellular signal‐regulated kinase are recruited for Fc receptor‐mediated phagocytosis during monocyte‐to‐macrophage …
      1745. Phosphatidylinositol 3–kinase in cumulus cells is responsible for both suppression of spontaneous maturation and induction of gonadotropin-stimulated …
      1746. Inhibition of Phosphatidylinositol 3‐kinase and p70S6 kinase blocks osteogenic protein‐1 induction of alkaline phosphatase activity in fetal rat calvaria cells
      1747. Neuroprotection by scatter factor/hepatocyte growth factor and FGF‐1 in cerebellar granule neurons is Phosphatidylinositol 3‐kinase/akt‐dependent and MAPK/CREB …
      1748. Down-regulation of the Phosphatidylinositol 3–kinase/Akt pathway is involved in retinoic acid-induced phosphorylation, degradation, and transcriptional …
      1749. … -mediated endocytosis and recycling of the neuron-specific Na+/H+ exchanger NHE5 isoform: regulation by Phosphatidylinositol 3′-kinase and the actin …
      1750. Stretch-induced retinal vascular endothelial growth factor expression is mediated by Phosphatidylinositol 3–kinase and protein kinase C (PKC)-ζ but not by …
      1751. Antagonism of rat β-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and Phosphatidylinositol 3–kinase …
      1752. Inhibition of Phosphatidylinositol 3‐kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma …
      1753. Up-regulation of Phosphatidylinositol 3–kinase and glucose transporter 4 in muscle of rats subjected to maternal undernutrition
      1754. AKT and the Phosphatidylinositol 3–kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment
      1755. Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a Phosphatidylinositol 3‐kinase (PI3) kinase‐dependent manner in Neuro2a cells
      1756. Vascular endothelial growth factor causes pulmonary vasodilation through activation of the Phosphatidylinositol–3–kinase-nitric oxide pathway in the late …
      1757. Src-Dependent Association of Cas and p85 Phosphatidylinositol 3′-kinase in v-crk-Transformed Cells
      1758. Differential activation of Phosphatidylinositol 3–kinase signaling during proliferation and differentiation of lens epithelial cells
      1759. … -1-Phosphate and Lysophosphatidic Acid Prevent Apoptosis in Osteoblastic Cells via a Signaling Pathway Involving Gi Proteins and Phosphatidylinositol–3 kinase
      1760. Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: Role of ERK MAP kinase and Phosphatidylinositol 3–kinase β
      1761. Purinergic P2Y12 receptor blockade inhibits shear-induced platelet Phosphatidylinositol 3–kinase activation
      1762. Adrenomedullin reduces VEGF-induced endothelial adhesion molecules and adhesiveness through a Phosphatidylinositol 3′-kinase pathway
      1763. Fibronectin enhances viability and alters cytoskeletal functions (with effects on the Phosphatidylinositol 3‐kinase pathway) in small cell lung cancer
      1764. Phosphatidylinositol 3–kinase-dependent, MEK-independent proliferation in response to CaR activation
      1765. Studies of the mitogen-activated protein kinases and Phosphatidylinositol–3 kinase in the lens. 2. The intercommunications
      1766. Lipid rafts as the signaling scaffold for NK cell activation: tyrosine phosphorylation and association of LAT with Phosphatidylinositol 3‐kinase and phospholipase C‐γ …
      1767. Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, Phosphatidylinositol 3–kinase and mitogen-activated …
      1768. Co-activation of the Phosphatidylinositol–3–kinase/Akt signaling pathway by N-methyl-D-aspartate and TrkB receptors in cerebellar granule cell neurons
      1769. 1α, 25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a Phosphatidylinositol 3–kinase/Ras/MEK/extracellular signal regulated …
      1770. Selenite-induced survival of HuH7 hepatoma cells involves activation of focal adhesion kinase–Phosphatidylinositol 3–kinase-Akt pathway and Rac1
      1771. Glucose-induced Phosphatidylinositol 3–kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-β receptor …
      1772. Synthetic studies of the Phosphatidylinositol 3–kinase inhibitor LY294002 and related analogues
      1773. … from PC12 Cells by Increasing Ca2+-Responsible Secretory Vesicles through the Activation of Mitogen-Activated Protein kinase and Phosphatidylinositol 3–kinase
      1774. Phosphatidylinositol 3–kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene …
      1775. … TCRγδ+ and Vδ2+ TCRγδ+ T lymphocytes from healthy donors and multiple sclerosis patients: Involvement of Phosphatidylinositol 3 kinase and calcium calmodulin …
      1776. Phosphatidylinositol 3–kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells …
      1777. … up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the Phosphatidylinositol 3–kinase/Akt signaling pathway in …
      1778. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through Phosphatidylinositol 3‐kinase and mitogen‐activated protein kinase pathways
      1779. Growth factor receptor-binding protein 10 (Grb10) as a partner of Phosphatidylinositol 3–kinase in metabolic insulin action
      1780. Phosphatidylinositol 3–kinase p85 adaptor function in T-cells: co-stimulation and regulation of cytokine transcription independent of associated p110
      1781. Peroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of Phosphatidylinositol 3–kinase: the role of nitric oxide synthase in rat …
      1782. BMP‐2 regulates cardiomyocyte contractility in a Phosphatidylinositol 3 kinase‐dependent manner
      1783. Phosphatidylinositol 3–kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells
      1784. Granulocyte-macrophage colony-stimulating factor signals for increased glucose transport via Phosphatidylinositol 3–kinase-and hydrogen peroxide …
      1785. Autocrine signaling through Ras regulates cell survival activity in human glioma cells: potential cross-talk between Ras and the Phosphatidylinositol 3–kinase-Akt …
      1786. Inhibition of the Phosphatidylinositol 3‘-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac
      1787. … factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the Phosphatidylinositol 3–kinase/AKT …
      1788. Phosphatidylinositol 3‘-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells
      1789. The Phosphatidylinositol 3–kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17β-estradiol-induced transcriptional activity of an estrogen sensitive …
      1790. Inhibition of lymphocyte kinase Lck and Phosphatidylinositol 3–kinase by a novel immunosuppressant, lymphostin
      1791. Role of Phosphatidylinositol 3‐kinase in the binding of Bordetella pertussis to human monocytes
      1792. Human neutrophil-expressed CD28 interacts with macrophage B7 to induce Phosphatidylinositol 3–kinase-dependent IFN-γ secretion and restriction of Leishmania …
      1793. … of a signature of interferon-γ-induced polypeptides that includes manganese-superoxide dismutase and the p85β subunit of Phosphatidylinositol 3–kinase
      1794. Decay‐accelerating factor induction by tumour necrosis factor‐α, through a Phosphatidylinositol‐3 kinase and protein kinase C‐dependent pathway, protects murine …
      1795. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal–regulated kinase pathway but not by the Phosphatidylinositol 3–kinase …
      1796. Targeting of Mitogen-Activated Protein kinases and Phosphatidylinositol 3 kinase Inhibits Hepatocyte Growth Factor/Scatter Factor–Induced Angiogenesis
      1797. Preferential binding of Grb2 or Phosphatidylinositol 3–kinase to the met receptor has opposite effects on HGF-induced myoblast proliferation
      1798. Hypoxia protects human lung microvascular endothelial and epithelial-like cells against oxygen toxicity: role of Phosphatidylinositol 3–kinase
      1799. … in human basophils by p38 mitogen‐activated protein kinase: phosphorylation is sensitive to the effects of Phosphatidylinositol 3‐kinase inhibitors and calcium …
      1800. Inhibition of nuclear factor κB and Phosphatidylinositol 3‐kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor α in mice
      1801. … induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of Phosphatidylinositol 3–kinase
      1802. Regulatory role of cAMP on expression of Cdk4 and p27Kip1 by inhibiting Phosphatidylinositol 3–kinase in corneal endothelial cells
      1803. … ) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative Phosphatidylinositol 3–kinase-independent pathway to …
      1804. … acid stimulates DNA synthesis in human microvascular endothelial cells via activation of Jak/STAT and Phosphatidylinositol 3–kinase/Akt signaling, leading to …
      1805. Necessity of tyrosine 719 and Phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine …
      1806. Recruitment of Phosphatidylinositol 3–kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism
      1807. Calcium receptor-induced serotonin secretion by parafollicular cells: role of Phosphatidylinositol 3–kinase-dependent signal transduction pathways
      1808. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and Phosphatidylinositol 3–kinase inhibitors
      1809. Phosphatidylinositol 3–kinase regulates glycosylPhosphatidylinositol hydrolysis through PLC-γ2 activation in erythropoietin-stimulated cells
      1810. A new class of mutations reveals a novel function for the original Phosphatidylinositol 3–kinase binding site
      1811. Involvement of Phosphatidylinositol 3–kinase in nuclear translocation of protein kinase C ζ induced by C2-ceramide in rat hepatocytes
      1812. Enhancement of ischemia‐induced tyrosine phosphorylation of Kv1. 2 by vascular endothelial growth factor via activation of Phosphatidylinositol 3‐kinase
      1813. Involvement of the Src kinase Lyn in phospholipase C-γ2 phosphorylation and Phosphatidylinositol 3–kinase activation in Epo signalling
      1814. … granulocyte–macrophage colony‐stimulating factor and interleukin‐5, inhibits apoptosis of human basophils through Phosphatidylinositol 3‐kinase: requirement of NF …
      1815. Insulin promotes formation of polymerized microtubules by a Phosphatidylinositol 3–kinase-independent, actin-dependent pathway in 3T3-L1 adipocytes
      1816. … (EPO)-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of Phosphatidylinositol 3–kinase and intranuclear generation of …
      1817. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a Phosphatidylinositol 3–kinase-dependent pathway
      1818. β‐Adrenergic receptor‐mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a Phosphatidylinositol 3‐kinase dependent pathway refractory to the …
      1819. Regulation of phospholipase C-γ2 via Phosphatidylinositol 3–kinase in macrophages
      1820. Degradation of IκBα in activated RAW264. 7 cells is blocked by the Phosphatidylinositol 3–kinase inhibitor LY294002
      1821. LY294002, an inhibitor of Phosphatidylinositol–3–kinase, causes preferential induction of apoptosis in human multidrug resistant cells
      1822. Involvement of Phosphatidylinositol–3–kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells
      1823. Aspirin protects Caco-2 cells from apoptosis after serum deprivation through the activation of a Phosphatidylinositol 3–kinase/AKT/p21Cip/WAF1pathway
      1824. Lactate-induced translocation of GLUT1 and GLUT4 is not mediated by the Phosphatidylinositol–3–kinase pathway in the rat heart
      1825. Insulin‐like growth factor‐1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through Phosphatidylinositol 3‐kinase and MAPK
      1826. Insulin stimulates spreading of skeletal muscle cells involving the activation of focal adhesion kinase, Phosphatidylinositol 3‐kinase and extracellular signal regulated …
      1827. Binding of Phosphatidylinositol 3, 4, 5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change
      1828. … -regulates the transcription of mouse lon homology ATP-dependent protease through extracellular signal-regulated protein kinase-and Phosphatidylinositol–3–kinase …
      1829. Phosphatidylinositol 3–kinase-like activity in Tetrahymena. Effects of wortmannin and LY 294002
      1830. Involvement of Phosphatidylinositol 3 kinase in the progesterone-induced oocyte maturation in Rana dybowskii
      1831. Growth arrest of PC12 cells by nerve growth factor is dependent on the Phosphatidylinositol 3‐kinase/Akt pathway via p75 neurotrophin receptor
      1832. … bad and glycogen synthase kinase–3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of Phosphatidylinositol 3–kinase
      1833. Wortmannin, a specific inhibitor of Phosphatidylinositol–3–kinase influences neurotrophin-induced spiral ganglion neurite growth
      1834. … -activated receptor gamma impedes Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis through Phosphatidylinositol 3–kinase …
      1835. External Qi of Yan Xin life science technology can revive or suppress enzyme activity of Phosphatidylinositol 3–kinase
      1836. Matrix-independent activation of Phosphatidylinositol 3–kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros …
      1837. Phosphatidylinositol 3–kinase is required for insulin-stimulated tyrosine phosphorylation of Shc in 3T3-L1 adipocytes
      1838. Transient ischemia enhances tyrosine phosphorylation and binding of the NMDA receptor to the Src homology 2 domain of Phosphatidylinositol 3‐kinase in the rat …
      1839. Kit/stem cell factor receptor‐induced Phosphatidylinositol 3′‐kinase signalling is not required for normal development and function of interstitial cells of Cajal in …
      1840. Cytoskeletal reorganization induced by insulin: involvement of Grb2/Ash, Ras and Phosphatidylinositol 3‐kinase signalling
      1841. Selective pharmacological inhibitors reveal the role of Syk tyrosine kinase, phospholipase C, Phosphatidylinositol–3′-kinase, and p38 mitogen-activated protein …
      1842. Phospholipase C and Phosphatidylinositol 3‐kinase signaling are involved in the exogenous arachidonic acid‐stimulated respiratory burst in human neutrophils
      1843. Control of proteolysis by norepinephrine and insulin in brown adipocytes: role of ATP, Phosphatidylinositol 3–kinase, and p70 S6K
      1844. … papillomavirus type 1 nucleotide 3225 3′ splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the Phosphatidylinositol 3–kinase …
      1845. Gene expression of the p85α regulatory subunit of Phosphatidylinositol 3–kinase in skeletal muscle from type 2 diabetic subjects
      1846. Detection of the p110 beta subunit of Phosphatidylinositol 3–kinase complexed with neutral endopeptidase.
      1847. Phosphatidylinositol 3–kinase mediates inhibitory effect of angiotensin II on sodium/glucose cotransporter in renal epithelial cells
      1848. Involvement of signaling through protein kinase C and Phosphatidylinositol 3–kinase in the excystation and metacystic development of Entamoeba invadens
      1849. … of glial cell‐derived neurotrophic factor and cardiotrophin‐1 protects PC12 cells from injury: Involvement of the Phosphatidylinositol 3‐kinase and mitogen‐activated …
      1850. α4 integrin signaling activates Phosphatidylinositol 3–kinase and stimulates T cell adhesion to intercellular adhesion molecule-1 to a similar extent as CD3, but …
      1851. Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and Phosphatidylinositol 3–kinase by vanadyl sulfate, a protein tyrosine …
      1852. Cbl PYXXM motifs activate the P85 subunit of Phosphatidylinositol 3–kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in …
      1853. An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase by Phosphatidylinositol 3–kinase
      1854. Association between the Met326Ile Polymorphism of the p85α Regulatory Subunit of Phosphatidylinositol 3–kinase and Prostate Cancer Risk: A Prospective Study
      1855. … coli K-1 interaction with human brain micro-vascular endothelial cells triggers phospholipase C-γ1 activation downstream of Phosphatidylinositol 3–kinase
      1856. Exposure to asphalt fumes activates activator protein-1 through the Phosphatidylinositol 3–kinase/Akt signaling pathway in mouse epidermal cells
      1857. … Ethanol on the Rat Glutamate Excitatory Amino Acid Transporter Type 3 Expressed in Xenopus Oocytes: Role of Protein kinase C and Phosphatidylinositol 3‐kinase
      1858. Functional role of Phosphatidylinositol 3–kinase in direct tumor lysis by human natural killer cells
      1859. Involvement of type I protein kinase A in the differentiation of L6 myoblast in conjunction with Phosphatidylinositol 3–kinase.
      1860. … cell cycle progression through the synthesis of c-Myc protein by internal ribosome entry site–mediated translation via Phosphatidylinositol 3–kinase pathway in human …
      1861. Src tyrosine kinase-induced loss of luteinizing hormone responsiveness is via a Ras-dependent, Phosphatidylinositol–3–kinase independent pathway
      1862. A positive role of Phosphatidylinositol 3–kinase in aging phenotype expression in cultured human diploid fibroblasts
      1863. Interleukin-2 receptors and interleukin-2-mediated signaling in myelin: activation of diacylglycerol kinase and Phosphatidylinositol 3–kinase
      1864. Phosphatidylinositol 3–kinase Inhibitor Failed to Reduce Cerebral Vasospasm in Dog Model of Experimental Subarachnoid Hemorrhage
      1865. Roles of tyrosine kinase–, 1-Phosphatidylinositol 3–kinase–, and mitogen-activated protein kinase–signaling pathways in ethanol-induced contractions of rat aortic …
      1866. Activation and Phosphatidylinositol 3–kinase-dependent phosphorylation of protein kinase C-epsilon by the B cell antigen receptor
      1867. Two modes of secretion in pancreatic acinar cells: involvement of Phosphatidylinositol 3–kinase and regulation by capacitative Ca2+ entry
      1868. Lipidomic processes in homeostatic and LPS-modified cell renewal cycle. Role of Phosphatidylinositol 3–kinase pathway in biomembrane synthesis and restitution of …
      1869. … pylori Lipopolysaccharide Interference with Gastric Mucin Synthesis by Peroxisome Proliferator‐Activated Receptor γ Activation Involves Phosphatidylinositol 3‐kinase …
      1870. Defective Activation of Atypical Protein kinase C ζ and λ by Insulin and Phosphatidylinositol–3,4,5-(PO4)3 in Skeletal Muscle of Rats Following High-Fat Feeding and …
      1871. Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated Phosphatidylinositol 3–kinase pathway.
      1872. α2 Adrenoceptor‐mediated vasoconstriction in porcine palmar lateral vein: role of Phosphatidylinositol 3‐kinase and EGF receptor transactivation
      1873. … factor-beta mediated contraction of human dermal fibroblast populated lattices is inhibited by Rho/GTPase inhibitor but does not require Phosphatidylinositol–3‘kinase.
      1874. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/Phosphatidylinositol 3–kinase signaling
      1875. Phosphatidylinositol‐3 kinase p85 enhances expression from the myelin basic protein promoter in oligodendrocytes
      1876. Differential ligand recognition by the Src and Phosphatidylinositol 3–kinase Src homology 3 domains: circular dichroism and ultraviolet resonance Raman studies
      1877. The role of Phosphatidylinositol 3–kinase (PI3K) in CO2 stimulation of the Na+/HCO3-cotransporter (NBC)
      1878. Growth-inhibitory effect of Phosphatidylinositol 3–kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family.
      1879. Growth and Molecular Profile of Lung Cancer Cells Expressing Ectopic LKB1 Down-Regulation of the Phosphatidylinositol 3′-Phosphate kinase/PTEN Pathway
      1880. ARNO but not cytohesin‐1 translocation is Phosphatidylinositol 3‐kinase‐dependent in HL‐60 cells
      1881. Stimulated tyrosine phosphorylation of Phosphatidylinositol 3–kinase causes acidic pH-induced contraction in spontaneously hypertensive rat aorta
      1882. Signal transducer and activator of transcription-3 and Phosphatidylinositol–3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones
      1883. Phosphatidylinositol–3 kinase-dependent activation of Akt does not correlate with either high mitogenicity or cell migration induced by FGF-1.
      1884. The Phosphatidylinositol–3 kinase pathway is not essential for insulin-like growth factor I receptor-mediated clonogenic radioresistance
      1885. PDGF stimulates DNA synthesis in human vascular smooth muscle cells via a novel wortmannin-insensitive Phosphatidylinositol 3–kinase
      1886. Promoter polymorphisms− 359T/C and− 303A/G of the catalytic subunit p110β gene of human Phosphatidylinositol 3–kinase are not associated with insulin secretion …
      1887. Co-operation of Phosphatidylinositol transfer protein with phosphoinositide 3–kinase g in vitro
      1888. Activation of Phosphatidylinositol 3–kinase in human breast carcinoma
      1889. Cell adhesion induces the plasminogen activator inhibitor-1 gene expression through Phosphatidylinositol 3–kinase/Akt activation in anchorage dependent cells
      1890. Choline phosphate potentiates sphingosine-1-phosphate-induced Raf-1 kinase activation dependent of Ras–Phosphatidylinositol–3–kinase pathway
      1891. In the article “Phosphatidylinositol 3–kinase Is Required for the Expression But Not for the Induction or the Maintenance of Long-Term Potentiation in the Hippocampal …
      1892. … cultured with a fusion protein of insulin‐like growth factor II (IGF‐II) and interleukin 3 (IL‐3) is associated with increases in Bcl‐xL and Phosphatidylinositol‐3 kinase …
      1893. Search for a molecular determinant in Phosphatidylinositol–3–kinase molecules, involved in the interaction with the beta-gamma-G protein dimer
      1894. Expression of an active p110 catalytic subunit of Phosphatidylinositol 3‐kinase alters the proliferative capacity of interleukin‐2 receptor signals
      1895. CD40 induces human multiple myeloma cell migration via Phosphatidylinositol 3–kinase/AKT/NF-B signaling
      1896. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system: Interaction of estrogen receptor α with Phosphatidylinositol 3-OH …
      1897. Role of the Phosphatidylinositol 3 kinase-Akt
      1898. TNF-alpha induced chondrocyte apoptosis in NF-κB suppression is augmented by inhibition of p38 mitogen-activated protein kinase or Phosphatidylinositol 3–kinase
      1899. Defective Hyphal Induction of a Candida albicans Phosphatidylinositol 3-Phosphate 5-kinase Null Mutant on Solid Media Does Not Lead to Decreased Virulence
      1900. The biological effect of the Phosphatidylinositol 3–kinase wortmannin following thermal neutron irradiation
      1901. Acetylcholine-induced production of reactive oxygen species in adult rabbit ventricular myocytes is dependent on Phosphatidylinositol 3-and Src-kinase activation and …
      1902. A Role for the Phosphatidylinositol–3–kinase Pathway in Preconditioning
      1903. Roles of Phosphatidylinositol 3–kinase (PI3K) and Rac1
      1904. Roles of Phosphatidylinositol 3–kinase (PI3K) and Rac 1
      1905. Gene expression profile analysis of the Phosphatidylinositol 3–kinase pathway in the developing small intestine
      1906. Defining the physiological role of Phosphatidylinositol 3–kinase protein kinase activity
      1907. Characterisation of aggresome formation by the class III Phosphatidylinositol 3–kinase and its adaptor protein, p150.
      1908. Class IA Phosphatidylinositol 3–kinase involvement in cytoskeletal regulation
      1909. Novel age-associated induction of components of the Phosphatidylinositol–3 kinase (PI3K)/Akt signaling in the intestine
      1910. TEL/platelet-derived growth factor receptor β activates Phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle
      1911. Negative regulation of transforming growth factorbeta/SMAD by Phosphatidylinositol 3–kinase pathway in neuroblastomas
      1912. Investigating the effect of altered nutrition on signalling via Drosophila class 1A Phosphatidylinositol–3 kinase (PI3K), and functional analysis of PI3K mutated …
      1913. Connective tissue growth factor inhibits apoptosis of human hypertrophic scar fibroblasts through Phosphatidylinositol 3–kinase/protein kinase B signal pathway
      1914. Regulation of androgen receptor activity and degradation by the Phosphatidylinositol–3–kinase/Akt pathway, PTEN tumor suppressor, and Mdm2
      1915. Epidermal growth factor-induced DNA synthesis: key roles for Phosphatidylinositol 3–kinase and the adaptor protein Gab2
      1916. Requirement of BMP-2-induced Phosphatidylinositol 3–kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene …
      1917. In vivo administration of glucosamine inhibited Phosphatidylinositol 3–kinase activity without affecting tyrosine phosphorylation of the insulin receptor or insulin …
      1918. Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3–kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells
      1919. Apoptosis of differentiated HL-60 cells induced by inhibitor of Phosphatidylinositol 3–kinase
      1920. 1141. Insulin-Like Growth Factor-1 Enhances Plasmid Transgene Expression through a Phosphatidylinositol 3–kinase-Dependent Pathway
      1921. Phosphatidylinositol (3, 4, 5) P3 is essential but not sufficient for protein kinase B (PKB) activation; Phosphatidylinositol (3, 4) P2 is required for PKB …
      1922. DEFECTS IN INTERMEDIATE INSULIN SIGNALING IN SKELETAL MUSCLE: Phosphatidylinositol (PI) 3–kinase AND GLUCOSE TRANSPORT
      1923. … CANCER: ANTIMONY VERSUS TECHNETIUM-99 FILTERED SULFUR COLLOID52. THE INVOLVEMENT OF Phosphatidylinositol 3–kinase (PI3-K)/AKT …
      1924. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the Phosphatidylinositol 3–kinase pathway in vascular smooth …
      1925. Phosphatidylinositol kinase enzymes regulate the retrograde axonal transport of NT‐3 and NT‐4 in sympathetic and sensory neurons
      1926. The Role of Phosphatidylinositol 3‘-OH kinase Signaling in Mammary Tumorigenesis
      1927. Epithelial–mesenchymal transition in development and cancer: role of Phosphatidylinositol 3′ kinase/AKT pathways
      1928. The pivotal role of Phosphatidylinositol 3–kinase–Akt signal transduction in virus survival
      1929. Phosphatidylinositol 3–kinase mutations identified in human cancer are oncogenic
      1930. Targeting the Phosphatidylinositol–3 kinase/Akt pathway for the treatment of cancer.
      1931. Inhibition of Rho-kinase leads to rapid activation of Phosphatidylinositol 3–kinase/protein kinase Akt and cardiovascular protection
      1932. The prognostic significance of Phosphatidylinositol 3–kinase pathway activation in human gliomas
      1933. Exercise activates the Phosphatidylinositol 3–kinase pathway
      1934. Early involvement of the Phosphatidylinositol 3–kinase/Akt pathway in lung cancer progression
      1935. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the Phosphatidylinositol 3–kinase-Akt pathway
      1936. Cell type-specific expression of the IκB kinases determines the significance of Phosphatidylinositol 3–kinase/Akt signaling to NF-κB activation
      1937. Type I transforming growth factor β receptor binds to and activates Phosphatidylinositol 3–kinase
      1938. Phosphatidylinositol 3–kinase–Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling
      1939. Regulation of Cu/Zn-superoxide dismutase expression via the Phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-κB
      1940. The Phosphatidylinositol‐3 kinase pathway regulates bladder cancer cell invasion
      1941. Novel role for Na, K-ATPase in Phosphatidylinositol 3–kinase signaling and suppression of cell motility
      1942. Inhibition of Phosphatidylinositol 3–kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.
      1943. … growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to Phosphatidylinositol 3–kinase/AKT …
      1944. … metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and Phosphatidylinositol 3–kinase/Akt signaling pathways
      1945. Focal adhesion kinase is upstream of Phosphatidylinositol 3–kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices …
      1946. Pancreatic stellate cell migration: role of the Phosphatidylinositol 3–kinase (PI3–kinase) pathway
      1947. Inhibition of the Phosphatidylinositol 3–kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
      1948. Tobacco Carcinogen-Induced Cellular Transformation Increases Activation of the Phosphatidylinositol 3′-kinase/Akt Pathway in Vitro and in Vivo
      1949. Phosphatidylinositol–3–kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury
      1950. Activation of the Phosphatidylinositol 3–kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas …
      1951. Cutting edge: T cell development requires the combined activities of the p110γ and p110δ catalytic isoforms of Phosphatidylinositol 3–kinase
      1952. Auxin-induced reactive oxygen species production requires the activation of Phosphatidylinositol 3–kinase
      1953. Involvement of the Phosphatidylinositol 3–kinase/rac1 and cdc42 pathways in radial migration of cortical neurons
      1954. Nongenomic androgen activation of Phosphatidylinositol 3‐kinase/Akt signaling pathway in MC3T3‐E1 osteoblasts
      1955. Flavivirus activates Phosphatidylinositol 3–kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection
      1956. Activation of the pro-survival Phosphatidylinositol 3–kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p38 MAPK …
      1957. Phosphatidylinositol 3–kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization
      1958. Interleukin-18 is a pro-hypertrophic cytokine that acts through a Phosphatidylinositol 3–kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling …
      1959. The p85α subunit of Phosphatidylinositol 3′-kinase binds to and stimulates the GTPase activity of Rab proteins
      1960. Knockdown of MTP18, a novel Phosphatidylinositol 3–kinase-dependent protein, affects mitochondrial morphology and induces apoptosis
      1961. Cross-Talk between Phosphatidylinositol 3–kinase/AKT and c-Jun NH2-Terminal kinase Mediates Survival of Isolated Human Islets
      1962. Endoplasmic reticulum stress–induced apoptosis is partly mediated by reduced insulin signaling through Phosphatidylinositol 3–kinase/Akt and increased glycogen …
      1963. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the Phosphatidylinositol 3–kinase pathway
      1964. Lithium activates the Wnt and Phosphatidylinositol 3–kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors
      1965. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by Phosphatidylinositol 3–kinase/protein kinase B inhibitors
      1966. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the Phosphatidylinositol 3–kinase/Akt-dependent pathway
      1967. Activation of Phosphatidylinositol 3–kinase by cellular prion protein and its role in cell survival
      1968. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-Phosphatidylinositol 3–kinase-dependent pathway during neuronal …
      1969. Inhibition of Phosphatidylinositol 3′-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells
      1970. The Phosphatidylinositol 3–kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-β1
      1971. Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells
      1972. Latent membrane protein 2A inhibits transforming growth factor-β1-induced apoptosis through the Phosphatidylinositol 3–kinase/Akt pathway
      1973. Microglia release activators of neuronal proliferation mediated by activation of mitogen‐activated protein kinase, Phosphatidylinositol‐3‐kinase/Akt and delta–Notch …
      1974. Acanthamoeba castellanii Induces Host Cell Death via a Phosphatidylinositol 3–kinase-Dependent Mechanism
      1975. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by Phosphatidylinositol 3 kinase
      1976. Both mitogen-activated protein kinase and Phosphatidylinositol 3–kinase signalling are required in epidermal growth factor-induced human trophoblast migration
      1977. … protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and Phosphatidylinositol 3–kinase …
      1978. Ceramide-1-phosphate promotes cell survival through activation of the Phosphatidylinositol 3–kinase/protein kinase B pathway
      1979. … inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting Phosphatidylinositol 3′-kinase …
      1980. Gi-protein-dependent inhibition of IL-12 production is mediated by activation of the Phosphatidylinositol 3–kinase-protein 3 kinase B/Akt pathway and JNK
      1981. … through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the Phosphatidylinositol 3–kinase/Akt-dependent pathway
      1982. Emodin inhibits tumor cell migration through suppression of the Phosphatidylinositol 3–kinase-Cdc42/Rac1 pathway
      1983. Inhibition of Phosphatidylinositol 3–kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment
      1984. … Induces Rapid Activation of Akt/Protein kinase B-Mammalian Target of Rapamycin-p70S6K Cascade through Phosphatidylinositol 3–kinase in Human Fibroblasts
      1985. REDD1 integrates hypoxia-mediated survival signaling downstream of Phosphatidylinositol 3–kinase
      1986. Mechanisms of erythropoietin‐mediated cardioprotection during ischemia‐reperfusion injury: role of protein kinase C and Phosphatidylinositol 3‐kinase signaling
      1987. Sequential Activation of Phosphatidylinositol 3–kinase, βPix, Rac1, and Nox1 in Growth Factor-Induced Production of H2O2
      1988. Production of matrix metalloproteinase‐9 by activated human monocytes involves a Phosphatidylinositol‐3 kinase/Akt/IKKα/NF‐κB pathway
      1989. Isoflurane protects against myocardial infarction during early reperfusion by activation of Phosphatidylinositol–3–kinase signal transduction: evidence for anesthetic …
      1990. … progenitors and differentiated osteoblasts by β-catenin-dependent and-independent signaling cascades involving Src/ERK and Phosphatidylinositol 3–kinase …
      1991. Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the Phosphatidylinositol 3–kinase/mTOR pathway
      1992. Human placental growth hormone increases expression of the p85 regulatory unit of Phosphatidylinositol 3–kinase and triggers severe insulin resistance in skeletal …
      1993. Induction of androgen receptor expression by Phosphatidylinositol 3–kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP …
      1994. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and Phosphatidylinositol 3–kinase/Akt signaling
      1995. WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of Phosphatidylinositol 3–kinase
      1996. Role of Phosphatidylinositol 3–kinase in the development of hepatocyte preconditioning
      1997. Overexpression of NBS1 contributes to transformation through the activation of Phosphatidylinositol 3–kinase/Akt
      1998. TGF-β1 represses activation and resultant death of microglia via inhibition of Phosphatidylinositol 3–kinase activity
      1999. Inhibition of Phosphatidylinositol 3–kinase amplifies TEGDMA-induced apoptosis in primary human pulp cells
      2000. Mutant epidermal growth factor receptor displays increased signaling through the Phosphatidylinositol–3 kinase/AKT pathway and promotes radioresistance in cells of …
      2001. Atypical protein kinase C (PKCζ/λ) is a convergent downstream target of the insulin-stimulated Phosphatidylinositol 3–kinase and TC10 signaling pathways
      2002. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of Phosphatidylinositol 3–kinase and Syk-mediated pathways
      2003. Modulation of Phosphatidylinositol‐3‐kinase/protein kinase B‐and mitogen‐activated protein kinase‐pathways by tea polyphenols in human prostate cancer cells
      2004. Inhibition of Phosphatidylinositol–3–kinase causes increased sensitivity to radiation through a PKB-dependent mechanism
      2005. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the Phosphatidylinositol 3–kinase/AKT-signaling pathway
      2006. Akt2, a novel functional link between p38 mitogen-activated protein kinase and Phosphatidylinositol 3–kinase pathways in myogenesis
      2007. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase-and Phosphatidylinositol 3–kinase-dependent signaling pathways
      2008. Regulation of heme oxygenase-1 expression through the Phosphatidylinositol 3–kinase/Akt pathway and the Nrf2 transcription factor in response to the …
      2009. Mammalian target of rapamycin positively regulates collagen type I production via a Phosphatidylinositol 3–kinase-independent pathway
      2010. Alteration of Phosphatidylinositol 3–kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL)
      2011. Aging is associated with decreased pancreatic acinar cell regeneration and Phosphatidylinositol 3–kinase/Akt activation
      2012. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the Phosphatidylinositol 3–kinase/Akt/mammalian target of rapamycin (PI3K …
      2013. PIKE (Phosphatidylinositol 3–kinase enhancer)-A GTPase stimulates Akt activity and mediates cellular invasion
      2014. Se-methylselenocysteine inhibits Phosphatidylinositol 3–kinase activity of mouse mammary epithelial tumor cells in vitro
      2015. CXCL16 signals via Gi, Phosphatidylinositol 3–kinase, Akt, IκB kinase, and nuclear factor-κB and induces cell-cell adhesion and aortic smooth muscle cell …
      2016. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-Phosphatidylinositol 3′-kinase signaling …
      2017. WNK1 activates SGK1 by a Phosphatidylinositol 3–kinase-dependent and non-catalytic mechanism
      2018. Phosphatidylinositol 3–kinase-Mediated Effects of Glucose on Vacuolar H+-ATPase Assembly, Translocation, and Acidification of Intracellular Compartments in Renal …
      2019. The Phosphatidylinositol–3–kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell …
      2020. … protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the Phosphatidylinositol 3–kinase/Akt antiapoptotic pathway
      2021. Transforming growth factor-β activation of Phosphatidylinositol 3–kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated …
      2022. Isoflurane-induced myocardial preconditioning is dependent on Phosphatidylinositol–3–kinase/Akt signalling
      2023. PTEN, but not SHIP2, suppresses insulin signaling through the Phosphatidylinositol 3–kinase/Akt pathway in 3T3-L1 adipocytes
      2024. Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of Phosphatidylinositol 3–kinase/AKT kinase
      2025. … stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of Phosphatidylinositol 3–kinase
      2026. Phosphatidylinositol 3–kinase C2α is essential for ATP-dependent priming of neurosecretory granule exocytosis
      2027. … -macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and Phosphatidylinositol 3–kinase/Akt
      2028. Phosphatidylinositol 3–kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients
      2029. Presenilins mediate Phosphatidylinositol 3–kinase/AKT and ERK activation via select signaling receptors: selectivity of PS2 in platelet-derived growth factor …
      2030. Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by Phosphatidylinositol 3–kinase and cytohesin-1
      2031. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a Phosphatidylinositol 3–kinase/Akt and p38 kinase-dependent STAT3 …
      2032. Phosphatidylinositol 3‐kinase and Akt effectors mediate insulin‐like growth factor‐I neuroprotection in dorsal root ganglia neurons
      2033. Transformation potential of Ras isoforms correlates with activation of Phosphatidylinositol 3–kinase but not ERK
      2034. Hypoxia-induced activation of p38 mitogen-activated protein kinase and Phosphatidylinositol 3′-kinase signaling pathways contributes to expression of interleukin 8 …
      2035. Participation of prolactin receptors and Phosphatidylinositol 3–kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to …
      2036. … ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and Phosphatidylinositol 3–kinase/Akt
      2037. A3 adenosine receptor activation inhibits cell proliferation via Phosphatidylinositol 3–kinase/Akt-dependent inhibition of the extracellular signal-regulated …
      2038. … -I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and Phosphatidylinositol 3–kinase …
      2039. … affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through Phosphatidylinositol 3–kinase …
      2040. Increased phosphorylation of AKAP by inhibition of Phosphatidylinositol 3–kinase enhances human sperm motility through tail recruitment of protein kinase A
      2041. Vacuolar H+-ATPase binding to microfilaments: regulation in response to Phosphatidylinositol 3–kinase activity and detailed characterization of the actin …
      2042. Inhibition of Phosphatidylinositol 3–kinase modifies boar sperm motion parameters
      2043. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the Phosphatidylinositol 3–kinase-Akt pathway
      2044. Phosphatidylinositol 3–kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas
      2045. Phosphatidylinositol 3–kinase/Akt regulates angiotensin II–induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and …
      2046. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the Phosphatidylinositol 3–kinase pathway: role of upstream stimulatory factor
      2047. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the Phosphatidylinositol 3–kinase/Akt and Raf/ERK pathways transmit …
      2048. … induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the Phosphatidylinositol 3–kinase/PTEN/AKT/mammalian …
      2049. Phosphatidylinositol 3–kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression
      2050. Zn2+ inhibits mitochondrial movement in neurons by Phosphatidylinositol 3–kinase activation
      2051. … activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/Phosphatidylinositol 3–kinase …
      2052. Activation of Phosphatidylinositol 3–kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and …
      2053. Platelet-derived growth factor stimulates membrane lipid synthesis through activation of Phosphatidylinositol 3–kinase and sterol regulatory element-binding …
      2054. Phosphatidylinositol 3–kinase is involved in α2 (I) collagen gene expression in normal and scleroderma fibroblasts
      2055. IGF-I inhibits apoptosis through the activation of the Phosphatidylinositol 3–kinase/Akt pathway in pituitary cells
      2056. Phosphatidylinositol 3–kinase Offsets cAMP-Mediated Positive Inotropic Effect via Inhibiting Ca2+ Influx in Cardiomyocytes
      2057. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via Phosphatidylinositol 3 kinase and ligand-independent …
      2058. Lipoteichoic acid induces nuclear factor‐κB activation and nitric oxide synthase expression via Phosphatidylinositol 3‐kinase, Akt, and p38 MAPK in RAW 264.7 …
      2059. Glucocorticoid receptor counteracts tumorigenic activity of Akt in skin through interference with the Phosphatidylinositol 3–kinase signaling pathway
      2060. Phosphatidylinositol–3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells
      2061. Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of Phosphatidylinositol 3–kinase/AKT/GSK-3β …
      2062. … -dependent insulinotropic polypeptide (GIP) stimulation of pancreatic β-cell survival is dependent upon Phosphatidylinositol 3–kinase (PI3K)/protein kinase B …
      2063. Role of the Phosphatidylinositol 3′-kinase–Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines
      2064. Signal regulatory protein α ligation induces macrophage nitric oxide production through JAK/STAT-and Phosphatidylinositol 3–kinase/Rac1/NAPDH oxidase/H2O2 …
      2065. Stable activation of Phosphatidylinositol 3–kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control
      2066. Activation of the Phosphatidylinositol 3–kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells
      2067. Hyaluronic acid induces osteopontin via the Phosphatidylinositol 3–kinase/Akt pathway to enhance the motility of human glioma cells
      2068. … regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via Phosphatidylinositol 3–kinase/AKT signaling pathway …
      2069. CD28 regulates the translation of Bcl-xL via the Phosphatidylinositol 3–kinase/mammalian target of rapamycin pathway
      2070. Impaired activation of Phosphatidylinositol 3–kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity
      2071. Regulation of cholinergic gene expression by nerve growth factor depends on the Phosphatidylinositol‐3′‐kinase pathway
      2072. Inhibition of Phosphatidylinositol 3′-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway
      2073. Nickel Compounds Act through Phosphatidylinositol–3–kinase/Akt-Dependent, p70S6k-Independent Pathway to Induce Hypoxia Inducible Factor Transactivation and …
      2074. Enteric neuroblasts require the Phosphatidylinositol 3–kinase/Akt/Forkhead pathway for GDNF-stimulated survival
      2075. Differential activation of the Phosphatidylinositol 3′-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells
      2076. Activation of Rac1 by Phosphatidylinositol 3‐kinase in vivo: role in activation of mitogen‐activated protein kinase (MAPK) pathways and retinoic acid‐induced …
      2077. Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a Phosphatidylinositol 3–kinase-dependent chromatin-remodeling …
      2078. Insulin generates free radicals by an NAD (P) H, Phosphatidylinositol 3′-kinase-dependent mechanism in human skin fibroblasts ex vivo
      2079. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a Phosphatidylinositol 3–kinase/ERK-dependent and Akt …
      2080. Phosphatidylinositol 3–kinase and frabin mediate Cryptosporidium parvum cellular invasion via activation of Cdc42
      2081. … /human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-Phosphatidylinositol 3–kinase-rho GTPase signal pathways …
      2082. Nerve growth factor promotes the survival of sympathetic neurons through the cooperative function of the protein kinase C and Phosphatidylinositol 3–kinase …
      2083. Roles of the Ras-MEK-mitogen-activated protein kinase and Phosphatidylinositol 3–kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation …
      2084. Inhibition of p38 mitogen-activated protein kinase and Phosphatidylinositol 3–kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 …
      2085. … induces proliferation, migration, and TGF-β1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and Phosphatidylinositol 3–kinase
      2086. p38 and EGF receptor kinase-mediated activation of the Phosphatidylinositol 3–kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression
      2087. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the Phosphatidylinositol 3–kinase/AKT/Ras homolog enriched in brain (Rheb) …
      2088. … line-derived neurotrophic factor increases intracellular calcium concentration: role of calcium/calmodulin in the activation of the Phosphatidylinositol 3–kinase …
      2089. Reciprocal control of Forkhead box O 3a and c-Myc via the Phosphatidylinositol 3–kinase pathway coordinately regulates p27Kip1 levels
      2090. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and Phosphatidylinositol 3–kinase cascades and requires …
      2091. … box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/Phosphatidylinositol 3–kinase/Akt signaling pathway
      2092. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via Phosphatidylinositol 3–kinase/Akt/nuclear factor-κB cascade …
      2093. … is enhanced by N-methyl-D-aspartate receptor activation: essential role of a TNF receptor 2-mediated Phosphatidylinositol 3–kinase-dependent NF-κB …
      2094. LY294002 inhibits LPS-induced NO production through a inhibition of NF-κB activation: independent mechanism of Phosphatidylinositol 3–kinase
      2095. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal–regulated kinase 1/2 and Phosphatidylinositol 3–kinase pathways
      2096. A late, prolonged activation of the Phosphatidylinositol 3–kinase pathway is required for T cell proliferation
      2097. Morphine enhances isoflurane-induced postconditioning against myocardial infarction: the role of Phosphatidylinositol–3–kinase and opioid receptors in rabbits
      2098. Calcium-induced Human Keratinocyte Differentiation Requires src- and fyn-mediated Phosphatidylinositol 3–kinase–dependent Activation of Phospholipase C-γ1
      2099. FGF-2 induced by interleukin-1β through the action of Phosphatidylinositol 3–kinase mediates endothelial mesenchymal transformation in corneal endothelial …
      2100. … of peroxisome proliferator-activated receptor-γ by insulin and C-peptide in kidney proximal tubular cells: dependent on Phosphatidylinositol 3–kinase activity
      2101. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the Phosphatidylinositol 3–kinase/Akt and MEK/ERK1/2 pathways
      2102. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the Phosphatidylinositol–3 kinase-dependent pathway in canine hearts
      2103. FSH activates Phosphatidylinositol 3–kinase/protein kinase B signaling pathway in 20-day-old Sertoli cells independently of IGF-I
      2104. Dexamethasone suppresses antigen-induced activation of Phosphatidylinositol 3–kinase and downstream responses in mast cells
      2105. Inhibition of the Phosphatidylinositol 3–kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung …
      2106. Apoptosis and inhibition of the Phosphatidylinositol 3–kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone
      2107. Identification of transcription factor binding sites upstream of human genes regulated by the Phosphatidylinositol 3–kinase and MEK/ERK signaling pathways
      2108. Up-regulation of endothelial nitric oxide synthase via Phosphatidylinositol 3–kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil …
      2109. TRAIL-induced apoptosis in human vascular endothelium is regulated by Phosphatidylinositol 3–kinase/Akt through the short form of cellular FLIP and Bcl-2
      2110. Topical treatment with inhibitors of the Phosphatidylinositol 3′-kinase/Akt and Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase …
      2111. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and Phosphatidylinositol 3–kinase signaling
      2112. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by Phosphatidylinositol–3 kinase/Akt in HER2 overexpressing cells
      2113. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through Phosphatidylinositol 3′-kinase/Akt, heat shock protein …
      2114. FasL (CD95L/APO-1L) resistance of neurons mediated by Phosphatidylinositol 3–kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane …
      2115. A role for Phosphatidylinositol 3–kinase in TCR-stimulated ERK activation leading to paxillin phosphorylation and CTL degranulation
      2116. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells: only Phosphatidylinositol 3′-kinase is important
      2117. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by Phosphatidylinositol 3–kinase/AKT signaling
      2118. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated Phosphatidylinositol 3–kinase/Akt/GSK-3β signaling and leads to an …
      2119. Trophic signals acting via Phosphatidylinositol–3 kinase are required for normal pre-implantation mouse embryo development
      2120. Human mesothelioma cells exhibit tumor cell–specific differences in Phosphatidylinositol 3–kinase/AKT activity that predict the efficacy of Onconase
      2121. … lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of Phosphatidylinositol 3–kinase but not Akt …
      2122. Inhibition of Phosphatidylinositol 3–kinase-and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells
      2123. HIV‐1 gp120‐induced TNF‐α production by primary human macrophages is mediated by Phosphatidylinositol‐3 (PI‐3) kinase and mitogen‐activated protein (MAP) …
      2124. … proliferator-activated receptor-γ by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a Phosphatidylinositol 3′-kinase …
      2125. A linear signal transduction pathway involving Phosphatidylinositol 3–kinase, protein kinase Cϵ, and MAPK in mesangial cells regulates interferon-γ-induced …
      2126. Inhibition of Phosphatidylinositol 3–kinase/Akt and histone deacetylase activity induces apoptosis in non–small cell lung cancer in vitro and in vivo
      2127. Interaction and functional analyses of human VPS34/p150 Phosphatidylinositol 3‐kinase complex with Rab7
      2128. The pro-inflammatory mediator leukotriene D4 induces Phosphatidylinositol 3–kinase and Rac-dependent migration of intestinal epithelial cells
      2129. … -Induced Oocyte Maturation in Atlantic Croaker (Micropogonias undulatus) Is Dependent on Activation of the Phosphatidylinositol 3–kinase/Akt Signal Transduction …
      2130. Inhibition of the Phosphatidylinositol 3′-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes
      2131. Treating breast cancer through novel inhibitors of the Phosphatidylinositol 3‘-kinase pathway
      2132. Phosphatidylinositol 3‐kinase and Akt participate in the FSH‐induced meiotic maturation of mouse oocytes
      2133. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits Phosphatidylinositol 3–kinase through binding to PIKE-L
      2134. Activation of Phosphatidylinositol 3–kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast …
      2135. The magnitude of Akt/Phosphatidylinositol 3′-kinase proliferating signaling is related to CD45 expression in human myeloma cells
      2136. Response of Non–Small Cell Lung Cancer Cells to the Inhibitors of Phosphatidylinositol 3–kinase/Akt- and MAPK kinase 4/c-Jun NH2-Terminal kinase Pathways …
      2137. RhoA activation mediates Phosphatidylinositol 3–kinase–dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft …
      2138. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the Phosphatidylinositol 3–kinase/protein kinase A/c-Raf …
      2139. … substrate metabolism of mouse cumulus-oocyte complexes: response to follicle-stimulating hormone is mediated by the Phosphatidylinositol 3–kinase pathway and is …
      2140. A Rac1/Phosphatidylinositol 3–kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide …
      2141. Protein phosphatase-2Cα as a positive regulator of insulin sensitivity through direct activation of Phosphatidylinositol 3–kinase in 3T3-L1 adipocytes
      2142. Suppression of Phosphatidylinositol 3–kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung …
      2143. Phosphatidylinositol 3–kinase signaling is involved in neurogenesis during Xenopus embryonic development
      2144. Phosphatidylinositol‐3 kinase is distinctively required for µ‐, but not κ‐opioid receptor‐induced activation of c‐Jun N‐terminal kinase
      2145. AMPA protects cultured neurons against glutamate excitotoxicity through a Phosphatidylinositol 3‐kinase‐dependent activation in extracellular signal‐regulated …
      2146. N-WASP and WAVE2 acting downstream of Phosphatidylinositol 3–kinase are required for myogenic cell migration induced by hepatocyte growth factor
      2147. Differential sensitivity of Phosphatidylinositol 3–kinase p110γ to isoforms of G protein βγ dimers
      2148. Epidermal growth factor stimulation of RPE cell survival: contribution of Phosphatidylinositol 3–kinase and mitogen-activated protein kinase pathways
      2149. PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits Phosphatidylinositol 3–kinase signaling and suppresses growth of solid tumors
      2150. Phosphatidylinositol 3–kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation
      2151. Post-ischemic cardioprotection by A2A adenosine receptors: dependent of Phosphatidylinositol 3–kinase pathway
      2152. Calorie restriction increases the ratio of Phosphatidylinositol 3–kinase catalytic to regulatory subunits in rat skeletal muscle
      2153. nitric oxide triggers the Phosphatidylinositol 3–kinase/Akt survival pathway in insulin-producing RINm5F cells by arousing Src to activate insulin receptor substrate-1
      2154. Phosphatidylinositol 3–kinase regulates thymic exit
      2155. … Group A2 Potentiates Genotoxic Stress in Part through the Modulation of Basal and DNA Damage–Dependent Phosphatidylinositol 3–kinase–Related Protein kinase …
      2156. Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for Phosphatidylinositol 3‐kinase inhibition
      2157. Pulmonary surfactant protein A activates a Phosphatidylinositol 3–kinase/calcium signal transduction pathway in human macrophages: participation in the up …
      2158. Novel mechanism of interaction of p85 subunit of Phosphatidylinositol 3–kinase and ErbB3 receptor-derived phosphotyrosyl peptides
      2159. Role for the pleckstrin homology domain-containing protein CKIP-1 in Phosphatidylinositol 3–kinase-regulated muscle differentiation
      2160. VEGF165 and angiopoietin-1 decreased myocardium infarct size through Phosphatidylinositol–3 kinase and Bcl-2 pathways
      2161. Hypothalamic Phosphatidylinositol 3‐kinase‐phosphodiesterase 3B‐cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion
      2162. Akt2, Phosphatidylinositol 3–kinase, and PTEN are in lipid rafts of intestinal cells: role in absorption and differentiation
      2163. CD40/CD40 homodimers are required for CD40-induced Phosphatidylinositol 3–kinase-dependent expression of B7. 2 by human B lymphocytes
      2164. A permissive role for Phosphatidylinositol 3–kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor
      2165. Epidermal growth factor–induced cyclooxygenase-2 expression is mediated through Phosphatidylinositol–3 kinase, not mitogen-activated protein/extracellular signal …
      2166. The Phosphatidylinositol 3–kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) …
      2167. Differential regulation of Phosphatidylinositol 3–kinase/Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced …
      2168. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via Phosphatidylinositol 3–kinase
      2169. Costimulation by CD137/4–1BB inhibits T cell apoptosis and induces Bcl‐xL and c‐FLIPshort via Phosphatidylinositol 3‐kinase and AKT/protein kinase B
      2170. A specific antagonist of the p110δ catalytic component of Phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction
      2171. The role of phospholipase C and Phosphatidylinositol 3–kinase in vascular smooth muscle cell migration and proliferation
      2172. … hydroxy estradiol induces expression of hypoxia-inducible factor 1α and vascular endothelial growth factor A through Phosphatidylinositol 3–kinase/Akt/FRAP pathway …
      2173. … class I antibodies confers resistance to endothelial cells against antibody complement‐mediated lysis by regulating Bad through the Phosphatidylinositol 3‐kinase/Akt …
      2174. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and Phosphatidylinositol 3–kinase but not extracellularly regulated …
      2175. SH2-B promotes insulin receptor substrate 1 (IRS1)-and IRS2-mediated activation of the Phosphatidylinositol 3–kinase pathway in response to leptin
      2176. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not Phosphatidylinositol 3–kinase-Akt signaling is responsible for fibroblast growth factor-9 …
      2177. … -induced signaling pathway in endothelial cells resulting in the overexpression of vascular endothelial growth factor involves Ras and Phosphatidylinositol 3–kinase
      2178. Low [Mg2+]e Enhances Arterial Spontaneous Tone via Phosphatidylinositol 3–kinase in DOCA-Salt Hypertension
      2179. Inhibition of either Phosphatidylinositol 3–kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer …
      2180. Phosphatidylinositol 3–kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival
      2181. … -δ12, 14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in Phosphatidylinositol 3–kinase-akt-NF-κB …
      2182. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via Phosphatidylinositol 3–kinase in glutamate-induced apoptosis of rat …
      2183. Comparison of Phosphatidylinositol–3–kinase signalling within a panel of human colorectal cancer cell lines with mutant or wild-type PIK3CA
      2184. Gαq inhibits cardiac L-type Ca2+ channels through Phosphatidylinositol 3–kinase
      2185. The influence of Phosphatidylinositol 3‐kinase/Akt pathway on the ischemic injury during rat liver graft preservation
      2186. … ‐stimulating factor‐, or IL‐3‐dependent survival of macrophages, but not proliferation, requires the expression of p21Waf1 through the Phosphatidylinositol 3‐kinase …
      2187. RhoA controls myoblast survival by inducing the Phosphatidylinositol 3‐kinase‐Akt signaling pathway
      2188. Functional integrity of nuclear factor κB, Phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor α-evoked Bcl-2 …
      2189. Phosphatidylinositol 3–kinase, phosphoinositide-specific phospholipase-Cγ and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 …
      2190. M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2–Sos association and Phosphatidylinositol 3–kinase …
      2191. … Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-α production through inhibition of Phosphatidylinositol 3–kinase/Akt activation in …
      2192. Activation of nuclear factor kappa B by diesel exhaust particles in mouse epidermal cells through Phosphatidylinositol 3–kinase/Akt signaling pathway
      2193. Phosphatidylinositol 3–kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation
      2194. Phosphatidylinositol 3–kinase inhibitors reveal a unique mechanism of enhancing insulin secretion in 832/13 rat insulinoma cells
      2195. The integrin β1 subunit transmembrane domain regulates Phosphatidylinositol 3–kinase-dependent tyrosine phosphorylation of Crk-associated substrate
      2196. Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll‐like receptor 2, and Phosphatidylinositol‐3‐kinase
      2197. cAMP-stimulated Na+ transport in H441 distal lung epithelial cells: role of PKA, Phosphatidylinositol 3–kinase, and sgk1
      2198. Roles of Phosphatidylinositol 3′-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial …
      2199. … regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the Phosphatidylinositol 3–kinase …
      2200. … cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, Phosphatidylinositol 3–kinase, Akt, c-Jun …
      2201. … Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3–kinase/Akt/Mammalian Target of …
      2202. Phosphatidylinositol 3–kinase inhibitors are a triple threat to ovarian cancer
      2203. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related Phosphatidylinositol 3–kinase/Akt and p38 mitogen …
      2204. Role of Phosphatidylinositol 3–kinase-γ in mediating lung neutrophil sequestration and vascular injury induced by E. coli sepsis
      2205. Aquaporin-2 is retrieved to the apical storage compartment via early endosomes and Phosphatidylinositol 3–kinase-dependent pathway
      2206. Regulation of granulocyte apoptosis by Phosphatidylinositol 3–kinase
      2207. … in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or Phosphatidylinositol 3–kinase
      2208. Phosphatidylinositol 3–kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers
      2209. Control of cell size through phosphorylation of upstream binding factor 1 by nuclear Phosphatidylinositol 3–kinase
      2210. Activation of Phosphatidylinositol 3‐kinase and c‐Jun‐N‐terminal kinase cascades enhances NF‐κB‐dependent gene transcription in BCG‐stimulated macrophages …
      2211. Mouse embryonic stem cells and preimplantation embryos require signaling through the Phosphatidylinositol 3‐kinase pathway to suppress apoptosis
      2212. Opposing roles of endothelial and smooth muscle Phosphatidylinositol 3–kinase in vasoconstriction: effects of rho-kinase and hypertension
      2213. … -independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of Phosphatidylinositol 3–kinase/protein kinase Akt …
      2214. Muscarinic M2 receptor stimulation of Cav1. 2b requires Phosphatidylinositol 3–kinase, protein kinase C, and c-Src
      2215. Vav-dependent and vav-independent Phosphatidylinositol 3–kinase activation in murine B cells determined by the nature of the stimulus
      2216. … of the heavy chain of tetanus toxin rescues cerebellar granule neurones from apoptotic death: involvement of Phosphatidylinositol 3‐kinase and mitogen‐activated …
      2217. Phosphatidylinositol 3–kinase/Akt pathway mediates heme oxygenase-1 regulation by lipopolysaccharide.
      2218. Possible involvement of Phosphatidylinositol 3–kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts
      2219. Deregulation of the Phosphatidylinositol–3 kinase signaling cascade is associated with neurodegeneration in Npc1−/− mouse brain
      2220. Hydrogen peroxide and epidermal growth factor activate Phosphatidylinositol 3–kinase and increase sodium transport in A6 cell monolayers
      2221. Involvement of Phosphatidylinositol 3–kinase and insulin-like growth factor-I in YXLST-mediated neuroprotection
      2222. Survivin contributes to the anti-apoptotic activities of transforming growth factor alpha in mouse blastocysts through Phosphatidylinositol 3‘-kinase pathway
      2223. … inhibits β-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and Phosphatidylinositol 3–kinase …
      2224. Phosphatidylinositol 3‐kinase inhibition enhances human sperm motility and sperm–zona pellucida binding
      2225. Modulation of Phosphatidylinositol 3–kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts
      2226. α1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol–3 kinase-, and Atypical Protein kinase C …
      2227. Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and Phosphatidylinositol 3‐kinase signalling and cell proliferation in serum‐deprived …
      2228. … via modulation of involucrin and transglutaminase expression through the integrin α3β1 and the Phosphatidylinositol 3–kinase/Akt signaling pathway
      2229. Phosphatidylinositol 3–kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and-dependent …
      2230. … -1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the Phosphatidylinositol 3–kinase/protein kinase B …
      2231. Mammalian target of rapamycin and 3–Phosphatidylinositol 3–kinase pathway inhibition enhances growth inhibition of transforming growth factor-β1 in prostate cancer …
      2232. Fibroblast growth factor-2 induces osteoblast survival through a Phosphatidylinositol 3–kinase-dependent,-β-catenin-independent signaling pathway
      2233. Activation of MMP-2 in response to vascular injury is mediated by Phosphatidylinositol 3–kinase-dependent expression of MT1-MMP
      2234. Adhesion-independent α6β4 integrin clustering is mediated by Phosphatidylinositol 3–kinase
      2235. … -induced integrin affinity maturation promotes recruitment of αVβ3 integrin to focal adhesions in endothelial cells: Evidence for a role of Phosphatidylinositol 3–kinase …
      2236. NGF-induced Phosphatidylinositol 3–kinase signaling pathway prevents thapsigargin-triggered ER stress-mediated apoptosis in PC12 cells
      2237. Optimal windows of statin use for immediate infarct limitation: 5′-nucleotidase as another downstream molecule of Phosphatidylinositol 3–kinase
      2238. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-Phosphatidylinositol 3–kinase signaling involves pleiotropic oncogenic …
      2239. Phosphatidylinositol 3–kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene
      2240. Transient Phosphatidylinositol 3–kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal …
      2241. Exogenous tissue inhibitor of metalloproteinase‐1 promotes endothelial cell survival through activation of the Phosphatidylinositol 3‐kinase/Akt pathway
      2242. Phosphatidylinositol 3–kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle
      2243. Enhancement of osteopontin expression in HepG2 cells by epidermal growth factor via Phosphatidylinositol 3–kinase signaling pathway
      2244. Cloning of Brassica napus phospholipase C2 (BnPLC2), Phosphatidylinositol 3–kinase (BnVPS34) and Phosphatidylinositol synthase1 (BnPtdIns S1)—comparative …
      2245. Biochemical and biological responses induced by coupling of Gab1 to Phosphatidylinositol 3–kinase in RET-expressing cells
      2246. … receptor β/δ (PPARβ/δ) increases the expression of prostaglandin E2 receptor subtype EP4: the roles of Phosphatidylinositol 3–kinase and CCAAT/enhancer …
      2247. Phosphatidylinositol 3–kinase p85α subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological …
      2248. α-Thrombin-mediated Phosphatidylinositol 3–kinase activation through release of Gβγ dimers from Gαq and Gαi2
      2249. Angiotensin II Regulation of the Na+ Pump Involves the Phosphatidylinositol–3 kinase and p42/44 Mitogen-Activated Protein kinase Signaling Pathways in Vascular …
      2250. Resensitization of P2Y Receptors by Growth Factor–Mediated Activation of the Phosphatidylinositol–3 kinase in Retinal Glial Cells
      2251. Upregulated function of Phosphatidylinositol‐3‐kinase in genetically hypertensive rats: a moderator of arterial hypercontractility
      2252. Adenosine A2A receptor facilitates calcium-dependent protein secretion through the activation of protein kinase A and Phosphatidylinositol–3 kinase in PC12 cells
      2253. … , a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing Phosphatidylinositol 3–kinase activity in human …
      2254. Leptin decreases renal medullary Na (+), K (+)-ATPase activity through Phosphatidylinositol 3–kinase dependent mechanism.
      2255. Differential involvement of Phosphatidylinositol 3–kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic …
      2256. … epidermal growth factor‐like growth factor stimulates cell proliferation in cerebral cortical cultures through Phosphatidylinositol 3′‐kinase and mitogen‐activated …
      2257. Two distinct regulatory mechanisms of neurotransmitter release by Phosphatidylinositol 3‐kinase
      2258. AND-34 Activates Phosphatidylinositol 3–kinase and Induces Anti-Estrogen Resistance in a SH2 and GDP Exchange Factor–Like Domain-Dependent Manner
      2259. Calcium oscillation and Phosphatidylinositol 3–kinase positively regulate integrin αIIbβ3-mediated outside-in signaling
      2260. Overexpression of the N-terminal end of the p55γ regulatory subunit of Phosphatidylinositol 3–kinase blocks cell cycle progression in gastric carcinoma cells
      2261. Inhibition of Phosphatidylinositol–3–kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria
      2262. … neurones by brain‐derived neurotrophic factor and Raf‐1 protein kinase: role of extracellular signal‐regulated protein kinase and Phosphatidylinositol 3‐kinase
      2263. Phosphatidylinositol–3–kinase activation mediates proline-rich tyrosine kinase 2 phosphorylation and recruitment to β1-integrins in human CD34+ cells
      2264. Angiopoietin-1 attenuates H2O2-induced SEK1/JNK phosphorylation through the Phosphatidylinositol 3–kinase/Akt pathway in vascular endothelial cells
      2265. RNA interference, A potential strategy for isoform-specific Phosphatidylinositol 3–kinase targeted therapy in ovarian cancer
      2266. Expression of insulin receptor substrates 1-3, glucose transporters GLUT-1-4, signal regulatory protein 1α, Phosphatidylinositol 3–kinase and protein kinase B at the …
      2267. Phosphatidylinositol 3–kinase regulates Ca2+ signaling in pancreatic acinar cells through inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase
      2268. In vitro metabolism of the Phosphatidylinositol 3–kinase inhibitor, wortmannin, by carbonyl reductase
      2269. Interleukin-2-induced survival of natural killer (NK) cells involving Phosphatidylinositol–3 kinase-dependent reduction of ceramide through acid sphingomyelinase …
      2270. T cell leukemia-1 modulates TCR signal strength and IFN-γ levels through Phosphatidylinositol 3–kinase and protein kinase C pathway activation
      2271. Adenosine A3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via Phosphatidylinositol–3′-kinase
      2272. Negative Feedback Regulation of Phosphatidylinositol 3‐kinase/Akt Pathway by Over‐Expressed Cyclooxygenase‐2 in Human Epidermal Cancer Cells
      2273. Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the Phosphatidylinositol 3–kinase and Akt pathway
      2274. Phosphatidylinositol 3–kinase/Akt-dependent and-independent protection against apoptosis in normal human melanocytes
      2275. Generation and functional in vivo characterization of a lipid kinase defective Phosphatidylinositol 3–kinase Vps34p of Candida albicans
      2276. Phosphatidylinositol‐3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells
      2277. … adhesion is controlled by src-kinases, whereas PF-4–mediated exocytosis requires the additional activation of p38 MAP kinase and Phosphatidylinositol 3–kinase
      2278. Prolactin and heregulin override DNA damage-induced growth arrest and promote Phosphatidylinositol–3 kinase-dependent proliferation in breast cancer cells
      2279. Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through Phosphatidylinositol 3–kinase–AKT pathway